| Date | KEGG | ATC | Active ingredient | Drug name | Company | Remark* | |
| 2024/11/15 | J07BB02 | influenza vaccine (surface antigen, inactivated, adjuvanted) | Fluad | Seqirus Netherlands B.V. | |||
| 2024/11/15 | J07BB02 | influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | Flucelvax | Seqirus Netherlands B.V. | |||
| 2024/11/14 | D08976 | L04AX06 | Pomalidomide | Pomalidomide Teva | Teva GmbH | G | |
| 2024/9/27 | D12963 | C02KX54 | Macitentan and tadalafil | Yuvanci | Janssen-Cilag International NV | ||
| 2024/9/25 | D09214 | L04AC05 | Ustekinumab | Fymskina | Formycon AG | ||
| 2024/9/25 | D09214 | L04AC05 | Ustekinumab | Otulfi | Fresenius Kabi Deutschland GmbH | B | |
| 2024/9/19 | D00184 | S01XA18 | Ciclosporin | Vevizye | Novaliq GmbH | ||
| 2024/9/19 | D05697 | S01LA04 | Ranibizumab | Ranibizumab Midas | Midas Pharma GmbH | B | |
| 2024/9/19 | D03218 | L01EK01 | Axitinib | Axitinib Accord | Accord Healthcare S.L.U. | G | |
| 2024/9/19 | D03257 | L01FD01 | Trastuzumab | Tuznue | Prestige Biopharma Belgium | ||
| 2024/9/19 | D12202 | L01FF13 | Toripalimab | Loqtorzi | TMC Pharma (EU) Limited | BLA | |
| 2024/9/19 | D11046 | D11AH11 | Delgocitinib | Anzupgo | LEO Pharma A/S | NME | |
| 2024/9/19 | D11527 | (L01FX31) | Zolbetuximab | Vyloy | Astellas Pharma Europe B.V. | O | BLA |
| 2024/9/19 | A05AX05 | Odevixibat sesquihydrate | Kayfanda | Ipsen Pharma | E | ||
| 2024/9/19 | D11208 | A05AX06 | Elafibranor | Iqirvo | Ipsen Pharma | C O | NME |
| 2024/9/12 | D09214 | L04AC05 | Ustekinumab | Eksunbi | Samsung Bioepis NL B.V. | B | |
| 2024/8/22 | D11534 | (L01FX34) | Odronextamab | Ordspono | Regeneron Ireland Designated Activity Company | C O | BLA |
| 2024/8/22 | D08399 | S01AX24 | Polihexanide | Akantior | SIFI SPA | O | NME |
| 2024/8/22 | D00095 | C01CA24 | Epinephrine | Eurneffy | Ars Pharmaceuticals Irl Limited | ||
| 2024/8/22 | D12607 | J07BX05 | Respiratory syncytial virus glycoprotein F mRNA | mResvia | Moderna Biotech Spain, S.L. | ||
| 2024/8/22 | D11696 | L04AJ07 | Crovalimab | Piasky | Roche Registration GmbH | BLA | |
| 2024/8/22 | D10927 | L01EN01 | Erdafitinib | Balversa | Janssen-Cilag International N.V. | NME | |
| 2024/8/22 | D10218 | L02BB04 | Enzalutamide | Enzalutamide Viatris | Viatris Limited | G | |
| 2024/8/22 | D09214 | L04AC05 | Ustekinumab | Steqeyma | Celltrion Healthcare Hungary Kft. | ||
| 2024/8/22 | D09670 | (C02KX06) | Sotatercept | Winrevair | Merck Sharp & Dohme B.V. | O P | BLA |
| 2024/8/22 | D11210 | V09AX07 | Flortaucipir (18F) | Tauvid | Eli Lilly Nederland B.V. | NME | |
| 2024/8/22 | D06413 | L01EA03 | Nilotinib | Nilotinib Accord | Accord Healthcare S.L.U. | G | |
| 2024/8/1 | D12835 | B01AD13 | Apadamtase alfa and cinaxadamtase alfa | Adzynma | Takeda Manufacturing Austria AG | O | |
| 2024/8/1 | Gallium (68Ga) chloride and germanium (68Ge) chloride | GalliaPharm | Eckert & Ziegler Radiopharma GmbH | ||||
| 2024/7/26 | D06414 | L01EA02 | Dasatinib monohydrate | Dasatinib Accord Healthcare | Accord Healthcare S.L.U. | G | |
| 2024/7/26 | D06409 | L01FG01 | Bevacizumab | Avzivi | FGK Representative Service GmbH | B | |
| 2024/7/26 | D08976 | L04AX06 | Pomalidomide | Pomalidomide Accord | Accord Healthcare S.L.U. | G | |
| 2024/7/24 | D12750 | L01FF11 | Sugemalimab | Cejemly | SFL Pharmaceuticals Deutschland GmbH | BLA | |
| 2024/7/24 | D12314 | H04AA02 | Dasiglucagon hydrochloride | Zegalogue | Zealand Pharma A/S | NME | |
| 2024/7/24 | D12908 | (B02BD17) | Fidanacogene elaparvovec | Durveqtix | Pfizer Europe MA EEIG | C P | BLA |
| 2024/7/24 | D08976 | L04AX06 | Pomalidomide | Pomalidomide Krka | Krka, d.d., Novo mesto | G | |
| 2024/7/24 | D08976 | L04AX06 | Pomalidomide | Pomalidomide Zentiva | Zentiva, k.s. | G | |
| 2024/7/24 | D00491 | L01CD01 | Paclitaxel | Apexelsin | Whiteoak Pharmaceutical B.V. | G | |
| 2024/6/28 | Chikungunya vaccine, live | Ixchiq | Valneva Austria GmbH | ||||
| 2024/6/27 | D08914 | L01XX41 | Eribulin mesylate | Eribulin Baxter | Baxter Holding B.V. | G | |
| 2024/6/27 | D10433 | G04BD15 | Vibegron | Obgemsa | Pierre Fabre Medicament | NME | |
| 2024/6/20 | D09214 | L04AC05 | Ustekinumab | Wezenla | Amgen Technology (Ireland) UC | B | |
| 2024/6/20 | D11977 | L01EK04 | Fruquintinib | Fruzaqla | Takeda Pharmaceuticals International AG Ireland | NME | |
| 2024/6/20 | D02596 | L04AC07 | Tocilizumab | Tofidence | Biogen Netherlands B.V. | ||
| 2024/6/17 | D11371 | L01EX27 | Capivasertib | Truqap | AstraZeneca AB | NME | |
| 2024/6/17 | D12441 | B02BD02 | Efanesoctocog alfa | Altuvoct | Swedish Orphan Biovitrum AB | O | BLA |
| 2024/6/3 | D12874 | J07BB03 | Influenza vaccine (live attenuated, nasal) | Fluenz | AstraZeneca AB | BLA | |
| 2024/5/29 | D02274 | M03CA01 | Dantrolene sodium, hemiheptahydrate | Agilus | Norgine B.V. | NME | |
| 2024/5/29 | D11811 | N07XX22 | Tofersen | Qalsody | Biogen Netherlands B.V. | O E | NME |
| 2024/5/27 | D00633 | C01CA04 | Dopamine hydrochloride | Neoatricon | BrePco Biopharma Limited | ||
| 2024/5/27 | D06409 | S01LA08 | Bevacizumab | Lytenava | Outlook Therapeutics Limited | BLA | |
| 2024/5/27 | D12252 | L04AJ08 | Iptacopan hydrochloride monohydrate | Fabhalta | Novartis Europharm Limited | O | NME |
| 2024/5/17 | D03684 | M05BX04 | Denosumab | Wyost | Sandoz GmbH | B | |
| 2024/5/17 | D12358 | A10AE07 | Insulin icodec | Awiqli | Novo Nordisk A/S | NME | |
| 2024/5/17 | D03684 | M05BX04 | Denosumab | Jubbonti | Sandoz GmbH | B | |
| 2024/5/16 | D05251 | R03DX05 | Omalizumab | Omlyclo | Celltrion Healthcare Hungary Kft. | B | |
| 2024/4/22 | D12889 | (J01DF51) | Aztreonam and avibactam | Emblaveo | Pfizer Europe MA EEIG | ||
| 2024/4/19 | D09214 | L04AC05 | Ustekinumab | Pyzchiva | Samsung Bioepis NL B.V. | B | |
| 2024/4/19 | D11641 | L04AJ09 | Danicopan | Voydeya | Alexion Europe SAS | O | NME |
| 2024/4/19 | D08860 | L04AA32 | Apremilast | Apremilast Accord | Accord Healthcare S.L.U. | G | |
| 2024/4/19 | D11487 | L01FF09 | Tislelizumab | Tizveni | BeiGene Ireland Ltd | ||
| 2024/4/19 | D11776 | (C09XX01) | Sparsentan | Filspari | Vifor France | C O | NME |
| 2024/4/19 | D11827 | L01FF10 | Retifanlimab | Zynyz | Incyte Biosciences Distribution B.V. | O | BLA |
| 2024/4/19 | J07BB02 | Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | Celldemic, Incellipan | Seqirus Netherlands B.V. | C | ||
| 2024/4/19 | D10396 | L01EX09 | Nintedanib esylate | Nintedanib Accord | Accord Healthcare S.L.U. | G | |
| 2024/3/31 | D05340 | N05AX13 | Paliperidone palmitate | Niapelf | Neuraxpharm Pharmaceuticals S.L. | G | |
| 2024/3/21 | D11986 | L03AA18 | Efbemalenograstim alfa | Ryzneuta | Evive Biotechnology Ireland Limited | BLA | |
| 2024/3/21 | D12818 | J01DE51 | Cefepime dihydrochloride monohydrate and enmetazobactam | Exblifep | Advanz Pharma Limited | ||
| 2024/2/19 | D07082 | B01AE07 | Dabigatran etexilate mesilate | Dabigatran Etexilate Teva | Laboratorios Leon Farma S.A. | G | |
| 2024/2/16 | D10931 | L04AE05 | Etrasimod arginine | Velsipity | Pfizer Europe MA EEIG | NME | |
| 2024/2/16 | D08976 | L04AX06 | Pomalidomide | Pomalidomide Viatris | Viatris Limited | G | |
| 2024/2/16 | D00126 | C01EB16 | Ibuprofen | Ibuprofen Gen.Orph | Gen.Orph | G | |
| 2024/2/9 | D12749 | B06AX05 | Exagamglogene autotemcel | Casgevy | Vertex Pharmaceuticals (Ireland) Limited | A C O | BLA |
| 2024/2/9 | D10964 | (N07XX25) | Omaveloxolone | Skyclarys | Reata Ireland Limited | O | NME |
| 2024/2/9 | D08914 | L01XX41 | Eribulin mesylate | Mevlyq | YES Pharmaceutical Development Services GmbH | G | |
| 2024/1/25 | D10889 | L01EJ04 | Momelotinib dihydrochloride monohydrate | Omjjara | GlaxoSmithKline | O | NME |
| 2024/1/5 | D12301 | L01XX77 | Adagrasib | Krazati | Mirati Therapeutics B.V. | C | NME |
| 2024/1/5 | D00491 | L01CD01 | Paclitaxel | Naveruclif | Accord Healthcare S.L.U. | G | |
| 2024/1/5 | D12182 | L04AG16 | Rozanolixizumab | Rystiggo | UCB Pharma | O | BLA |
| 2024/1/5 | D03021 | L01BC07 | Azacitidine | Azacitidine Kabi | Fresenius Kabi Deutschland GmbH | G | |
| 2024/1/5 | D09214 | L04AC05 | Ustekinumab | Uzpruvo | Stada Arzneimittel AG | B | |
| 2024/1/5 | D05697 | S01LA04 | Ranibizumab | Rimmyrah | Qilu Pharma Spain S.L. | B | |
| 2024/1/5 | D10176 | L01EE01 | Trametinib dimethyl sulfoxide | Spexotras | Novartis Europharm Limited | O | |
| 2023/12/22 | D11198 | J02AX08 | Rezafungin acetate | Rezzayo | Mundipharma GmbH | O | NME |
| 2023/12/15 | D11695 | A16AB24 | Pegzilarginase | Loargys | Immedica Pharma AB | O E | BLA |
| 2023/12/14 | D11000 | H02AB18 | Vamorolone | Agamree | Santhera Pharmaceuticals GmbH | O | NME |
| 2023/12/7 | D12435 | V08CA12 | Gadopiclenol | Elucirem, Vueway | Guerbet, Bracco Imaging S.p.A. | NME | |
| 2023/12/7 | D12058 | (L01FX32) | Elranatamab | Elrexfio | Pfizer Europe MA EEIG | C | BLA |
| 2023/12/1 | D12356 | L04AJ06 | Zilucoplan sodium | Zilbrysq | UCB Pharma S.A. | NME | |
| 2023/11/17 | D12395 | H05AA05 | Palopegteriparatide | Yorvipath | Ascendis Pharma | O | NME |
| 2023/11/16 | D09633 | D11AH10 | Lebrikizumab | Ebglyss | Almirall, S.A. | BLA | |
| 2023/11/15 | D00621 | C09AA02 | Enalapril maleate | Aqumeldi | Proveca Pharma Limited | ||
| 2023/11/15 | D03257 | L01FD01 | Trastuzumab | Herwenda | Sandoz GmbH | B | |
| 2023/11/6 | D09956 | L01EX11 | Quizartinib dihydrochloride | Vanflyta | Daiichi Sankyo Europe GmbH | NME | |
| 2023/10/30 | D12050 | L01EL05 | Pirtobrutinib | Jaypirca | Eli Lilly Nederland B.V. | C | NME |
| 2023/9/29 | D08635 | L02BX02 | Degarelix acetate | Degarelix Accord | Accord Healthcare S.L.U. | G | |
| 2023/9/22 | D12368 | L01FX27 | Epcoritamab | Tepkinly | AbbVie Deutschland GmbH | O C | BLA |
| 2023/9/22 | D06886 | L04AG03 | Natalizumab | Tyruko | Sandoz GmbH | B | |
| 2023/9/15 | D11848 | L01BC58 | Decitabine and cedazuridine | Inaqovi | Otsuka Pharmaceutical Netherlands B.V. | ||
| 2023/9/15 | D11970 | L04AF08 | Ritlecitinib tosilate | Litfulo | Pfizer Europe MA EEIG | NME | |
| 2023/9/15 | D11693 | R05DB29 | Gefapixant citrate | Lyfnua | Merck Sharp & Dohme B.V. | NME | |
| 2023/9/15 | D11487 | L01FF09 | Tislelizumab | Tevimbra | Novartis Europharm | BLA | |
| 2023/9/15 | D11672 | L02BA04 | Elacestrant hydrochloride | Orserdu | Stemline Therapeutics B.V. | NME | |
| 2023/9/15 | D10517 | L01XX02 | Crisantaspase | Enrylaze | Jazz Pharmaceuticals Ireland Limited | BLA | |
| 2023/9/15 | D09574 | S01LA05 | Aflibercept | Yesafili | Viatris Limited | B | |
| 2023/9/15 | D02596 | L04AC07 | Tocilizumab | Tyenne | Fresenius Kabi Deutschland GmbH | B | |
| 2023/9/15 | D10548 | J05AJ04 | Cabotegravir | Apretude | ViiV Healthcare B.V. | NME | |
| 2023/8/23 | D12607 | J07BX05 | Respiratory syncytial virus vaccines | Abrysvo | Pfizer Europe MA EEIG | A | BLA |
| 2023/8/21 | D12180 | L01FX29 | Talquetamab | Talvey | Janssen-Cilag International N.V. | O C | BLA |
| 2023/8/11 | D11313 | N02CD07 | Atogepant | Aquipta | AbbVie Deutschland GmbH | NME | |
| 2023/7/26 | D04300 | N03AX27 | Ganaxolone | Ztalmy | Marinus Pharmaceuticals Emerald Limited | O | NME |
| 2023/7/24 | D12132 | V09IX16 | Piflufolastat (18F) | Pylclari | Curium Pet France | NME | |
| 2023/7/7 | D11833 | L01FX28 | Glofitamab | Columvi | Roche Registration GmbH | C | BLA |
| 2023/7/4 | D11725 | L01EN04 | Futibatinib | Lytgobi | Taiho Pharma Netherlands B.V. | C | NME |
| 2023/6/26 | D05032 | A16AX06 | Miglustat | Opfolda | Amicus Therapeutics Europe Limited | ||
| 2023/6/26 | D12265 | C01EB24 | Mavacamten | Camzyos | Bristol-Myers Squibb Pharma EEIG | NME | |
| 2023/6/23 | D05940 | V03AB35 | Sugammadex sodium | Sugammadex Piramal | Piramal Critical Care B.V. | G | |
| 2023/6/6 | D12607 | J07BX05 | Respiratory syncytial virus recombinant glycoprotein F stabilised in the pre-fusion conformation (RSVPreF3) | Arexvy | GlaxoSmithKline Biologicals S.A. | BLA | |
| 2023/5/31 | D07299 | N03AX18 | Lacosamide | Lacosamide Adroiq | Extrovis EU Ltd. | G | |
| 2023/5/31 | D11243 | L04AG14 | Ublituximab | Briumvi | Propharma Group The Netherlands B.V. | BLA | |
| 2023/5/26 | D00443 | C03DA01 | Spironolactone | Qaialdo | Nova Laboratories Ireland Limited | ||
| 2023/5/26 | D03940 | L04AJ01 | Eculizumab | Epysqli | Samsung Bioepis NL B.V. | B | |
| 2023/5/26 | D07082 | B01AE07 | Dabigatran etexilate mesilate | Dabigatran etexilate Accord | Accord Healthcare S.L.U. | G | |
| 2023/5/26 | D01091 | V03AB06 | Sodium thiosulfate | Pedmarqsi | Fennec Pharmaceuticals Limited | ||
| 2023/5/26 | D11123 | L04AC24 | Mirikizumab | Omvoh | Eli Lilly Nederland B.V. | BLA | |
| 2023/5/26 | D05940 | V03AB35 | Sugammadex sodium | Sugammadex Adroiq | Extrovis EU Ltd. | G | |
| 2023/5/15 | D00753 | L01EG04 | Sirolimus | Hyftor | Plusultra pharma GmbH | O | |
| 2023/5/4 | D11090 | L01XM02 | Ivosidenib | Tibsovo | Les Laboratoires Servier | O | NME |
| 2023/5/4 | D11685 | A16AB20 | Pegunigalsidase alfa | Elfabrio | Chiesi Farmaceutici S.p.A | BLA | |
| 2023/4/24 | D11078 | B03XA08 | Vadadustat | Vafseo | Akebia Europe Limited | NME | |
| 2023/4/19 | D12653 | L01XK52 | Niraparib and abiraterone | Akeega | Janssen-Cilag International N.V. | ||
| 2023/4/19 | D09960 | D11AH09 | Ruxolitinib phosphate | Opzelura | Incyte Biosciences Distribution B.V. | ||
| 2023/4/19 | D03940 | L04AJ01 | Eculizumab | Bekemv | Amgen Technology (Ireland) UC | B | |
| 2023/3/31 | D10261 | A10BD07 | Sitagliptin and metformin hydrochloride | Sitagliptin / Metformin hydrochloride Sun | Sun Pharmaceutical Industries Europe B.V. | G | |
| 2023/3/30 | J07BN04 | COVID-19 Vaccine (recombinant, adjuvanted) | Bimervax | Hipra Human Health S.L. | |||
| 2023/3/24 | D11817 | L04AF07 | Deucravacitinib | Sotyktu | Bristol-Myers Squibb Pharma EEIG | NME | |
| 2023/3/24 | D09763 | A10BK01 | Dapagliflozin | Dapagliflozin Viatris | Viatris Limited | G | |
| 2023/3/20 | D11798 | A16AB23 | Cipaglucosidase alfa | Pombiliti | Amicus Therapeutics Europe Limited | BLA | |
| 2023/2/20 | D12500 | B02BD16 | Etranacogene dezaparvovec | Hemgenix | CSL Behring GmbH | O C | BLA |
| 2023/2/20 | D06657 | L01FX20 | Tremelimumab | Imjudo | AstraZeneca AB | BLA | |
| 2023/2/15 | D03846 | L04AX07 | Dimethyl fumarate | Dimethyl fumarate Accord | Accord Healthcare S.L.U. | G | |
| 2023/1/12 | D06078 | H05AA02 | Teriparatide | Kauliv | Strides Pharma (Cyprus) Limited | B | |
| 2023/1/10 | D05940 | V03AB35 | Sugammadex sodium | Sugammadex Amomed | AOP Orphan Pharmaceuticals GmbH | G | |
| 2023/1/10 | D01583 | L04AX05 | Pirfenidone | Pirfenidone Viatris | Viatris Limited | G | |
| 2022/12/16 | D11146 | L01XL09 | Tabelecleucel | Ebvallo | Atara Biotherapeutics Ireland Limited | O | BLA |
| 2022/12/12 | D03846 | L04AX07 | Dimethyl fumarate | Dimethyl fumarate Teva | Teva GmbH | G | |
| 2022/12/9 | D10952 | A05AX04 | Maralixibat chloride | Livmarli | Mirum Pharmaceuticals International B.V. | O E | NME |
| 2022/12/9 | D12335 | V10XX05 | Lutetium (177Lu) vipivotide tetraxetan | Pluvicto | Novartis Europharm Limited | NME | |
| 2022/12/9 | D12257 | V09IX14 | Ga-68 gozetotide | Locametz | Novartis Europharm Limited | NME | |
| 2022/12/5 | D12227 | J07BX04 | Dengue tetravalent vaccine (live, attenuated) | Qdenga | Takeda GmbH | VAC | |
| 2022/12/2 | D06495 | H01CB02 | Octreotide acetate | Mycapssa | Amryt Pharmaceuticals DAC | O | NME |
| 2022/11/18 | D06078 | H05AA02 | Teriparatide | Teriparatide Sun | Sun Pharmaceutical Industries Europe B.V. | ||
| 2022/11/15 | D11530 | L04AJ04 | Sutimlimab | Enjaymo | Genzyme Europe BV | O | BLA |
| 2022/11/10 | J07BN04 | SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain) | VidPrevtyn Beta | Sanofi Pasteur | VAC | ||
| 2022/11/9 | D06272 | L01EX02 | Sorafenib tosilate | Sorafenib Accord | Accord Healthcare S.L.U. | G | |
| 2022/11/9 | D10172 | L04AK02 | Teriflunomide | Teriflunomide Accord | Accord Healthcare S.L.U. | G | |
| 2022/11/9 | D05697 | S01LA04 | Ranibizumab | Ximluci | STADA Arzneimittel AG | B | |
| 2022/11/9 | D04859 | J05AX10 | Maribavir | Livtencity | Takeda Pharmaceuticals International AG Ireland Branch | O | NME |
| 2022/11/9 | D11408 | B06AX04 | Mitapivat | Pyrukynd | Agios Netherlands B.V. | O | NME |
| 2022/11/7 | D08170 | N05CH01 | Melatonin | Melatonin Neurim | RAD Neurim Pharmaceuticals EEC SARL | ||
| 2022/10/31 | D11380 | J06BD08 | Nirsevimab | Beyfortus | AstraZeneca AB | BLA | |
| 2022/9/19 | D11771 | R03DX11 | Tezepelumab | Tezspire | AstraZeneca AB | BLA | |
| 2022/9/19 | D00754 | L04AX02 | Thalidomide | Thalidomide Lipomed | Lipomed GmbH | ||
| 2022/9/15 | D12334 | L01FY02 | Nivolumab and relatlimab | Opdualag | Bristol-Myers Squibb Pharma EEIG | ||
| 2022/9/15 | D09033 | L04AD03 | Voclosporin | Lupkynis | Otsuka Pharmaceutical Netherlands B.V. | NME | |
| 2022/9/15 | D10828 | Lutetium (177Lu) chloride | Illuzyce | Billev Pharma Aps | NME | ||
| 2022/9/15 | D11780 | A16AX19 | Fosdenopterin hydrobromide dihydrate | Nulibry | Comharsa Life Sciences | O | NME |
| 2022/9/15 | D11916 | N07XX18 | Vutrisiran sodium | Amvuttra | Alnylam Netherlands B.V. | O | BLA |
| 2022/9/15 | D11516 | S01LA09 | Faricimab | Vabysmo | Roche Registration GmbH | BLA | |
| 2022/9/15 | D11360 | A10BX16 | Tirzepatide | Mounjaro | Eli Lilly Nederland B.V. | NME | |
| 2022/8/25 | D11404 | L01EA06 | Asciminib hydrochloride | Scemblix | Novartis Europharm Limited | O | NME |
| 2022/8/25 | D05697 | S01LA04 | Ranibizumab | Ranivisio | Midas Pharma GmbH | B | |
| 2022/8/24 | D12434 | B02BD15 | Valoctocogene roxaparvovec | Roctavian | BioMarin International Limited | O C | BLA |
| 2022/8/23 | D12177 | L01FX24 | Teclistamab | Tecvayli | Janssen-Cilag International N.V. | C | BLA |
| 2022/8/17 | D12162 | J05AX31 | Lenacapavir sodium | Sunlenca | Gilead Sciences Ireland Unlimited Company | NME | |
| 2022/8/17 | D10424 | N02CC08 | Lasmiditan succinate | Rayvow | Eli Lilly Nederland B.V. | NME | |
| 2022/8/17 | D06409 | L01FG01 | Bevacizumab | Vegzelma | Celltrion Healthcare Hungary Kft. | B | |
| 2022/8/17 | D11870 | L01AA10 | Melphalan flufenamide hydrochloride | Pepaxti | Oncopeptides AB | NME | |
| 2022/8/10 | D11876 | L04AA58 | Efgartigimod alfa | Vyvgart | Argenx | O | BLA |
| 2022/7/22 | D10261 | A10BD07 | Sitagliptin and metformin hydrochloride | Sitagliptin / Metformin hydrochloride Accord | Accord Healthcare S.L.U. | G | |
| 2022/7/18 | D12407 | A16AB26 | Eladocagene exuparvovec | Upstaza | PTC Therapeutics International Limited | O E | BLA |
| 2022/7/18 | D04768 | A16AX20 | Lonafarnib | Zokinvy | EigerBio Europe Limited | O E | NME |
| 2022/7/15 | D04302 | H01CC01 | Ganirelix acetate | Ganirelix Gedeon Richter | Chemical Works of Gedeon Richter Plc. | G | |
| 2022/7/15 | D05940 | V03AB35 | Sugammadex sodium | Sugammadex Fresenius Kabi | Fresenius Kabi Deutschland GmbH | G | |
| 2022/7/15 | D00246 | A07EA06 | Budesonide | Kinpeygo | Calliditas Therapeutics AB | O C | |
| 2022/7/15 | B02BD08 | Eptacog beta (activated) | Cevenfacta | Laboratoire Francais du Fractionnement et des Biotechnologies | |||
| 2022/7/15 | D07908 | J01DH03 | Ertapenem | Ertapenem SUN | SUN Pharmaceutical Industries (Europe) B.V. | G | |
| 2022/6/24 | J07BN03 | SARS-CoV-2 virus (inactivated) Wuhan strain hCoV-19 / Italy / INMI1-isl / 2020 | COVID-19 Vaccine (inactivated, adjuvanted) Valneva | Valneva Austria GmbH | VAC | ||
| 2022/6/20 | D01583 | L04AX05 | Pirfenidone | Pirfenidone AET | Alfred E. Tiefenbacher | G | |
| 2022/6/3 | D11463 | L01FX25 | Mosunetuzumab | Lunsumio | Roche Registration GmbH | O C | BLA |
| 2022/5/31 | D01275 | L01DB01 | Doxorubicin hydrochloride | Zolsketil pegylated liposomal | Accord Healthcare S.L.U. | ||
| 2022/5/25 | D12315 | L01XL05 | Ciltacabtagene autoleucel | Carvykti | Janssen-Cilag International NV | O C | BLA |
| 2022/5/24 | D12337 | L02AE02 | Leuprorelin mesilate | Camcevi | Accord Healthcare S.L.U. | ||
| 2022/5/19 | D10689 | N07XX05 | Amifampridine phosphate | Amifampridine SERB | SERB SA | G | |
| 2022/5/13 | D03846 | L04AX07 | Dimethyl fumarate | Dimethyl fumarate Neuraxpharm | Laboratorios Lesvi S.L. | G | |
| 2022/5/13 | D03846 | L04AX07 | Dimethyl fumarate | Dimethyl fumarate Polpharma | Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. | G | |
| 2022/5/13 | D03846 | L04AX07 | Dimethyl fumarate | Dimethyl fumarate Mylan | Mylan Ireland Limited | G | |
| 2022/4/29 | D11887 | N05CJ03 | Daridorexant hydrochloride | Quviviq | Idorsia Pharmaceuticals Deutschland GmbH | NME | |
| 2022/4/29 | D10888 | L02BX04 | Relugolix | Orgovyx | Myovant Sciences Ireland Limited | NME | |
| 2022/4/25 | D10890 | V03AX04 | Difelikefalin acetate | Kapruvia | Vifor Fresenius Medical Care Renal Pharma France | NME | |
| 2022/4/25 | D10663 | N02CD06 | Rimegepant sulfate | Vydura | Biohaven Pharmaceutical Ireland DAC | NME | |
| 2022/4/13 | D11525 | L01FX13 | Enfortumab vedotin | Padcev | Astellas Pharma Europe B.V. | BLA | |
| 2022/4/4 | D11990 | L01XL08 | Lisocabtagene maraleucel | Breyanzi | Bristol-Myers Squibb Pharma EEIG | BLA | |
| 2022/4/1 | D12296 | L01XX75 | Tebentafusp | Kimmtrak | Immunocore Ireland Limited | O | |
| 2022/3/28 | D06889 | L03AA13 | Pegfilgrastim | Stimufend | Fresenius Kabi Deutschland GmbH | B | |
| 2022/3/24 | D06414 | L01EA02 | Dasatinib | Dasatinib Accordpharma | Accord Healthcare S.L.U. | G | |
| 2022/3/24 | D06414 | L01EA02 | Dasatinib | Dasatinib Accord | Accord Healthcare S.L.U. | G | |
| 2022/2/21 | D10825 | N04BX04 | Opicapone | Ontilyv | Bial Portela & Companhia S.A. | NME | |
| 2022/2/16 | D10261 | A10BD07 | Metformin hydrochloride and sitagliptin hydrochloride monohydrate | Sitagliptin / Metformin hydrochloride Mylan | Mylan Ireland Limited | G | |
| 2022/2/16 | D01798 | A16AX07 | Sapropterin dihydrochloride | Sapropterin Dipharma | Dipharma B.V. | G | |
| 2022/2/16 | D10633 | C03DA05 | Finerenone | Kerendia | Bayer AG | NME | |
| 2022/2/14 | D11082 | L04AG11 | Anifrolumab | Saphnelo | AstraZeneca AB | BLA | |
| 2022/2/14 | D00426 | N05AX08 | Risperidone | Okedi | Laboratorios Farmacéuticos Rovi, S.A. | NME | |
| 2022/2/14 | D12207 | J07AL02 | Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) | Apexxnar | Pfizer Europe MA EEIG | VAC | |
| 2022/2/14 | D10990 | H01AC08 | Somatrogon | Ngenla | Pfizer Europe MA EEIG | O | BLA |
| 2022/1/28 | D12269 | J05AE30 | Nirmatrelvir and ritonavir | Paxlovid | Pfizer Europe MA EEIG | C | EUA |
| 2022/1/24 | D11303 | N02CD05 | Eptinezumab | Vyepti | H. Lundbeck A/S | BLA | |
| 2022/1/11 | D11093 | L04AJ05 | Avacopan | Tavneos | Vifor Fresenius Medical Care Renal Pharma France | O | NME |
| 2022/1/11 | D10260 | V03AF09 | Glucarpidase | Voraxaze | SERB SAS | O | BLA |
| 2022/1/6 | D11557 | J05AX24 | Tecovirimat monohydrate | Tecovirimat SIGA | SIGA Technologies Netherlands B.V. | NME | |
| 2021/12/20 | D12336 | J07BN04 | COVID-19 Vaccine (recombinant, adjuvanted) | Nuvaxovid | Novavax CZ, a.s. | C | VAC |
| 2021/12/17 | D12014 | J06BD05 | Sotrovimab | Xevudy | GlaxoSmithKline Trading Services Limited | BLA | |
| 2021/12/13 | D11613 | L04AJ03 | Pegcetacoplan | Aspaveli | Swedish Orphan Biovitrum AB (publ) | O | NME |
| 2021/12/9 | D11400 | D11AH08 | Abrocitinib | Cibinqo | Pfizer Europe MA EEIG | NME | |
| 2021/11/22 | D11422 | L01EL03 | Zanubrutinib | Brukinsa | BeiGene Ireland Ltd | NME | |
| 2021/11/22 | D10985 | L01FX17 | Sacituzumab govitecan | Trodelvy | Gilead Sciences Ireland UC | BLA | |
| 2021/11/18 | D11353 | L01EX19 | Ripretinib | Qinlock | Deciphera Pharmaceuticals B.V. | O | NME |
| 2021/11/15 | D05940 | V03AB35 | Sugammadex sodium | Sugammadex Mylan | Mylan Ireland Limited | G | |
| 2021/11/15 | D11154 | L04AX09 | Diroximel fumarate | Vumerity | Biogen Netherlands B.V. | NME | |
| 2021/11/12 | D07086 | B01AF01 | Rivaroxaban | Rivaroxaban Mylan | Mylan Ireland Limited | G | |
| 2021/11/12 | D12241 | J06BD06 | Regdanvimab | Regkirona | Celltrion Healthcare Hungary Kft. | BLA | |
| 2021/11/12 | D12142 | J06BD07 | Casirivimab and imdevimab | Ronapreve | Roche Registration GmbH | ||
| 2021/9/22 | D01441 | L01EA01 | Imatinib mesilate | Imatinib Koanaa | Koanaa Healthcare GmbH | G | |
| 2021/9/1 | D10749 | N07XX11 | Pitolisant | Ozawade | Bioprojet Pharma | ||
| 2021/8/26 | D11601 | L01FX12 | Tafasitamab | Minjuvi | Incyte Biosciences Distribution B.V. | O C | BLA |
| 2021/8/26 | D11190 | M05BX07 | Vosoritide | Voxzogo | BioMarin International Limited | O | NME |
| 2021/8/20 | D11550 | L04AC21 | Bimekizumab | Bimzelx | UCB Pharma S.A. | BLA | |
| 2021/8/20 | D09701 | L02BX03 | Abiraterone acetate | Abiraterone Mylan | Mylan Ireland Limited | G | |
| 2021/8/18 | D11556 | L01XL07 | Idecabtagene vicleucel | Abecma | Celgene Europe BV | O C | BLA |
| 2021/8/18 | D10593 | B03XA05 | Roxadustat | Evrenzo | Astellas Pharma Europe B.V. | NME | |
| 2021/7/16 | D12150 | A16AX21 | Elivaldogene autotemcel | Skysona | Bluebird bio (Netherlands) B.V. | O | BLA |
| 2021/7/16 | D11691 | D06BX03 | Tirbanibulin | Klisyri | Almirall, S.A. | NME | |
| 2021/7/16 | D11927 | A08AA12 | Setmelanotide | Imcivree | Rhythm Pharmaceuticals Limited | O | NME |
| 2021/7/16 | D11051 | C01DX22 | Vericiguat | Verquvo | Bayer AG | NME | |
| 2021/7/16 | D11716 | A05AX05 | Odevixibat | Bylvay | Albireo | A E O | NME |
| 2021/6/24 | D11079 | L04AC19 | Satralizumab | Enspryng | Roche Registration GmbH | O | BLA |
| 2021/6/21 | D00238 | L04AX01 | Azathioprine | Jayempi | Nova Laboratories Ireland Limited | ||
| 2021/6/17 | D11753 | C10AX17 | Evinacumab | Evkeeza | Regeneron Ireland Designated Activity Company | E | BLA |
| 2021/6/17 | D09979 | D11AH07 | Tralokinumab | Adtralza | LEO Pharma A/S | BLA | |
| 2021/5/27 | D00088 | H02AB09 | Hydrocortisone | Efmody | Diurnal Europe B.V. | ||
| 2021/5/19 | D11215 | L04AE04 | Ponesimod | Ponvory | Janssen-Cilag International N.V. | NME | |
| 2021/5/19 | D12047 | G03AA18 | Drospirenone and estetrol monohydrate | Drovelis | Gedeon Richter Plc. | ||
| 2021/5/19 | D12047 | G03AA18 | Drospirenone and estetrol monohydrate | Lydisilka | Estetra SPRL | ||
| 2021/5/19 | D11658 | L01EM04 | Duvelisib | Copiktra | Verastem Europe GmbH | NME | |
| 2021/4/30 | D11674 | B06AC06 | Berotralstat hydrochloride | Orladeyo | BioCryst Ireland Limited | NME | |
| 2021/4/30 | D12048 | A12BA30 | Potassium citrate and potassium bicarbonate | Sibnayal | Advicenne S.A. | ||
| 2021/4/26 | D09701 | L02BX03 | Abiraterone acetate | Abiraterone Accord | Accord Healthcare S.L.U. | G | |
| 2021/4/21 | D11366 | L01FF07 | Dostarlimab | Jemperli | GlaxoSmithKline (Ireland) Limited | C | BLA |
| 2021/3/31 | D11194 | H01AC07 | Somapacitan | Sogroya | Novo Nordisk A/S | O | BLA |
| 2021/3/26 | D11222 | L01XX66 | Selinexor | Nexpovio | Karyopharm Europe GmbH | C | NME |
| 2021/3/26 | D11150 | N03AX25 | Cenobamate | Ontozry | Arvelle Therapeutics Netherlands B.V. | NME | |
| 2021/3/26 | D08699 | R03AK06 | Salmeterol xinafoate and fluticasone propionate | Seffalair Spiromax | Teva B.V. | ||
| 2021/3/26 | D08699 | R03AK06 | Salmeterol xinafoate and fluticasone propionate | BroPair Spiromax | Teva B.V. | ||
| 2021/3/26 | D01892 | C10AX | Icosapent ethyl | Vazkepa | Amarin Pharmaceuticals Ireland Limited | ||
| 2021/3/26 | D09314 | L04AG12 | Ofatumumab | Kesimpta | Novartis Ireland Ltd | ||
| 2021/3/26 | D11788 | N05CD14 | Remimazolam | Byfavo | Paion Netherlands B.V. | NME | |
| 2021/3/26 | D00583 | L01AC01 | Thiotepa | Thiotepa Riemser | Riemser Pharma GmbH | G | |
| 2021/3/26 | D06409 | L01FG01 | Bevacizumab | Alymsys | Mabxience Research SL | B | |
| 2021/3/26 | D11417 | L01EN02 | Pemigatinib | Pemazyre | Incyte Biosciences Distribution B.V. | O C | NME |
| 2021/3/26 | D11406 | M09AX10 | Risdiplam | Evrysdi | Roche Registration GmbH | A O | NME |
| 2021/3/26 | D06409 | L01FG01 | Bevacizumab | Oyavas | Stada Arzneimittel AG | B | |
| 2021/3/11 | D12129 | J07BN02 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | COVID-19 Vaccine Janssen | Janssen-Cilag International NV | C | VAC |
| 2021/2/18 | J07BC01 | Hepatitis B surface antigen | Heplisav B | Dynavax GmbH | |||
| 2021/2/11 | D00116 | H04AA01 | Glucagon | Ogluo | Xeris Pharmaceuticals Ireland Limited | ||
| 2021/2/11 | D02597 | L04AB04 | Adalimumab | Yuflyma | Celltrion Healthcare Hungary Kft. | B | |
| 2021/2/11 | D11141 | L01EH03 | Tucatinib | Tukysa | Seagen B.V. | NME | |
| 2021/2/11 | D09813 | L04AX04 | Lenalidomide monohydrate | Lenalidomide Krka | Krka, d.d., Novo mesto | G | |
| 2021/2/11 | D09813 | L04AX04 | Lenalidomide monohydrate | Lenalidomide Krka d.d. | Krka, d.d., Novo mesto | G | |
| 2021/2/11 | D09813 | L04AX04 | Lenalidomide monohydrate | Lenalidomide Krka d.d. Novo mesto | Krka, d.d., Novo mesto | G | |
| 2021/2/8 | D09932 | L01FB02 | Moxetumomab pasudotox | Lumoxiti | AstraZeneca AB | O | NME |
| 2021/2/4 | D10708 | J05AX29 | Fostemsavir trometamol | Rukobia | ViiV Healthcare B.V. | NME | |
| 2021/1/29 | D12115 | J07BN02 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | Vaxzevria | AstraZeneca AB | C | VAC |
| 2021/1/18 | D11529 | L01FD04 | Trastuzumab deruxtecan | Enhertu | Daiichi Sankyo Europe GmbH | C | BLA |
| 2021/1/11 | D06409 | L01FG01 | Bevacizumab | Onbevzi | Samsung Bioepis NL B.V. | B | |
| 2021/1/7 | D11358 | L01XX67 | Tagraxofusp | Elzonris | Stemline Therapeutics B.V. | O E | BLA |
| 2021/1/7 | D11021 | J05AX25 | Baloxavir marboxil | Xofluza | Roche Registration GmbH | NME | |
| 2021/1/7 | D11558 | S01EE51 | Latanoprost and netarsudil | Roclanda | Aerie Pharmaceuticals Ireland Limited | ||
| 2021/1/6 | D12114 | J07BN01 | COVID-19 mRNA vaccine (nucleoside-modified) | COVID-19 Vaccine Moderna | Moderna Biotech Spain, S.L. | C | VAC |
| 2020/12/21 | D11971 | J07BN01 | COVID-19 mRNA vaccine (nucleoside-modified) | Comirnaty | BioNTech Manufacturing GmbH | C | VAC |
| 2020/12/21 | D11934 | L01FY01 | Pertuzumab and trastuzumab | Phesgo | Roche Registration GmbH | ||
| 2020/12/18 | D04148 | N03AX26 | Fenfluramine hydrochloride | Fintepla | Zogenix ROI Limited | O | NME |
| 2020/12/18 | D04687 | L04AX04 | Lenalidomide | Lenalidomide Mylan | Mylan Ireland Limited | G | |
| 2020/12/17 | D10549 | J05AJ04 | Cabotegravir sodium | Vocabria | ViiV Healthcare B.V. | NME | |
| 2020/12/17 | N07 | Autologous CD34+ cells encoding ARSA gene | Libmeldy | Orchard Therapeutics (Netherlands) BV | O | ||
| 2020/12/17 | D09720 | J05AG05 | Rilpivirine | Rekambys | Janssen-Cilag International N.V. | NME | |
| 2020/12/17 | V01 | Defatted powder of Arachis hypogaea L., semen (peanuts) | Palforzia | Aimmune Therapeutics Ireland Limited | |||
| 2020/12/14 | D11880 | L01XL06 | Brexucabtagene autoleucel | Tecartus | Kite Pharma EU B.V. | O | BLA |
| 2020/12/14 | L01X | Autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured | Tecartus | Kite Pharma EU B.V. | O | ||
| 2020/12/09 | D11931 | C10AX16 | Inclisiran | Leqvio | Novartis Europharm Limited | BLA | |
| 2020/12/09 | D11584 | R03AL11 | Formoterol fumarate dihydrate, glycopyrronium bromide and budesonide | Trixeo Aerosphere | AstraZeneca AB | NME | |
| 2020/11/19 | D11926 | A16AX18 | Lumasiran sodium | Oxlumo | Alnylam Netherlands B.V. | O | BLA |
| 2020/11/18 | D10776 | J06BC04 | Obiltoxaximab | Obiltoxaximab SFL | SFL Pharmaceuticals Deutschland GmbH | O E | BLA |
| 2020/11/18 | D10535 | J07AH08 | Meningococcal group A, C, W-135 and Y conjugate vaccine | MenQuadfi | Sanofi Pasteur | ||
| 2020/11/18 | D06889 | L03AA13 | Pegfilgrastim | Nyvepria | Pfizer Europe MA EEIG | B | |
| 2020/11/16 | D07552 | N01BB01 | Bupivacaine | Exparel liposomal | Pacira Ireland Limited | ||
| 2020/11/16 | D08173 | L01AA03 | Melphalan hydrochloride | Phelinun | ADIENNE S.r.l. S.U. | ||
| 2020/11/16 | J07BB02 | Influenza quadrivalent vaccine (rdna) | Supemtek | Sanofi Pasteur | |||
| 2020/11/16 | D07086 | B01AF01 | Rivaroxaban | Rivaroxaban Accord | Accord Healthcare S.L.U. | G | |
| 2020/11/5 | D10893 | L01EL02 | Acalabrutinib | Calquence | AstraZeneca AB | NME | |
| 2020/10/28 | D11480 | B06AX01 | Crizanlizumab | Adakveo | Novartis Europharm Limited | O C | BLA |
| 2020/10/27 | D00865 | J01GB06 | Amikacin sulfate | Arikayce liposomal | Insmed Netherlands B.V. | O | NME |
| 2020/9/24 | D06409 | L01FG01 | Bevacizumab | Equidacent | Centus Biotherapeutics Europe Limited | B | |
| 2020/9/24 | D11279 | L01EX18 | Avapritinib | Ayvakyt | Blueprint Medicines (Netherlands) B.V. | O | NME |
| 2020/9/24 | N01BB59 | Bupivacaine and meloxicam | Zynrelef | Heron Therapeutics, B.V. | |||
| 2020/9/24 | D04127 | N07XX07 | Fampridine | Fampridine Accord | Accord Healthcare S.L.U. | G | |
| 2020/9/24 | D11106 | L04AF04 | Filgotinib maleate | Jyseleca | Gilead Sciences Ireland UC | NME | |
| 2020/9/17 | D02106 | L01XX27 | Arsenic trioxide | Arsenic trioxide medac | medac Gesellschaft für klinische Spezialpräparate mbH | G | |
| 2020/8/28 | D09755 | L01CD04 | Cabazitaxel | Cabazitaxel Accord | Accord Healthcare S.L.U. | G | |
| 2020/8/27 | D06078 | H05AA02 | Teriparatide | Livogiva | Theramex Ireland Limited | B | |
| 2020/8/25 | D11595 | L01FX15 | Belantamab mafodotin | Blenrep | GlaxoSmithKline Limited | O C | BLA |
| 2020/8/25 | D11470 | L04AA41 | Imlifidase | Idefirix | Hansa Biopharma AB | O C | NME |
| 2020/8/21 | D11700 | R07AX32 | Ivacaftor, tezacaftor and elexacaftor | Kaftrio | Vertex Pharmaceuticals Limited | O | NME |
| 2020/8/19 | D07603 | N06BC01 | Caffeine citrate | Gencebok | Gennisium Pharma | ||
| 2020/8/19 | D06409 | L01FG01 | Bevacizumab | Aybintio | Samsung Bioepis NL B.V. | B | |
| 2020/8/19 | D02312 | V04CG05 | Methylthioninium chloride | Methylthioninium chloride Cosmo | Cosmo Technologies Ltd | ||
| 2020/7/31 | D10772 | J01MA25 | Pretomanid | Pretomanid | FGK Representative Service GmbH | O C | NME |
| 2020/7/31 | D10926 | L01EX14 | Entrectinib | Rozlytrek | Roche Registration GmbH | ||
| 2020/7/31 | D11878 | J05AX28 | Bulevirtide acetate | Hepcludex | MYR GmbH | O | NME |
| 2020/7/27 | D11011 | L01EM03 | Alpelisib | Piqray | Novartis Europharm Limited | NME | |
| 2020/7/27 | D03257 | L01FD01 | Trastuzumab | Zercepac | Accord Healthcare S.L.U. | B | |
| 2020/7/27 | D11631 | J01XX12 | Lefamulin | Xenleta | Nabriva Therapeutics Ireland DAC | ||
| 2020/7/23 | D03213 | B01AF02 | Apixaban | Apixaban Accord | Accord Healthcare S.L.U. | G | |
| 2020/7/3 | D11472 | J05AB16 | Remdesivir | Veklury | Gilead Sciences Ireland UC | C | NME |
| 2020/7/3 | D11861 | R03AL12 | Indacaterol, glycopyrronium bromide, mometasone | Zimbus Breezhaler | Novartis Europharm Limited | ||
| 2020/7/3 | D11861 | R03AL12 | Indacaterol, glycopyrronium bromide, mometasone | Enerzair Breezhaler | Novartis Europharm Limited | ||
| 2020/7/1 | J07BX02 | Ebola vaccine (rDNA, replication-incompetent) | Zabdeno | Janssen-Cilag International N.V. | E | ||
| 2020/7/1 | J07BX02 | Ebola vaccine (rDNA replication-incompetent) | Mvabea | Janssen-Cilag International N.V. | E | ||
| 2020/6/26 | D11107 | L01XJ03 | Glasdegib maleate | Daurismo | Pfizer Europe MA EEIG | O | NME |
| 2020/6/25 | D11701 | B03XA06 | Luspatercept | Reblozyl | Celgene Europe B.V. | O | BLA |
| 2020/6/25 | D04475 | A10AB05 | Insulin aspart | Insulin aspart Sanofi | sanofi-aventis groupe | B | |
| 2020/6/25 | D10001 | L04AE01 | Fingolimod | Fingolimod Accord | Accord Healthcare S.L.U. | G | |
| 2020/6/18 | D05339 | N05AX13 | Paliperidone | Paliperidone Janssen-Cilag International | Janssen-Cilag International N.V. | ||
| 2020/5/30 | D11862 | R03AK14 | Indacaterol and mometasone furoate | Bemrist Breezhaler | Novartis Europharm Limited | ||
| 2020/5/30 | D11862 | R03AK14 | Indacaterol acetate and mometasone furoate | Atectura Breezhaler | Novartis Europharm Limited | ||
| 2020/5/30 | D11050 | L01FC02 | Isatuximab | Sarclisa | sanofi-aventis groupe | BLA | |
| 2020/5/20 | D00742 | L04AB01 | Etanercept | Nepexto | Mylan IRE Healthcare Limited | B | |
| 2020/5/20 | J07BB02 | Influenza vaccine (surface antigen, inactivated, adjuvanted) | Fluad Tetra | Seqirus Netherlands B.V. | |||
| 2020/5/20 | D10967 | L04AE02 | Ozanimod hydrochloride | Zeposia | Celgene Europe BV | NME | |
| 2020/5/20 | D09595 | R03AK07 | Budesonide and formoterol fumarate dihydrate | Budesonide/Formoterol Teva Pharma B.V. | Teva Pharma B.V. | ||
| 2020/5/18 | D11559 | M09AX09 | Onasemnogene abeparvovec | Zolgensma | AveXis EU Limited | O C | BLA |
| 2020/4/23 | D11013 | J01DI04 | Cefiderocol sulfate tosilate | Fetcroja | Shionogi B.V. | NME | |
| 2020/4/17 | D01079 | J01AA12 | Tigecycline | Tigecycline Accord | Accord Healthcare S.L.U. | G | |
| 2020/4/3 | D10025 | A10BJ06 | Semaglutide | Rybelsus | Novo Nordisk A/S | ||
| 2020/4/3 | D03505 | H05BX01 | Cinacalcet hydrochloride | Cinacalcet Accordpharma | Accord Healthcare S.L.U. | G | |
| 2020/4/3 | D08628 | B01AC21 | Treprostinil sodium | Trepulmix | SciPharm SÃ rl | O | NME |
| 2020/4/1 | D10691 | C10AX15 | Bempedoic acid | Nilemdo | Daiichi Sankyo Europe GmbH | NME | |
| 2020/4/1 | J07AE02 | Cholera vaccine (recombinant, live, oral) | Vaxchora | Emergent Netherlands B.V. | |||
| 2020/4/1 | D02106 | L01XX27 | Arsenic trioxide | Arsenic trioxide Mylan | Mylan Ireland Limited | G | |
| 2020/4/1 | D02994 | L01FA01 | Rituximab | Ruxience | Pfizer Europe MA EEIG | B | |
| 2020/3/27 | D11794 | C10BA10 | Bempedoic acid and ezetimibe | Nustendi | Daiichi Sankyo Europe GmbH | ||
| 2020/3/27 | D11045 | L02BB06 | Darolutamide | Nubeqa | Bayer AG | NME | |
| 2020/3/27 | D10873 | D11AH06 | Crisaborole | Staquis | Pfizer Europe MA EEIG | NME | |
| 2020/3/27 | D03021 | L01BC07 | Azacitidine | Azacitidine Mylan | Mylan Ireland Limited | G | |
| 2020/3/24 | D04477 | A10AB04 | Insulin lispro | Lyumjev (previously Liumjev) | Eli Lilly Nederland B.V. | ||
| 2020/3/24 | D03021 | L01BC07 | Azacitidine | Azacitidine betapharm | betapharm Arzneimittel GmbH | G | |
| 2020/3/2 | D11702 | A16AX16 | Givosiran | Givlaari | Alnylam Netherlands B.V. | O | BLA |
| 2020/2/13 | D02597 | L04AB04 | Adalimumab | Amsparity | Pfizer Europe MA EEIG | B | |
| 2020/2/13 | D11083 | S01LA06 | Brolucizumab | Beovu | Novartis Europharm Limited | ||
| 2020/2/13 | D03021 | L01BC07 | Azacitidine | Azacitidine Accord | Accord Healthcare S.L.U. | G | |
| 2020/2/13 | D00514 | N05CM18 | Dexmedetomidine | Dexmedetomidine Accord | Accord Healthcare S.L.U. | G | |
| 2020/2/13 | D11621 | J01DH56 | Imipenem, cilastatin and relebactam | Recarbrio | Merck Sharp & Dohme B.V. | ||
| 2020/1/16 | D10761 | L01FX14 | Polatuzumab vedotin | Polivy | Roche Registration GmbH | O C | BLA |
| 2020/1/16 | D11328 | N06BA14 | Solriamfetol hydrochloride | Sunosi | Jazz Pharmaceuticals Ireland Limited | NME | |
| 2020/1/13 | D11072 | L04AE03 | Siponimod fumaric acid | Mayzent | Novartis Europharm Limited | NME | |
| 2020/1/9 | D09348 | B02BX09 | Fostamatinib disodium | Tavlesse | Rigel Pharmaceuticals B.V. | NME | |
| 2020/1/9 | D10513 | B01AC30 | Clopidogrel and acetylsalicyclic acid | Clopidogrel / Acetylsalicylic acid Mylan | Mylan S.A.S. | G | |
| 2020/1/9 | D11062 | H02CA02 | Osilodrostat phosphate | Isturisa | Novartis Europharm Limited | O | NME |
| 2019/12/19 | D06889 | L03AA13 | Pegfilgrastim | Cegfila (previously Pegfilgrastim Mundipharma) (updated) | Mundipharma Biologics S.L. | B | |
| 2019/12/18 | D10627 | N06AX27 | Esketamine hydrochloride | Spravato | Janssen-Cilag International N.V. | ||
| 2019/12/16 | D09331 | J01MA23 | Delafloxacin meglumine | Quofenix | A. Menarini Industrie Farmaceutiche Riunite s.r.l. | NME | |
| 2019/12/16 | D00116 | H04AA01 | Glucagon | Baqsimi | Eli Lilly Nederland B.V. | ||
| 2019/12/16 | D11048 | L04AF03 | Upadacitinib | Rinvoq | AbbVie Deutschland GmbH & Co. KG | NME | |
| 2019/12/9 | D10156 | M05BX06 | Romosozumab | Evenity | UCB Pharma S.A. | BLA | |
| 2019/11/19 | D11031 | S01EX05 | Netarsudil mesylate | Rhokiinsa | Aerie Pharmaceuticals Ireland Ltd | NME | |
| 2019/11/14 | D02740 | N01BB20 | Lidocaine and prilocaine | Senstend | Plethora Pharma Solutions Limited | ||
| 2019/11/14 | D03546 | L01BB06 | Clofarabine | Ivozall | ORPHELIA Pharma SAS | G | |
| 2019/11/14 | D03150 | L01XG01 | Bortezomib | Bortezomib Fresenius Kabi | Fresenius Kabi Deutschland GmbH | G | |
| 2019/11/14 | D02106 | L01XX27 | Arsenic trioxide | Arsenic trioxide Accord | Accord Healthcare S.L.U. | G | |
| 2019/11/11 | D11711 | A10BD25 | Dapagliflozin, metformin and saxagliptin | Qtrilmet | AstraZeneca AB | ||
| 2019/11/11 | J07BX02 | Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live) | Ervebo | Merck Sharp & Dohme B.V. | C | ||
| 2019/10/24 | D10800 | L01EX13 | Gilteritinib fumarate | Xospata | Astellas Pharma Europe B.V. | NME | |
| 2019/9/27 | D00783 | M03AX01 | Botulinum toxin type A | Nuceiva | Evolus Pharma Limited | ||
| 2019/9/26 | D03669 | V03AC03 | Deferasirox | Deferasirox Mylan | Mylan S.A.S | G | |
| 2019/9/26 | D09575 | J05AX23 | Ibalizumab | Trogarzo | Theratechnologies International Limited | BLA | |
| 2019/9/19 | D11138 | L01EX12 | Larotrectinib sulfate | Vitrakvi | Bayer AG | C | NME |
| 2019/9/19 | D10915 | N03AX24 | Cannabidiol | Epidyolex | GW Pharma (International) B.V. | O | NME |
| 2019/9/19 | D00059 | N04BA01 | Levodopa | Inbrija | Acorda Therapeutics Ireland Limited | ||
| 2019/8/26 | D07299 | N03AX18 | Lacosamide | Lacosamide UCB | UCB Pharma S.A. | ||
| 2019/8/23 | D11142 | C01CX09 | Angiotensin II acetate | Giapreza | La Jolla Pharmaceutical II B.V. | ||
| 2019/8/2 | D03021 | L01BC07 | Azacitidine | Azacitidine Celgene | Celgene Europe BV | ||
| 2019/7/25 | V03AF11 | L-Arginine hydrochloride / L-Lysine hydrochloride | LysaKare | Advanced Accelerator Applications | |||
| 2019/7/25 | D02555 | J02AC04 | Posaconazole | Posaconazole AHCL | Accord Healthcare S.L.U. | G | |
| 2019/7/25 | D02555 | J02AC04 | Posaconazole | Posaconazole Accord | Accord Healthcare S.L.U. | G | |
| 2019/7/25 | D00736 | A16AX12 | Trientine dihydrochloride | Cufence | Univar BV | ||
| 2019/7/2 | D11054 | L04AJ02 | Ravulizumab | Ultomiris | Alexion Europe SAS | NME | |
| 2019/7/1 | D00341 | L01XX05 | Hydroxycarbamide | Xromi | Nova Laboratories Ireland Limited | ||
| 2019/7/1 | D11522 | J05AR25 | Dolutegravir and lamivudine | Dovato | ViiV Healthcare Ltd. | ||
| 2019/6/28 | D11108 | L01FF06 | Cemiplimab | Libtayo | Regeneron Ireland U.C. | C | NME |
| 2019/6/25 | D10014 | V09AB03 | Ioflupane (123i) | Striascan | CIS bio international | ||
| 2019/6/20 | D07253 | L01AB02 | Treosulfan | Trecondi | medac Gesellschaft für klinische Spezialpräparate mbH | ||
| 2019/6/20 | D07077 | C02KX02 | Ambrisentan | Ambrisentan Mylan | Mylan S.A.S | G | |
| 2019/6/20 | D10758 | B02BD02 | Turoctocog alfa pegol | Esperoct | Novo Nordisk A/S | ||
| 2019/6/20 | D10733 | L01XK04 | Talazoparib | Talzenna | Pfizer Europe MA EEIG | NME | |
| 2019/6/19 | D07132 | N07BC01 | Buprenorphine | Sixmo | L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. | ||
| 2019/5/29 | B06A | Autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene | Zynteglo | bluebird bio (Netherlands) B.V. | O | ||
| 2019/5/6 | D00491 | L01CD01 | Paclitaxel | Pazenir | Teva B.V. | G | |
| 2019/5/6 | D11012 | L01ED05 | Lorlatinib | Lorviqua | Pfizer Europe MA EEIG | C | NME |
| 2019/5/3 | D11650 | C10AX18 | Volanesorsen | Waylivra | Akcea Therapeutics Ireland Limited | O | NME |
| 2019/5/3 | D11077 | A16AB19 | Pegvaliase | Palynziq | BioMarin International Limited | O | NME |
| 2019/4/26 | D11029 | V03AB38 | Andexanet alfa | Ondexxya | Portola Netherlands B.V. | ||
| 2019/4/26 | D11052 | L04AC18 | Risankizumab | Skyrizi | AbbVie Deutschland GmbH & Co. KG | NME | |
| 2019/4/26 | D10669 | A10BK06 | Sotagliflozin | Zynquista | sanofi-aventis groupe | ||
| 2019/4/26 | D06889 | L03AA13 | Pegfilgrastim | Grasustek | Juta Pharma GmbH | B | |
| 2019/4/2 | D10514 | L01EB07 | Dacomitinib | Vizimpro | Pfizer Europe MA EEIG | NME | |
| 2019/4/2 | D02597 | L04AB04 | Adalimumab | Idacio, Kromeya | Fresenius Kabi Deutschland GmbH | B | |
| 2019/3/28 | D11055 | N02CD03 | Fremanezumab | Ajovy | Teva GmbH | NME | |
| 2019/3/28 | D01206 | M04AA03 | Febuxostat | Febuxostat Krka | Krka, d.d., Novo mesto | G | |
| 2019/3/25 | D07471 | J05AE08 | Atazanavir | Atazanavir Krka | Krka, d.d., Novo mesto | G | |
| 2019/2/18 | D00063 | J01GB01 | Tobramycin | Vantobra | Pari Pharma GmbH | ||
| 2019/2/18 | D10476 | B02BX07 | Lusutrombopag | Mulpleo | Shionogi B.V. | NME | |
| 2019/2/18 | D05032 | A16AX06 | Miglustat | Miglustat Dipharma | Dipharma B.V. | G | |
| 2019/2/18 | D10478 | A06AH05 | Naldemedine tosylate | Rizmoic | Shionogi B.V. | NME | |
| 2019/2/15 | D11027 | L03AB15 | Ropeginterferon alfa-2b | Besremi | AOP Orphan Pharmaceuticals AG | ||
| 2019/2/14 | D06409 | L01FG01 | Bevacizumab | Zirabev | Pfizer Europe MA EEIG | B | |
| 2019/1/14 | D11040 | L02BB05 | Apalutamide | Erleada | Janssen-Cilag International N.V. | NME | |
| 2019/1/11 | D10562 | V04CD06 | Macimorelin acetate | Macimorelin Aeterna Zentaris | Aeterna Zentaris GmbH | NME | |
| 2019/1/7 | D01965 | G04CA04 | Silodosin | Silodosin Recordati | Recordati Ireland Ltd | G | |
| 2018/12/18 | D11036 | R03AL07 | Glycopyrrolate and formoterol | Bevespi Aerosphere | AstraZeneca AB | ||
| 2018/12/18 | D00639 | C01BB02 | Mexiletine hydrochloride | Namuscla | Lupin Europe GmbH | O | |
| 2018/12/12 | D03257 | L01FD01 | Trastuzumab | Ogivri | Mylan S.A.S | B | |
| 2018/12/12 | J07BB02 | Influenza vaccine surface antigen inactivated prepared in cell cultures | Flucelvax Tetra | Seqirus Netherlands B.V. | |||
| 2018/12/12 | D12227 | J07BX04 | Dengue tetravalent vaccine | Dengvaxia | Sanofi Pasteur | ||
| 2018/11/22 | D11094 | B06AC05 | Lanadelumab | Takhzyro | Shire Pharmaceuticals Ireland Ltd | O | BLA |
| 2018/11/22 | D06889 | L03AA13 | Pegfilgrastim | Ziextenzo | Sandoz GmbH | B | |
| 2018/11/22 | D10624 | J05AG06 | Doravirine | Pifeltro | Merck Sharp & Dohme B.V. | NME | |
| 2018/11/22 | D10624 | J05AG06 | Doravirine | Delstrigo | Merck Sharp & Dohme B.V. | O | |
| 2018/11/22 | D10759 | B02BD02 | Damoctocog alfa pegol | Jivi | Bayer AG | ||
| 2018/11/22 | D11008 | S01XA27 | Voretigene neparvovec | Luxturna | Novartis Europharm Limited | ||
| 2018/11/22 | D10866 | L01ED04 | Brigatinib | Alunbrig | Takeda Pharma A/S | NME | |
| 2018/11/20 | D06889 | L03AA13 | Pegfilgrastim | Fulphila | Mylan S.A.S | B | |
| 2018/11/20 | D06889 | L03AA13 | Pegfilgrastim | Pelmeg | Cinfa Biotech S.L. | B | |
| 2018/11/20 | D00491 | L01CD01 | Paclitaxel | Apealea | Oasmia Pharmaceutical AB | ||
| 2018/11/20 | D07132 | N07BC01 | Buprenorphine | Buvidal | Camurus AB | NME | |
| 2018/11/20 | D11015 | J01DH52 | Meropenem and vaborbactam | Vabomere | Rempex London Ltd | NME | |
| 2018/11/14 | D10936 | N02CD02 | Galcanezumab | Emgality | Eli Lilly Nederland B.V. | BLA | |
| 2018/10/31 | D11042 | R07AX31 | Tezacaftor and ivacaftor | Symkevi | Vertex Pharmaceuticals (Europe) Ltd. | O | NME |
| 2018/9/27 | D01977 | L01EB01 | Gefitinib | Gefitinib Mylan | Mylan S.A.S. | G | |
| 2018/9/26 | D10688 | L01EF03 | Abemaciclib | Verzenios | Eli Lilly Nederland B.V. | NME | |
| 2018/9/21 | D10808 | L01FF03 | Durvalumab | Imfinzi | AstraZeneca AB | BLA | |
| 2018/9/21 | D06889 | L03AA13 | Pegfilgrastim | Udenyca | ERA Consulting GmbH | B | |
| 2018/9/20 | D06889 | L03AA13 | Pegfilgrastim | Pelgraz | Accord Healthcare Limited | B | |
| 2018/9/20 | D00535 | N03AG04 | Vigabatrin | Kigabeq | ORPHELIA Pharma SAS | NME | |
| 2018/9/20 | D10604 | L01EE03 | Binimetinib | Mektovi | Pierre Fabre Medicament | NME | |
| 2018/9/20 | D04687 | L04AX04 | Lenalidomide | Lenalidomide Accord | Accord Healthcare Limited | G | |
| 2018/9/20 | D08170 | N05CH01 | Melatonin | Slenyto | RAD Neurim Pharmaceuticals EEC Ltd. | ||
| 2018/9/20 | D10369 | J01AA13 | Eravacycline | Xerava | Tetraphase Pharmaceuticals Ireland Limited | NME | |
| 2018/9/19 | D07416 | V03AC02 | Deferiprone | Deferiprone Lipomed | Lipomed GmbH | G | |
| 2018/9/19 | D11053 | L01EC03 | Encorafenib | Braftovi | Pierre Fabre Medicament | NME | |
| 2018/9/17 | D10400 | L04AC17 | Tildrakizumab | Ilumetri | Almirall S.A | NME | |
| 2018/9/16 | D02597 | L04AB04 | Adalimumab | Hulio | Mylan S.A.S. | ||
| 2018/8/31 | D08681 | B02BD10 | Vonicog alfa | Veyvondi | Baxalta Innovations GmbH | ||
| 2018/8/31 | D10898 | L01EH02 | Neratinib | Nerlynx | Puma Biotechnology Limited | NME | |
| 2018/8/30 | D11160 | B01AX07 | Caplacizumab | Cablivi | Ablynx NV | O | BLA |
| 2018/8/27 | D09687 | G03XB02 | Ulipristal acetate | Ulipristal Acetate Gedeon Richter | Gedeon Richter Plc. | ||
| 2018/8/27 | D10794 | N07XX12 | Patisiran | Onpattro | Alnylam Netherlands B.V. | O | NME |
| 2018/8/23 | D11144 | L01XL03 | Axicabtagene ciloleucel | Yescarta | Kite Pharma EU B.V. | O | BLA |
| 2018/8/23 | D11004 | A16AB18 | Vestronidase alfa | Mepsevii | Ultragenyx Germany GmbH | O E | BLA |
| 2018/8/23 | D11390 | L01XY01 | Daunorubicin / cytarabine | Vyxeos | Jazz Pharmaceuticals Ireland Limited | O | |
| 2018/8/23 | D11175 | M04AA51 | Lesinurad and allopurinol | Duzallo | Grunenthal GmbH | NME | |
| 2018/8/22 | D11386 | L01XL04 | Tisagenlecleucel | Kymriah | Novartis Europharm Limited | BLA | |
| 2018/7/29 | D05014 | A16AA07 | Metreleptin | Myalepta | Aegerion Pharmaceuticals B.V. | O E | BLA |
| 2018/7/26 | D05177 | A16AX04 | Nitisinone | Nityr | Cycle Pharmaceuticals Ltd | G | |
| 2018/7/26 | D03257 | L01FD01 | Trastuzumab | Trazimera | Pfizer Europe MA EEIG | B | |
| 2018/7/26 | D10309 | N05AX16 | Brexpiprazole | Rxulti | Otsuka Pharmaceutical Europe Ltd | NME | |
| 2018/7/26 | D10928 | N02CD01 | Erenumab | Aimovig | Novartis Europharm Limited | BLA | |
| 2018/7/25 | D02597 | L04AB04 | Adalimumab | Hefiya | Sandoz GmbH | B | |
| 2018/7/25 | D02597 | L04AB04 | Adalimumab | Halimatoz | Sandoz GmbH | B | |
| 2018/7/25 | D02597 | L04AB04 | Adalimumab | Hyrimoz | Sandoz GmbH | B | |
| 2018/7/18 | D00254 | L01AD01 | Carmustine | Carmustine Obvius | Obvius Investment B.V. | G | |
| 2018/7/06 | D00184 | S01XA18 | Ciclosporin | Verkazia | Santen Oy | O | |
| 2018/7/05 | D10941 | N07XX15 | Inotersen sodium | Tegsedi | Ionis USA Ltd | O | NME |
| 2018/6/25 | D05938 | N01AH03 | Sufentanil | Dzuveo | FGK Representative Service GmbH | ||
| 2018/6/21 | D11039 | J05AR20 | Bictegravir, embitcitabine and tenofovir alafenamide | Biktarvy | Gilead Sciences International Limited | NME | |
| 2018/5/24 | D00336 | A10BB01 | Glibenclamide | Amglidia | Ammtek | O | |
| 2018/5/24 | D10982 | L01XK03 | Rucaparib | Rubraca | Clovis Oncology UK Limited | O | NME |
| 2018/5/22 | D07472 | L01BA04 | Pemetrexed | Pemetrexed Krka | KRKA d.d. | G | |
| 2018/5/18 | D02598 | L04AB02 | Infliximab | Zessly | Sandoz GmbH | B | |
| 2018/5/16 | D03257 | L01FD01 | Trastuzumab | Kanjinti | Amgen Europe B.V., Breda | B | |
| 2018/5/16 | D11282 | J05AR21 | Dolutegravir sodium and rilpivirine hydrochloride | Juluca | ViiV Healthcare UK Limited | ||
| 2018/5/15 | D05597 | B01AC22 | Prasugrel | Prasugrel Mylan | Mylan S.A.S | G | |
| 2018/4/26 | R03AL09 | Beclometasone / Formoterol / Glycopyrronium bromide | Trydonis | Chiesi Farmaceutici S.p.A. | |||
| 2018/4/23 | R03AL09 | Beclometasone / Formoterol / Glycopyrronium bromide | Riarify | Chiesi Farmaceutici S.p.A. | |||
| 2018/4/19 | D03259 | L01FX02 | Gemtuzumab ozogamicin | Mylotarg | Pfizer Limited | O | BLA |
| 2018/4/13 | D03829 | J05AH03 | Peramivir | Alpivab | Biocryst UK Limited | NME | |
| 2018/3/23 | D11024 | A16AB15 | Velmanase alfa | Lamzede | Chiesi Farmaceutici S.p.A. | O E | BLA |
| 2018/3/23 | D11066 | A10BD24 | Ertugliflozin / Sitagliptin | Steglujan | Merck Sharp & Dohme Limited | ||
| 2018/3/23 | D11067 | A10BD23 | Ertugliflozin / Metformin hydrochloride | Segluromet | Merck Sharp & Dohme Limited | ||
| 2018/3/23 | D03250 | A10AE04 | Insulin glargine | Semglee | Mylan S.A.S | B | |
| 2018/3/23 | D11397 | L04AX08 | Darvadstrocel | Alofisel | Tigenix, S.A.U. | O | BLA |
| 2018/3/22 | D10727 | V03AE10 | Sodium zirconium cyclosilicate | Lokelma | AstraZeneca AB | NME | |
| 2018/3/21 | J07BK03 | Herpes zoster vaccine | Shingrix | GlaxoSmithkline Biologicals SA | |||
| 2018/3/21 | D11043 | A10BK04 | Ertugliflozin | Steglatro | Merck Sharp & Dohme Limited | NME | |
| 2018/2/23 | D10821 | B02BX06 | Emicizumab | Hemlibra | Roche Registration Limited | BLA | |
| 2018/2/19 | D10913 | M05BX05 | Burosumab | Crysvita | Kyowa Kirin Limited | O C | BLA |
| 2018/2/15 | D07455 | L01XX35 | Anagrelide | Anagrelide Mylan | Mylan S.A.S. | G | |
| 2018/2/9 | D00088 | H02AB09 | Hydrocortisone | Alkindi | Diurnal Limited | ||
| 2018/2/8 | D03257 | L01FD01 | Trastuzumab | Herzuma | Celltrion Healthcare Hungary Kft. | B | |
| 2018/2/8 | D10025 | A10BJ06 | Semaglutide | Ozempic | Novo Nordisk A/S | NME | |
| 2018/2/8 | D10851 | J05AR06 | Efavirenz, emtricitabine and tenofovir disoproxil | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | KRKA, d.d., Novo mesto | G | |
| 2018/1/26 | D03656 | J05AE10 | Darunavir | Darunavir Krka | KRKA, d.d., Novo mesto | G | |
| 2018/1/18 | D03656 | J05AE10 | Darunavir | Darunavir Krka d.d. | KRKA, d.d., Novo mesto | G | |
| 2018/1/14 | D06409 | L01FG01 | Bevacizumab | Mvasi | Amgen Europe B.V. | B | |
| 2018/1/8 | D00246 | A07EA06 | Budesonide | Jorveza | Dr. Falk Pharma GmbH | O | |
| 2018/1/8 | D01161 | L02BA03 | Fulvestrant | Fulvestrant Mylan | Mylan S.A.S | G | |
| 2018/1/8 | D09874 | R03DX10 | Benralizumab | Fasenra | AstraZeneca AB | BLA | |
| 2018/1/8 | D05218 | L04AG08 | Ocrelizumab | Ocrevus | Roche Registration Limited | BLA | |
| 2018/1/8 | D10760 | B02BD02 | Rurioctocog alfa pegol | Adynovi | Baxalta Innovations GmbH | ||
| 2018/1/8 | D08409 | G03XX01 | Prasterone | Intrarosa | Endoceutics Limited | ||
| 2018/1/8 | D10801 | J05AX18 | Letermovir | Prevymis | Merck Sharp & Dohme Limited | O | NME |
| 2017/12/8 | D00107 | L04AD02 | Tacrolimus | Tacforius | Teva B.V. | G | |
| 2017/11/16 | D11895 | L01XK02 | Niraparib tosylate monohydrate | Zejula | Tesaro UK Limited | O | NME |
| 2017/11/15 | D03257 | L01FD01 | Trastuzumab | Ontruzant | Samsung Bioepis NL B.V. | B | |
| 2017/11/15 | D08066 | L01EA01 | Imatinib | Imatinib Teva B.V. | Teva B.V. | G | |
| 2017/11/15 | D11035 | R03AL08 | Fluticasone furoate / umeclidinium / vilanterol | Trelegy Ellipta | GlaxoSmithKline Trading Services | ||
| 2017/11/15 | D11035 | R03AL08 | Fluticasone furoate / umeclidinium / vilanterol | Elebrato Ellipta | GlaxoSmithKline Trading Services Limited | ||
| 2017/11/10 | D02597 | L04AB04 | Adalimumab | Cyltezo | Boehringer Ingelheim International GmbH | B | |
| 2017/11/10 | D10438 | L04AC16 | Guselkumab | Tremfya | Janssen-Cilag International N.V. | BLA | |
| 2017/11/10 | D10973 | L01XD07 | Padeliporfin | Tookad | STEBA Biotech S.A | NME | |
| 2017/11/10 | B02BC | Human fibrinogen / human thrombin | VeraSeal | Instituto Grifols, S.A. | |||
| 2017/11/10 | D10250 | N07BC51 | Buprenorphine / naloxone | Zubsolv | Mundipharma Corporation Limited | ||
| 2017/11/9 | D08249 | V03AB15 | Naloxone | Nyxoid | Mundipharma Corporation (Ireland) Limited | ||
| 2017/11/9 | D05032 | A16AX06 | Miglustat | Miglustat Gen.Orph | Gen.Orph | G | |
| 2017/11/9 | D00427 | J05AE03 | Ritonavir | Ritonavir Mylan | MYLAN S.A.S | G | |
| 2017/9/27 | D10354 | D11AH05 | Dupilumab | Dupixent | sanofi-aventis groupe | BLA | |
| 2017/9/26 | D11033 | V10XX04 | Lutetium 177Lu oxodotreotide | Lutathera | Advanced Accelerator Applications | O | |
| 2017/9/25 | D04008 | J05AF10 | Entecavir | Entecavir Accord | Accord Healthcare Ltd | G | |
| 2017/9/21 | D10773 | L01FF05 | Atezolizumab | Tecentriq | Roche Registration Limited | BLA | |
| 2017/9/20 | D11382 | J05AR22 | Darunavir / Cobicistat / Emtricitabine / Tenofovir alafenamide | Symtuza | Janssen-Cilag International N.V. | ||
| 2017/9/18 | D10817 | L01FF04 | Avelumab | Bavencio | Merck Serono Europe Limited | O | BLA |
| 2017/9/18 | D07299 | N03AX18 | Lacosamide | Lacosamide Accord | Accord Healthcare Ltd | G | |
| 2017/9/18 | D05029 | L01EX10 | Midostaurin | Rydapt | Novartis Europharm Ltd | O | NME |
| 2017/9/18 | D04008 | J05AF10 | Entecavir | Entecavir Mylan | Mylan S.A.S | G | |
| 2017/9/17 | D09974 | A16AX15 | Telotristat ethyl | Xermelo | Ipsen Pharma | O | NME |
| 2017/9/5 | D11649 | A16AX12 | Trientine tetrahydrochloride | Cuprior | GMP-Orphan SA | ||
| 2017/9/5 | D10851 | J05AR06 | Efavirenz, emtricitabine and tenofovir disoproxil | Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan | Mylan S.A.S | G | |
| 2017/8/24 | D02597 | L04AB04 | Adalimumab | Imraldi | Samsung Bioepis UK Limited (SBUK) | B | |
| 2017/8/24 | D05177 | A16AX04 | Nitisinone | Nitisinone MDK | MendeliKABS Europe Ltd | G | |
| 2017/8/24 | D10190 | L01EK03 | Tivozanib hydrochloride monohydrate | Fotivda | EUSA Pharma (UK) Limited | NME | |
| 2017/8/22 | D01370 | L01BB04 | Cladribine | Mavenclad | Merck Serono Europe Limited | ||
| 2017/8/22 | D10979 | L01EF02 | Ribociclib | Kisqali | Novartis Europharm Ltd | NME | |
| 2017/7/26 | D11014 | J05AP57 | Glecaprevir and pibrentasvir | Maviret | AbbVie Limited | NME | |
| 2017/7/26 | D10900 | J05AP56 | Sofosbuvir, velpatasvir and voxilaprevir | Vosevi | Gilead Sciences International Ltd | NME | |
| 2017/7/19 | D11037 | V03AE09 | Patiromer sorbitex calcium | Veltassa | Vifor Fresenius Medical Care Renal Pharma France | NME | |
| 2017/7/18 | D04477 | A10AB04 | Insulin lispro | Insulin lispro Sanofi | sanofi-aventis groupe | B | |
| 2017/7/17 | R03AL09 | Beclometasone / Formoterol / Glycopyrronium bromide | Trimbow | Chiesi Farmaceutici S.p.A. | |||
| 2017/7/17 | D10061 | L04AC12 | Brodalumab | Kyntheum | LEO Pharma A/S | BLA | |
| 2017/7/17 | D10851 | J05AR06 | Efavirenz, emtricitabine and tenofovir disoproxil | Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva | Zentiva k.s. | G | |
| 2017/7/13 | D09997 | N05AX15 | Cariprazine | Reagila | Gedeon Richter | ||
| 2017/7/13 | D02994 | L01FA01 | Rituximab | Ritemvia | Celltrion Healthcare Hungary Kft. | B | |
| 2017/7/13 | D02994 | L01FA01 | Rituximab | Rituzena | Celltrion Healthcare Hungary Kft. | B | |
| 2017/7/13 | D02994 | L01FA01 | Rituximab | Blitzima | Celltrion Healthcare Hungary Kft. | B | |
| 2017/7/10 | M09AX02 | Spheroids of human autologous matrix-associated chondrocytes | Spherox | CO.DON AG | |||
| 2017/7/6 | D11028 | S01XA24 | Cenegermin | Oxervate | Dompe farmaceutici s.p.a. | O | BLA |
| 2017/6/28 | D08933 | L01FB01 | Inotuzumab ozogamicin | Besponsa | Pfizer Limited | O | BLA |
| 2017/6/23 | D00742 | L04AB01 | Etanercept | Erelzi | Sandoz GmbH | ||
| 2017/6/23 | D03846 | L04AX07 | Dimethyl fumarate | Skilarence | Almirall S.A | ||
| 2017/6/23 | D10161 | L04AC14 | Sarilumab | Kevzara | Sanofi-Aventis Groupe | NME | |
| 2017/6/23 | D07130 | A16AA05 | Carglumic acid | Ucedane | Lucane Pharma | G | |
| 2017/6/15 | D02994 | L01FA01 | Rituximab | Rixathon, Riximyo | Sandoz GmbH | B | |
| 2017/6/15 | D01206 | M04AA03 | Febuxostat | Febuxostat Mylan | Mylan S.A.S | G | |
| 2017/6/15 | D02994 | L01FA01 | Rituximab | Riximyo | Sandoz GmbH | B | |
| 2017/6/2 | D05428 | G04BX15 | Pentosan polysulfate sodium | Elmiron | bene-Arzneimittel GmbH | ||
| 2017/6/2 | D10757 | B02BD04 | Nonacog beta pegol | Refixia | Novo Nordisk A/S | ||
| 2017/5/30 | D10813 | A16AB17 | Cerliponase alfa | Brineura | BioMarin International Limited | O E | BLA |
| 2017/5/30 | D10791 | M09AX07 | Nusinersen | Spinraza | Biogen Idec Ltd | O | NME |
| 2017/5/24 | J07AH09 | Meningococcal group b vaccine (recombinant, adsorbed) | Trumenba | Pfizer Limited | |||
| 2017/5/22 | D07165 | C01EB17 | Ivabradine | Ivabradine Accord | Accord Healthcare Ltd | G | |
| 2017/5/21 | D10860 | V09IX12 | Fluciclovine 18F | Axumin | Blue Earth Diagnostics Ltd | ||
| 2017/5/8 | D10559 | L01FX06 | Dinutuximab beta | Dinutuximab beta Apeiron | Apeiron Biologics AG | O E | |
| 2017/4/28 | D10777 | L01FC01 | Daratumumab | Darzalex | Blue Earth Diagnostics Ltd | BLA | |
| 2017/4/28 | D02297 | J05AR03 | Emtricitabine and tenofovir disoproxil | Emtricitabine/Tenofovir disoproxil Krka d.d. | KRKA, d.d., Novo mesto | G | |
| 2017/4/24 | D05364 | H05AA03 | Parathyroid hormone | Natpar | Shire Pharmaceuticals Ireland Ltd | O C | BLA |
| 2017/4/24 | D07472 | L01BA04 | Pemetrexed | Pemetrexed Pfizer | Pfizer Europe MA EEIG | G | |
| 2017/4/19 | D10742 | A04AD14 | Rolapitant | Varuby | Tesaro UK Limited | ||
| 2017/4/19 | D09710 | B01AF03 | Edoxaban | Roteas | Daiichi Sankyo Europe GmbH | ||
| 2017/4/10 | D00163 | A05AA01 | Chenodeoxycholic acid | Chenodeoxycholic acid Leadiant | Leadiant GmbH | O E | |
| 2017/3/29 | D00142 | L01BA01 | Methotrexate | Jylamvo | Therakind Limited | ||
| 2017/3/22 | D05032 | A16AX06 | Miglustat | Yargesa | JensonR+ Limited | G | |
| 2017/3/22 | D02008 | G04BE08 | Tadalafil | Tadalafil Lilly | Eli Lilly Nederland B.V. | ||
| 2017/3/22 | D02597 | L04AB04 | Adalimumab | Solymbic | Amgen Europe B.V. | B | |
| 2017/3/22 | D01080 | J01XX09 | Daptomycin | Daptomycin Hospira | Hospira UK Limited | G | |
| 2017/3/21 | D02597 | L04AB04 | Adalimumab | Amgevita | Amgen Europe B.V. | B | |
| 2017/3/21 | D09783 | L04AF01 | Tofacitinib citrate | Xeljanz | Pfizer Limited | NME | |
| 2017/3/20 | D10181 | R03BB07 | Umeclidinium bromide | Rolufta Ellipta | GlaxoSmithKline Trading Services Limited | ||
| 2017/3/3 | D07671 | L01AA05 | Chlormethine | Ledaga | Actelion Registration Ltd. | O | |
| 2017/2/27 | D02716 | N02BF02 | Pregabalin | Pregabalin Zentiva | Zentiva k.s. | G | |
| 2017/2/17 | D02994 | L01FA01 | Rituximab | Truxima | Celltrion Healthcare Hungary Kft. | B | |
| 2017/2/16 | D10450 | L01ED03 | Alectinib | Alecensa | Roche Registration GmbH | NME | |
| 2017/2/13 | D10842 | B02BD02 | Simoctocog alfa | Vihuma | Octapharma AB | ||
| 2017/2/13 | D00742 | L04AB01 | Etanercept | Lifmior | Pfizer Limited | ||
| 2017/2/13 | D10308 | L04AF02 | Baricitinib | Olumiant | Eli Lilly Nederland B.V. | NME | |
| 2017/1/18 | D03634 | S01XA21 | Mercaptamine | Cystadrops | Orphan Europe S.A.R.L. | O | |
| 2017/1/18 | D10453 | J06BC03 | Bezlotoxumab | Zinplava | Merck Sharp & Dohme Limited | NME | |
| 2017/1/11 | D11034 | A10AE54 | Insulin glargine and lixisenatide | Suliqua | Sanofi-Aventis Groupe | ||
| 2017/1/11 | D06078 | H05AA02 | Teriparatide | Movymia | STADA Arzneimittel AG | B | |
| 2017/1/9 | D02008 | G04BE08 | Tadalafil | Tadalafil | Mylan S.A.S | G | |
| 2017/1/9 | D04475 | A10AB05 | Insulin aspart | Fiasp | Novo Nordisk A/S | ||
| 2017/1/9 | D10428 | J05AF13 | Tenofovir alafenamide | Vemlidy | Gilead Sciences International Ltd | ||
| 2017/1/4 | D10818 | B02BD02 | Lonoctocog alfa | Afstyla | CSL Behring GmbH | ||
| 2017/1/4 | D06078 | H05AA02 | Teriparatide | Terrosa | Gedeon Richter Plc. | B | |
| 2017/1/3 | D03250 | A10AE04 | Insulin glargine | Lusduna | Merck Sharp & Dohme Limited | B | |
| 2017/1/3 | D03656 | J05AE10 | Darunavir | Darunavir Mylan | Mylan S.A.S. | G | |
| 2016/12/16 | D02297 | J05AR03 | Emtricitabine and tenofovir disoproxil | Emtricitabine/Tenofovir disoproxil Mylan | Mylan S.A.S | G | |
| 2016/12/12 | D06400 | G03GA10 | Follitropin delta | Rekovelle | Ferring Pharmaceuticals A/S | ||
| 2016/12/12 | D09360 | A05AA04 | Obeticholic acid | Ocaliva | Intercept Pharma Ltd | O C | NME |
| 2016/12/9 | D02297 | J05AR03 | Emtricitabine / tenofovir disoproxil | Emtricitabine/Tenofovir disoproxil Krka | KRKA, d.d., Novo mesto | G | |
| 2016/12/8 | D03955 | V09IX | Edotreotide | SomaKit TOC | Advanced Accelerator Applications | O | |
| 2016/12/8 | D11391 | J05AF07 | Tenofovir disoproxil | Tenofovir disoproxil Mylan | Mylan S.A.S | G | |
| 2016/12/4 | D10679 | L01XX52 | Venetoclax | Venclyxto | AbbVie Ltd | O C | NME |
| 2016/11/21 | D10131 | L01XG03 | Ixazomib citrate | Ninlaro | Takeda Pharma A/S | O C | NME |
| 2016/11/14 | D08514 | G04BE03 | Sildenafil | Granpidam | Accord Healthcare Ltd | G | |
| 2016/11/11 | D10677 | H05BX04 | Etelcalcetide hydrochloride | Parsabiv | Amgen Europe B.V. | NME | |
| 2016/11/11 | D10588 | A10BD19 | Empagliflozin and linagliptin | Glyxambi | Boehringer Ingelheim International GmbH | ||
| 2016/11/11 | D07165 | C01EB17 | Ivabradine | Ivabradine Zentiva | JensonR+ Limited | G | |
| 2016/11/11 | D07165 | C01EB17 | Ivabradine | Ivabradine Zentiva | Zentiva, k.s. | G | |
| 2016/11/9 | D09939 | L01FX10 | Olaratumab | Lartruvo | Eli Lilly Nederland B.V. | O | BLA |
| 2016/11/9 | D10372 | L01EF01 | Palbociclib | Ibrance | Pfizer Limited | NME | |
| 2016/11/9 | D02297 | J05AR03 | Emtricitabine and tenofovir disoproxil | Emtricitabine/Tenofovir disoproxil Zentiva | Zentiva k.s. | G | |
| 2016/10/14 | D01061 | L01CE02 | Irinotecan hydrochloride trihydrate | Onivyde | Baxalta Innovations GmbH | O | |
| 2016/9/19 | D10403 | A07DA06 | Eluxadoline | Truberzi | Aptalis Pharma SAS | NME | |
| 2016/9/15 | D08514 | G04BE03 | Sildenafil | Mysildecard | Mylan S.A.S. | G | |
| 2016/9/15 | D00540 | A03AB02 | Glycopyrronium bromide | Sialanar | Proveca Limited | ||
| 2016/9/15 | D03674 | B01AB05 | Enoxaparin sodium | Thorinane, Inhixa | Pharmathen S.A., Techdow Europe AB | B | |
| 2016/9/15 | D10834 | J05AF07 | Tenofovir disoproxil | Tenofovir disoproxil Zentiva | Zentiva k.s. | G | |
| 2016/9/14 | D03674 | B01AB05 | Enoxaparin sodium | Thorinane | Pharmathen S.A. | B | |
| 2016/9/9 | D10062 | L01EX07 | Cabozantinib | Cabometyx | Ipsen Pharma | ||
| 2016/8/25 | D09919 | L01EX08 | Lenvatinib | Kisplyx | Eisai Europe Ltd | ||
| 2016/8/22 | D07471 | J05AE08 | Atazanavir | Atazanavir Mylan | Mylan S.A.S. | G | |
| 2016/8/18 | D08699 | R03AK06 | Salmeterol / fluticasone propionate | Aerivio Spiromax | Teva B.V. | ||
| 2016/8/18 | D00142 | L01BA01 | Methotrexate | Nordimet | Nordic Group B.V. | ||
| 2016/8/18 | D08699 | R03AK06 | Salmeterol xinafoate and fluticasone propionate | Aerivio Spiromax, Airexar Spiromax | Teva B.V. | ||
| 2016/8/18 | L01 | Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2) | Zalmoxis | MolMed SpA | O C | ||
| 2016/8/15 | D08985 | R03DX08 | Reslizumab | Cinqaero | Teva Pharmaceuticals Limited | BLA | |
| 2016/7/22 | D03150 | L01XG01 | Bortezomib | Bortezomib Hospira, Bortezomib Sun | Hospira UK Limited, SUN Pharmaceutical Industries (Europe) B.V. | G | |
| 2016/7/22 | D07472 | L01BA04 | Pemetrexed | Pemetrexed Fresenius Kabi | Fresenius Kabi Oncology Plc | G | |
| 2016/7/22 | D03150 | L01XG01 | Bortezomib | Bortezomib Hospira | Pfizer Europe MA EEIG | G | |
| 2016/7/22 | D10778 | J05AP54 | Elbasvir and grazoprevir | Zepatier | Merck Sharp & Dohme Limited | NME | |
| 2016/7/15 | D10826 | A10BD21 | Saxagliptin and dapagliflozin | Qtern | Astra Zeneca AB | ||
| 2016/7/6 | D10828 | V10X | Lutetium (177 Lu) chloride | EndolucinBeta | ITG Isotope Technologies Garching GmbH | ||
| 2016/7/6 | D10827 | J05AP55 | Sofosbuvir and velpatasvir | Epclusa | Gilead Sciences International Ltd | NME | |
| 2016/7/1 | D03639 | L04AC01 | Daclizumab | Zinbryta | Biogen Idec Ltd | BLA | |
| 2016/6/29 | A09AA02 | Pancreas powder | Enzepi | Allergan Pharmaceuticals International Ltd | |||
| 2016/6/24 | D10825 | N04BX04 | Opicapone | Ongentys | Bial - Portela & C_, S.A. | ||
| 2016/6/23 | D10779 | J01DD52 | Ceftazidime and avibactam | Zavicefta | AstraZeneca AB | NME | |
| 2016/6/21 | D10836 | J05AR19 | Emtricitabine, rilpivirine and tenofovir alafenamide | Odefsey | Gilead Sciences International Ltd | ||
| 2016/5/26 | D02598 | L04AB02 | Infliximab | Flixabi | Samsung Bioepis UK Limited (SBUK) | B | |
| 2016/5/26 | L03 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence | Strimvelis | GlaxoSmithKline Trading Services Limited | O | ||
| 2016/5/26 | D07175 | A04AA05 | Palonosetron | Palonosetron Accord | Accord Healthcare Ltd | G | |
| 2016/5/26 | D10226 | C09DX04 | Sacubitril / valsartan | Neparvis | Novartis Europharm Ltd | ||
| 2016/5/25 | D05031 | A16AX14 | Migalastat hydrochloride | Galafold | Amicus Therapeutics UK Ltd | O | NME |
| 2016/5/20 | J07BB03 | Pandemic influenza vaccine (H5N1) (live attenuated, nasal) | Pandemic influenza vaccine H5N1 MedImmune | MedImmune LLC | C | ||
| 2016/5/12 | D10522 | B02BD04 | Eftrenonacog alfa | Alprolix | Biogen Idec Ltd | O | |
| 2016/5/12 | D09994 | B01AC27 | Selexipag | Uptravi | Actelion Registration Ltd | NME | |
| 2016/5/11 | D09337 | L01FX08 | Elotuzumab | Empliciti | Bristol-Myers Squibb | BLA | |
| 2016/5/11 | D10770 | B02BD04 | Albutrepenonacog alfa | Idelvion | CSL Behring GmbH | O | |
| 2016/4/25 | D10071 | L04AC13 | Ixekizumab | Taltz | Eli Lilly Nederland B.V. | BLA | |
| 2016/4/25 | D10526 | L01BC59 | Trifluridine / tipiracil hydrochloride | Lonsurf | Les Laboratoires Servier | NME | |
| 2016/4/21 | D10835 | J05AR17 | Emtricitabine / tenofovir alafenamide | Descovy | Gilead Sciences International Ltd | ||
| 2016/4/8 | D05343 | A04AA05 | Palonosetron hydrochloride | Palonosetron Hospira | Hospira UK Limited | G | |
| 2016/4/4 | D10829 | N04BD02 | Rasagiline tartrate | Rasagiline Mylan | Mylan S.A.S. | G | |
| 2016/3/31 | D10749 | N07XX11 | Pitolisant | Wakix | Bioprojet Pharma | O | |
| 2016/3/31 | D00538 | N03AX15 | Zonisamide | Zonisamide Mylan | Mylan S.A.S. | G | |
| 2016/3/22 | D09745 | C09DB01 | Amlodipine / valsartan besilate | Amlodipine / Valsartan Mylan | Mylan S.A.S | G | |
| 2016/3/16 | D00292 | H02AB02 | Dexamethasone | Neofordex | Laboratoires CTRS | ||
| 2016/3/16 | B02BD13 | human coagulation factor X | Coagadex | Bio Products Laboratory Limited | O | ||
| 2016/2/18 | D09921 | M04AB05 | Lesinurad | Zurampic | Gr_nenthal GmbH | NME | |
| 2016/2/18 | D05401 | B02BD02 | Octocog alfa | Iblias | Bayer Pharma AG | ||
| 2016/2/18 | D05401 | B02BD02 | Octocog alfa | Kovaltry | Bayer Pharma AG | ||
| 2016/2/18 | D10833 | B03AB10 | Ferric maltol | Feraccru | Shield TX (UK) Limited | ||
| 2016/2/15 | D06480 | J06AA01 | Diphtheria | Vaxelis | MCM Vaccine B.V. | ||
| 2016/2/15 | D10018 | L01FE03 | Necitumumab | Portrazza | Eli Lilly Nederland B.V. | BLA | |
| 2016/2/11 | D02501 | J02AX04 | Caspofungin acetate | Caspofungin Accord | Accord Healthcare Ltd | ||
| 2016/2/1 | D10766 | L01EB04 | Osimertinib mesylate | Tagrisso | AstraZeneca AB | C | NME |
| 2016/1/18 | D07472 | L01BA04 | Pemetrexed disodium hemipentahydrate | Pemetrexed Accord | Accord Healthcare Ltd | G | |
| 2016/1/18 | D07472 | L01BA04 | Pemetrexed diacid monohydrate | Armisarte (previously Pemetrexed Actavis) | Actavis Group PTC ehf | ||
| 2016/1/14 | D05387 | L01XX24 | Pegaspargase | Oncaspar | Baxalta Innovations GmbH | ||
| 2016/1/14 | D03AX13 | Birch bark extract | Episalvan | Birken AG | |||
| 2016/1/14 | D02997 | L01XX02 | Asparaginase | Spectrila | Medac Gesellschaft fuer klinische Spezialpraeparate mbH | BLA | |
| 2016/1/14 | D02498 | J05AR10 | Lopinavir / ritonavir | Lopinavir/Ritonavir Mylan | Mylan S.A.S. | G | |
| 2016/1/13 | D08879 | N03AX23 | Brivaracetam | Briviact | UCB Pharma SA | NME | |
| 2016/1/13 | D00742 | L04AB01 | Etanercept | Benepali | Samsung Bioepis UK Limited (SBUK) | B | |
| 2016/1/11 | D06888 | B01AC16 | Eptifibatide | Eptifibatide Accord | Accord Healthcare Limited | G | |
| 2015/12/16 | D09966 | L01XL02 | Talimogene laherparepvec | Imlygic | Amgen Europe B.V. | BLA | |
| 2015/12/2 | D04923 | R03DX09 | Mepolizumab | Nucala | GlaxoSmithKline Trading Services | BLA | |
| 2015/12/2 | D10596 | L01BA04 | Pemetrexed disodium hemipentahydrate | Ciambra | Menarini International Operations Luxembourg S.A. | G | |
| 2015/11/27 | D07472 | L01BA04 | Pemetrexed | Pemetrexed medac | Medac Gesellschaft fur klinische Spezialpraparate mbH | G | |
| 2015/11/27 | D10127 | A16AX09 | Glycerol phenylbutyrate | Ravicti | Horizon Pharma Ireland Limited | O | |
| 2015/11/23 | D09325 | L01FX07 | Blinatumomab | Blincyto | Amgen Europe B.V. | O C | BLA |
| 2015/11/20 | D10615 | L01EE02 | Cobimetinib hemifumarate | Cotellic | Roche Registration Ltd | NME | |
| 2015/11/20 | D10699 | A05AA03 | Cholic acid | Kolbam | Retrophin Europe Ltd | O E | |
| 2015/11/20 | D10741 | V03AB37 | Idarucizumab | Praxbind | Boehringer Ingelheim International GmbH | BLA | |
| 2015/11/20 | D07472 | L01BA04 | Pemetrexed | Pemetrexed Hospira | Hospira UK Limited | G | |
| 2015/11/19 | D03505 | H05BX01 | Cinacalcet hydrochloride | Cinacalcet Mylan | Mylan S.A.S. | G | |
| 2015/11/19 | D10830 | B02BD02 | Efmoroctocog alfa | Elocta | Swedish Orphan Biovitrum AB (publ) | ||
| 2015/11/19 | D10685 | R07AX30 | Lumacaftor / ivacaftor | Orkambi | Vertex Pharmaceuticals (Europe) Ltd | NME | |
| 2015/11/19 | D00253 | N04BA02 | Levodopa / carbidopa | Numient | Impax Laboratories (Netherlands) BV | ||
| 2015/11/19 | D10811 | N02AB03 | Fentanyl hydrochloride | Ionsys | Incline Therapeutics Europe Ltd | ||
| 2015/11/19 | D10755 | J05AR18 | Elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide | Genvoya | Gilead Sciences International Ltd | NME | |
| 2015/11/19 | D08880 | L01XG02 | Carfilzomib | Kyprolis | Amgen Europe B.V. | O | NME |
| 2015/11/19 | D10226 | C09DX04 | Sacubitril / valsartan | Entresto | Novartis Europharm Ltd | NME | |
| 2015/11/16 | D01164 | N05AX12 | Aripiprazole | Aripiprazole Accord | Accord Healthcare Ltd | G | |
| 2015/11/16 | D10586 | A10BD15 | Dapagliflozin and metformin | Ebymect | AstraZeneca AB | ||
| 2015/11/11 | D10831 | B02BD02 | Susoctocog alfa | Obizur | Baxalta Innovations GmbH | E | |
| 2015/11/9 | D09763 | A10BK01 | Dapagliflozin propanediol monohydrate | Edistride | AstraZeneca AB | ||
| 2015/10/15 | D10643 | Isavuconazonium sulfate | Cresemba | Basilea Medical Ltd | O | NME | |
| 2015/9/23 | D10335 | C10AX14 | Alirocumab | Praluent | sanofi-aventis groupe | BLA | |
| 2015/9/23 | D09993 | V03AE08 | Ferric citrate coordination complex | Fexeric | Keryx Biopharma UK Ltd | ||
| 2015/9/18 | D10596 | L01BA04 | Pemetrexed disodium hemipentahydrate | Pemetrexed Sandoz | Sandoz GmbH | G | |
| 2015/9/18 | D10577 | J01DI54 | Ceftolozane sulfate and tazobactam sodium | Zerbaxa | Merck Sharp & Dohme Limited | NME | |
| 2015/9/18 | D05938 | N01AH03 | Sufentanil | Zalviso | Grunenthal GmbH | ||
| 2015/9/17 | D00606 | C02AC02 | Guanfacine hydrochloride | Intuniv | Shire Pharmaceuticals Ireland Ltd | ||
| 2015/9/14 | D07472 | L01BA04 | Pemetrexed | Pemetrexed Lilly | Eli Lilly Netherlands | G | |
| 2015/9/8 | D01750 | N06BX13 | Idebenone | Raxone | Santhera Pharmaceuticals (Deutschland) GmbH | O E | |
| 2015/9/8 | D07165 | C01EB17 | Ivabradine | Ivabradine Anpharm | Anpharm Przedsi_biorstwo Farmaceutyczne S.A. | ||
| 2015/8/28 | D10595 | A16AB13 | Asfotase alfa | Strensiq | Alexion Europe SAS | O E | BLA |
| 2015/8/28 | D10019 | L01XH03 | Panobinostat lactate anhydrous | Farydak | Novartis Europharm Ltd | O | NME |
| 2015/8/28 | D02716 | N02BF02 | Pregabalin | Pregabalin Accord | Accord Healthcare Limited | G | |
| 2015/8/28 | D10377 | A16AB14 | Sebelipase alfa | Kanuma | Alexion Europe SAS | O | BLA |
| 2015/8/28 | D02165 | L01CD02 | Docetaxel trihydrate | Taxespira (previously Docetaxel Hospira UK Limited ) | Hospira UK Limited | G | |
| 2015/8/20 | D07880 | N06AX21 | Duloxetine | Duloxetine Zentiva | Zentiva, k.s. | G | |
| 2015/8/20 | D01164 | N05AX12 | Aripiprazole | Aripiprazole Sandoz | Sandoz GmbH | G | |
| 2015/8/20 | D11965 | B02AB02 | human alpha1-proteinase inhibitor | Respreeza | CSL Behring GmbH | ||
| 2015/8/14 | D10559 | L01FX06 | Dinutuximab | Unituxin | United Therapeutics Europe Ltd | O | BLA |
| 2015/8/14 | D10729 | L01XJ02 | Sonidegib diphosphate | Odomzo | Novartis Europharm Ltd | NME | |
| 2015/7/28 | D10837 | S01FB51 | Phenylephrine and ketorolac | Omidria | Omeros London Limited | ||
| 2015/7/20 | D03150 | L01XG01 | Bortezomib | Bortezomib Accord | Accord Healthcare Ltd | G | |
| 2015/7/17 | D10557 | C10AX13 | Evolocumab | Repatha | Amgen Europe B.V. | BLA | |
| 2015/7/17 | D10574 | L01FF02 | Pembrolizumab | Keytruda | Merck Sharp & Dohme Limited | BLA | |
| 2015/7/13 | D10753 | J05AR15 | Atazanavir and cobicistat | Evotaz | Bristol-Myers Squibb Pharma EEIG | ||
| 2015/7/3 | D09388 | N05CH03 | Tasimelteon | Hetlioz | Vanda Pharmaceuticals Ltd | O | NME |
| 2015/6/30 | D01164 | N05AX12 | Aripiprazole | Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) | Mylan S.A.S | G | |
| 2015/6/25 | D01164 | N05AX12 | Aripiprazole | Aripiprazole Zentiva | Zentiva, k.s. | G | |
| 2015/6/25 | D02716 | N02BF02 | Pregabalin | Pregabalin Mylan Pharma, Pregabalin Mylan | Generics UK Limited, Generics (UK) Limited | G | |
| 2015/6/19 | D09546 | B01AF03 | Edoxaban tosylate | Lixiana | Daiichi Sankyo Europe GmbH | NME | |
| 2015/6/19 | D02716 | N02BF02 | Pregabalin | Pregabalin Sandoz | Sandoz GmbH | G | |
| 2015/6/19 | D07880 | N06AX21 | Duloxetine | Duloxetine Mylan | Generics (UK) Limited | G | |
| 2015/6/19 | D10316 | L01FF01 | Nivolumab | Opdivo | Bristol-Myers Squibb Pharma EEIG | BLA | |
| 2015/6/19 | V09 | Lutetium, isotope of mass 177 | Lumark | I.D.B. Radiopharmacy B.V. | |||
| 2015/6/19 | D02716 | N02BF02 | Pregabalin | Pregabalin Sandoz GmbH | Sandoz GmbH | G | |
| 2015/6/10 | D11863 | J07BM03 | human papillomavirus 9-valent vaccine (recombinant, adsorbed) | Gardasil 9 | Sanofi Pasteur MSD | ||
| 2015/5/28 | D09920 | L01EX08 | Lenvatinib mesylate | Lenvima | Eisai Europe Ltd | O | NME |
| 2015/5/27 | D10752 | A10BD20 | Empagliflozin / metformin | Synjardy | Boehringer Ingelheim GmbH | ||
| 2015/5/27 | D01213 | C03XA01 | Tolvaptan | Jinarc | Otsuka Pharmaceutical Europe Ltd | ||
| 2015/5/27 | D00578 | J02AC03 | Voriconazole | Voriconazole Hospira | Hospira UK limited | G | |
| 2015/5/27 | D10572 | A04AA55 | Fosnetupitant and palonosetron hydrochloride | Akynzeo | Helsinn Birex Pharmaceuticals Ltd | NME | |
| 2015/5/6 | D10551 | L01ED02 | Ceritinib | Zykadia | Novartis Europharm Ltd | C | NME |
| 2015/4/13 | D06889 | L03AA13 | Pegfilgrastim | Ristempa | Amgen Europe B.V. | ||
| 2015/3/26 | D10754 | J05AR16 | lamivudine / raltegravir potassium | Dutrebis | Merck Sharp & Dohme Limited | ||
| 2015/3/26 | D00588 | J01MA12 | Levofloxacin hemihydrate | Quinsair | Raptor Pharmaceuticals Europe BV | ||
| 2015/3/26 | D10751 | A08AA62 | Naltrexone / bupropion | Mysimba | Orexigen Therapeutics Ireland Limited | ||
| 2015/3/23 | D03359 | B01AC25 | Cangrelor | Kengrexal | Chiesi Farmaceutici S.p.A. | NME | |
| 2015/3/23 | D06404 | A10BJ02 | Liraglutide | Saxenda | Novo Nordisk A/S | ||
| 2015/3/23 | D09686 | J01XX11 | Tedizolid phosphate | Sivextro | Merck Sharp & Dohme Ltd | NME | |
| 2015/3/19 | D05271 | J01XA05 | Oritavancin diphosphate | Orbactiv | The Medicines Company UK Ltd | NME | |
| 2015/3/19 | B02BC | human fibrinogen / human thrombin | Raplixa | ProFibrix BV (Mallinckrodt Pharmaceuticals) | |||
| 2015/3/19 | D00184 | S01XA18 | Ciclosporin | Ikervis | Santen Oy | ||
| 2015/3/18 | D00063 | J01GB01 | Tobramycin | Vantobra | Pari Pharma GmbH | ||
| 2015/2/26 | D01983 | V03AE02 | Sevelamer hydrochloride | Tasermity | Genzyme Europe BV | ||
| 2015/2/24 | D10191 | N04BD03 | Safinamide methanesulfonate | Xadago | Zambon SpA | NME | |
| 2015/2/19 | D03640 | J01XA04 | Dalbavancin | Xydalba | Durata Therapeutics International B.V. | NME | |
| 2015/2/19 | D07729 | B01AC04 | Clopidogrel | Clopidogrel ratiopharm | Teva B.V. | G | |
| 2015/2/17 | S01XA19 | Ex vivo expanded autologous human corneal epithelial cells containing stem cells | Holoclar | Chiesi Farmaceutici S.p.A. | O C | ||
| 2015/1/19 | D09894 | A16AX10 | Eliglustat | Cerdelga | Genzyme Europe BV | O | NME |
| 2015/1/19 | D09766 | B01AC26 | Vorapaxar sulfate | Zontivity | Merck Sharp & Dohme Limited | NME | |
| 2015/1/15 | D09967 | L04AC10 | Secukinumab | Cosentyx | Novartis Europharm Ltd | BLA | |
| 2015/1/15 | D08958 | G03XC05 | Ospemifene | Senshio | Shionogi Limited | NME | |
| 2015/1/15 | D10745 | J05AP53 | Ombitasvir / paritaprevir / ritonavir | Viekirax | AbbVie Ltd | ||
| 2015/1/15 | D10581 | J05AP09 | Dasabuvir sodium monohydrate | Exviera | AbbVie Ltd | ||
| 2015/1/15 | D10396 | L01EX09 | Nintedanib | Ofev | Boehringer Ingelheim International GmbH | O | NME |
| 2015/1/15 | D06642 | V03AE02 | Sevelamer carbonate | Sevelamer carbonate Zentiva | Genzyme Europe BV | ||
| 2015/1/15 | D08860 | L04AA32 | Apremilast | Otezla | Celgene Europe Limited | NME | |
| 2015/1/12 | D08469 | N04BD02 | Rasagiline | Rasagiline ratiopharm | Teva B.V. | ||
| 2014/12/22 | D10511 | D02BB02 | Afamelanotide | Scenesse | Clinuvel UK Limited | O E | |
| 2014/12/19 | D10538 | B02BD04 | Nonacog gamma | Rixubis | Baxalta Innovations GmbH | ||
| 2014/12/19 | D09371 | L01FG02 | Ramucirumab | Cyramza | Eli Lilly Nederland B.V. | BLA | |
| 2014/12/16 | D10579 | G03CC07 | Oestrogens conjugated / bazedoxifene acetate | Duavive | Pfizer Limited | NME | |
| 2014/12/16 | D09730 | L01XK01 | Olaparib | Lynparza | AstraZeneca AB | O | NME |
| 2014/12/8 | D07880 | N06AX21 | Duloxetine | Duloxetine Lilly | Eli Lilly Nederland B.V. | ||
| 2014/12/8 | D10375 | A06AH03 | Naloxegol oxalate | Moventig | Kyowa Kirin Limited | NME | |
| 2014/12/5 | D05340 | N05AX13 | Paliperidone palmitate | Trevicta (previously Paliperidone Janssen) | Janssen-Cilag International NV | ||
| 2014/11/21 | D02008 | G04BE08 | Tadalafil | Tadalafil Mylan | Generics (UK) Limited | G | |
| 2014/11/21 | D10481 | L01EX09 | Nintedanib | Vargatef | Boehringer Ingelheim International GmbH | NME | |
| 2014/11/21 | D09889 | A10BJ05 | Dulaglutide | Trulicity | Eli Lilly Nederland B.V. | BLA | |
| 2014/11/19 | D00351 | J02AB02 | Ketoconazole | Ketoconazole HRA | Laboratoire HRA Pharma | O | |
| 2014/11/19 | D10832 | J05AR14 | Darunavir ethanolate / cobicistat | Rezolsta | Janssen-Cilag International N.V. | ||
| 2014/11/19 | D11857 | R03AL05 | Aclidinium bromide / formoterol fumarate dihydrate | Brimica Genuair, Duaklir Genuair | AstraZeneca AB | ||
| 2014/11/19 | D09595 | R03AK07 | Budesonide / formoterol fumarate dihydrate | Budesonide/Formoterol Teva Pharma B.V., Vylaer Spiromax, Budesonide/Formoterol Teva | Teva Pharma B.V. | ||
| 2014/11/19 | D11543 | V09IA09 | Tilmanocept | Lymphoseek | Navidea Biopharmaceuticals Limited | ||
| 2014/11/17 | D10578 | J05AP51 | Sofosbuvir / ledipasvir | Harvoni | Gilead Sciences International Ltd | NME | |
| 2014/10/21 | D10223 | L01EL01 | Ibrutinib | Imbruvica | Janssen-Cilag International NV | O | NME |
| 2014/9/22 | D00248 | L01AB01 | Busulfan | Busulfan Fresenius Kabi | Fresenius Kabi Oncology Plc. | G | |
| 2014/9/18 | D11567 | A10AE56 | Insulin degludec / liraglutide | Xultophy | Novo Nordisk A/S | ||
| 2014/9/18 | D03235 | L03AA02 | Filgrastim | Accofil | Accord Healthcare Ltd | B | |
| 2014/9/18 | D10560 | L01EM01 | Idelalisib | Zydelig | Gilead Sciences International Ltd | NME | |
| 2014/9/9 | D03250 | A10AE04 | Insulin glargine | Abasaglar (previously Abasria) | Eli Lilly Regional Operations GmbH | B | |
| 2014/9/1 | D10600 | J05AR13 | Abacavir sulfate / dolutegravir sodium / lamivudine | Triumeq | ViiV Healthcare UK Limited | ||
| 2014/9/1 | D10513 | B01AC30 | Clopidogrel / acetylsalicylic acid | Clopidogrel/Acetylsalicylic acid Teva | Teva Pharma B.V. | ||
| 2014/8/26 | V03AE05 | mixture of polynuclear iron(III)-oxyhydroxide, sucrose and starches | Velphoro | Vifor Fresenius Medical Care Renal Pharma France | |||
| 2014/8/22 | D10105 | J05AP07 | Daclatasvir dihydrochloride | Daklinza | Bristol-Myers Squibb Pharma EEIG | NME | |
| 2014/8/22 | D10231 | V09AX04 | Flutemetamol (18F) | Vizamyl | GE Healthcare Ltd | NME | |
| 2014/7/31 | D09323 | M09AX03 | Ataluren | Translarna | PTC Therapeutics International Limited | O C | |
| 2014/7/23 | D09321 | L01FA03 | Obinutuzumab | Gazyvaro | Roche Registration Ltd | O | NME |
| 2014/7/22 | D10842 | B02BD02 | Simoctocog alfa (rFVIII) | Nuwiq | Octapharma AB | ||
| 2014/7/18 | D10854 | S01EC54 | Brinzolamide / brimonidine tartrate | Simbrinza | Alcon Laboratories (UK) Ltd | ||
| 2014/7/18 | D10483 | L03AB13 | Peginterferon beta-1a | Plegridy | Biogen Idec Ltd | BLA | |
| 2014/7/18 | D00107 | L04AD02 | Tacrolimus monohydrate | Envarsus | Chiesi Farmaceutici S.p.A. | ||
| 2014/6/30 | D10176 | L01EE01 | Trametinib dimethyl sulfoxide | Mekinist | Novartis Europharm Limited | NME | |
| 2014/5/22 | D00900 | J05AH02 | Oseltamivir phosphate | Ebilfumin | Actavis Group PTC ehf | G | |
| 2014/5/22 | D10459 | A10BK03 | Empagliflozin | Jardiance | Boehringer Ingelheim International GmbH | NME | |
| 2014/5/22 | D08083 | L04AG05 | Vedolizumab | Entyvio | Takeda Pharma A/S | BLA | |
| 2014/5/22 | D09669 | L04AC11 | Siltuximab | Sylvant | Janssen-Cilag International NV | O | BLA |
| 2014/5/14 | D10469 | J05AP05 | Simeprevir | Olysio | Janssen-Cilag International N.V. | NME | |
| 2014/5/8 | D10533 | R03AL03 | Umeclidinium bromide / vilanterol | Laventair, Anoro | Glaxo Group Ltd | NME | |
| 2014/5/2 | D10501 | R03AK10 | Fluticasone furoate / vilanterol trifenatate | Revinty Ellipta | Glaxo Group Ltd | ||
| 2014/4/28 | D10333 | A16AB12 | Elosulfase alfa | Vimizim | BioMarin Europe Ltd | O | BLA |
| 2014/4/28 | D09785 | J04AK06 | Delamanid | Deltyba | Otsuka Novel Products GmbH | O C | NME |
| 2014/4/28 | D10181 | R03BB07 | Umeclidinium bromide | Incruse | Glaxo Group Ltd | ||
| 2014/4/28 | D09595 | R03AK07 | Budesonide / formoterol fumarate dihydrate | BiResp Spiromax, DuoResp Spiromax | Teva Pharma B.V. | ||
| 2014/4/23 | D10505 | R03AL04 | Indacaterol maleate / glycopyrronium bromide | Ulunar Breezhaler | Novartis Europharm Ltd | ||
| 2014/4/23 | D00483 | C07AA05 | Propranolol hydrochloride | Hemangiol | Pierre Fabre Dermatologie | ||
| 2014/4/23 | D10587 | A10BD16 | Canagliflozin / metformin | Vokanamet | Janssen-Cilag International N.V. | ||
| 2014/4/10 | D02716 | N02BF02 | Pregabalin | Pregabalin Pfizer | Pfizer Limited | ||
| 2014/4/7 | D00162 | J04AA01 | para-Aminosalicylic acid | Granupas (previously Para-aminosalicylic acid Lucane) | Lucane Pharma | O | |
| 2014/3/27 | D04429 | G03GA05 | Follitropin alfa | Bemfola | Finox Biotech AG | B | |
| 2014/3/27 | D09572 | C02KX05 | Riociguat | Adempas | Bayer Pharma AG | O | NME |
| 2014/3/21 | D10095 | L01EX07 | Cabozantinib | Cometriq | Ipsen Pharma | O C | NME |
| 2014/3/21 | D08843 | A10BJ04 | Albiglutide | Eperzan | GlaxoSmithKline Trading Services Limited | BLA | |
| 2014/3/21 | D04820 | N05AE05 | Lurasidone hydrochloride | Latuda | Sunovion Pharmaceuticals Europe Ltd | NME | |
| 2014/3/5 | D09873 | J04AK05 | Bedaquiline fumarate | Sirturo | Janssen-Cilag International N.V. | O C | NME |
| 2014/2/21 | D02076 | D11AX21 | Brimonidine tartrate | Mirvaso | Galderma International | ||
| 2014/2/20 | D01964 | S01EE04 | Travoprost | Izba | Alcon Laboratories (UK) Ltd | ||
| 2014/2/20 | D10002 | V09AX06 | Florbetaben (18F) | Neuraceq | Piramal Imaging Limited | NME | |
| 2014/1/30 | D03846 | L04AX07 | Dimethyl fumarate | Tecfidera | Biogen Idec Ltd | NME | |
| 2014/1/16 | D10586 | A10BD15 | Dapagliflozin and metformin | Xigduo | Bristol-Myers Squibb/AstraZeneca EEIG | ||
| 2014/1/16 | D10113 | J05AJ03 | Dolutegravir | Tivicay | ViiV Healthcare | NME | |
| 2014/1/16 | D01968 | M05BA08 | Zoledronic acid monohydrate | Zoledronic Acid Accord | Accord Healthcare Limited | G | |
| 2014/1/16 | D10366 | J05AP08 | Sofosbuvir | Sovaldi | Gilead Sciences International Ltd | NME | |
| 2014/1/8 | D00709 | N03AX14 | Levetiracetam | Levetiracetam Hospira | Hospira UK Limited | G | |
| 2013/12/20 | D10135 | C02KX04 | Macitentan | Opsumit | Actelion Registration Ltd | O | NME |
| 2013/12/18 | D10185 | N06AX26 | Vortioxetine | Brintellix | H. Lundbeck A/S | NME | |
| 2013/12/4 | J07BB03 | Influenza vaccine (live attenuated, nasal) | Fluenz Tetra | MedImmune LLC | |||
| 2013/12/4 | D04905 | N06DX01 | Memantine hydrochloride | Memantine Accord | Accord Healthcare Limited | G | |
| 2013/11/15 | D02740 | N01BB20 | Lidocaine / prilocaine | Fortacin | Plethora Solutions Limited | ||
| 2013/11/15 | D09980 | L01FD03 | Trastuzumab emtansine | Kadcyla | Roche Registration Ltd | BLA | |
| 2013/11/15 | D09592 | A10BK02 | Canagliflozin | Invokana | Janssen-Cilag International N.V. | NME | |
| 2013/11/15 | D01164 | N05AX12 | Aripiprazole | Abilify Maintena | Otsuka Pharmaceutical Europe Ltd | ||
| 2013/11/13 | D06677 | J05AJ02 | Elvitegravir | Vitekta | Gilead Sciences International Ltd | ||
| 2013/11/13 | D10398 | V10XX03 | Radium Ra223 dichloride | Xofigo | Bayer Pharma AG | NME | |
| 2013/11/13 | D10227 | B02BD02 | Turoctocog alfa | NovoEight | Novo Nordisk A/S | ||
| 2013/11/13 | D10501 | R03AK10 | Fluticasone furoate / vilanterol | Relvar Ellipta | Glaxo Group Ltd | NME | |
| 2013/11/11 | D10293 | N04BA03 | Levodopa / carbidopa / entacapone | Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) | Orion Corporation | ||
| 2013/10/18 | D03235 | L03AA02 | Filgrastim | Grastofil | Apotex Europe BV | B | |
| 2013/10/18 | D07423 | B01AX01 | Defibrotide | Defitelio | Gentium S.r.l. | O E | NME |
| 2013/9/27 | D04429 | G03GA05 | Follitropin alfa | Ovaleap | Teva Pharma B.V. | B | |
| 2013/9/25 | B02BC | human fibrinogen / human thrombin | Evarrest | Omrix Biopharmaceuticals N. V. | |||
| 2013/9/25 | D09733 | L01EB03 | Afatinib dimaleate | Giotrif | Boehringer Ingelheim International GmbH | NME | |
| 2013/9/25 | D08066 | L01EA01 | Imatinib | Imatinib medac | Medac | G | |
| 2013/9/19 | D10253 | A10BD13 | Alogliptin benzoate / metformin hydrochloride | Vipdomet | Takeda Pharma A/S | ||
| 2013/9/19 | D10159 | A10BD09 | Alogliptin benzoate / pioglitazone hydrochloride | Incresync | Takeda Pharma A/S | ||
| 2013/9/19 | D10505 | R03AL04 | Indacaterol maleate / glycopyrronium bromide | Xoterna Breezhaler, Ultibro Breezhaler | Novartis Europharm Ltd | ||
| 2013/9/19 | D06553 | A10BH04 | Alogliptin benzoate | Vipidia | Takeda Pharma A/S | NME | |
| 2013/9/19 | D09881 | V03AX03 | Cobicistat | Tybost | Gilead Sciences International Ltd | ||
| 2013/9/12 | D10699 | A05AA03 | Cholic acid | Orphacol | Laboratoires CTRS | O E | NME |
| 2013/9/12 | D02802 | L04AG06 | Alemtuzumab | Lemtrada | Genzyme Therapeutics Ltd | ||
| 2013/9/10 | D02598 | L04AB02 | Infliximab | Remsima | Celltrion Healthcare Hungary Kft. | B | |
| 2013/9/10 | D02598 | L04AB02 | Infliximab | Inflectra | Hospira UK Limited | B | |
| 2013/9/6 | D10468 | A16AA04 | Mercaptamine bitartrate | Procysbi | Raptor Pharmaceuticals Europe BV | O | |
| 2013/8/26 | D10104 | L01EC02 | Dabrafenib mesilate | Tafinlar | Novartis Europharm Limited | NME | |
| 2013/8/26 | D10137 | L01EX05 | Regorafenib | Stivarga | Bayer Pharma AG | NME | |
| 2013/8/26 | D10172 | L04AK02 | Teriflunomide | Aubagio | Sanofi-aventis Groupe | NME | |
| 2013/8/26 | D01984 | A02BC05 | Esomeprazole magnesium trihydrate | Nexium Control | Pfizer Consumer Healthcare Ltd | ||
| 2013/8/26 | D10857 | C10BA04 | Fenofibrate / simvastatin | Cholib | Mylan Products Limited | ||
| 2013/8/12 | B02BD06 | human coagulation factor VIII / human von willebrand factor | Voncento | CSL Behring GmbH | |||
| 2013/8/5 | D08976 | L04AX06 | Pomalidomide | Imnovid (previously Pomalidomide Celgene) | Celgene Europe Ltd | O | NME |
| 2013/8/5 | D02691 | H01AC01 | Somatropin | Somatropin Biopartners | BioPartners GmbH | ||
| 2013/7/31 | J07BX | modified vaccinia Ankara virus | Imvanex | Bavarian Nordic A/S | E | ||
| 2013/7/31 | D07475 | G02CX01 | Atosiban acetate | Atosiban SUN | Sun Pharmaceutical Industries Europe B.V. | G | |
| 2013/7/31 | D09638 | C10AX12 | Lomitapide mesylate | Lojuxta | Aegerion Pharmaceuticals | E | NME |
| 2013/7/31 | D05868 | A16AX03 | Sodium phenylbutyrate | Pheburane | Lucane Pharma | ||
| 2013/7/25 | D10242 | L03AA14 | Lipegfilgrastim | Lonquex | Sicor Biotech UAB | ||
| 2013/7/12 | D09992 | L01XJ01 | Vismodegib | Erivedge | Roche Registration Ltd | C | NME |
| 2013/7/1 | D08066 | L01EA01 | Imatinib | Imatinib Accord | Accord Healthcare Ltd | G | |
| 2013/7/1 | D09951 | L01EA05 | Ponatinib hydrochloride | Iclusig | Ariad Pharma Ltd | O | NME |
| 2013/6/24 | D01227 | C02KX01 | Bosentan monohydrate | Stayveer | Marklas Nederlands BV | ||
| 2013/6/21 | D01223 | L01BC06 | Capecitabine | Capecitabine SUN | Sun Pharmaceutical Industries Europe B.V. | G | |
| 2013/6/21 | D10218 | L02BB04 | Enzalutamide | Xtandi | Astellas Pharma Europe B.V. | NME | |
| 2013/6/21 | D03217 | G04BE10 | Avanafil | Spedra | Menarini International Operations Luxembourg S.A. | NME | |
| 2013/6/13 | D04905 | N06DX01 | Memantine hydrochloride | Memantine ratiopharm | Ratiopharm GmbH | G | |
| 2013/5/24 | D10756 | J05AR09 | Elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil | Stribild | Gilead Sciences International Limited | NME | |
| 2013/5/16 | D06458 | J06BA01 | Human normal immunoglobulin | HyQvia | Baxalta Innovations GmbH | ||
| 2013/5/16 | D00578 | J02AC03 | Voriconazole | Voriconazole Accord | Accord Healthcare Ltd | G | |
| 2013/4/29 | D04905 | N06DX01 | Memantine hydrochloride | Marixino (previously Maruxa) | Consilient Health Ltd | G | |
| 2013/4/22 | D04905 | N06DX01 | Memantine hydrochloride | Memantine LEK, Memantine Mylan | Pharmathen S.A., Generics [UK] Limited | G | |
| 2013/4/22 | D08174 | N06DX01 | Memantine | Nemdatine | Actavis Group PTC ehf. | G | |
| 2013/4/17 | J07CA09 | diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type-b conjugate vaccine (adsorbed) | Hexyon | Sanofi Pasteur MSD SNC | |||
| 2013/4/17 | D08066 | L01EA01 | Imatinib | Imatinib Actavis | Actavis Group PTC ehf | G | |
| 2013/4/17 | J07CA09 | Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type-b conjugate vaccine (adsorbed) | Hexacima | Sanofi Pasteur S.A. | |||
| 2013/3/27 | D09728 | L01EA04 | Bosutinib monohydrate | Bosulif | Pfizer Ltd | O C | NME |
| 2013/3/13 | D09646 | S01XA22 | Ocriplasmin | Jetrea | ThromboGenics NV | BLA | |
| 2013/3/13 | D09219 | C09DA07 | Telmisartan / hydrochlorothiazide | Tolucombi, Actelsar HCT | Krka, d.d., Novo mesto, Actavis Group hf | G | |
| 2013/3/4 | D05446 | L01FD02 | Pertuzumab | Perjeta | Roche Registration Limited | BLA | |
| 2013/2/25 | D10812 | N07BB05 | Nalmefene hydrochloride dihydrate | Selincro | H. Lundbeck A/S | ||
| 2013/2/20 | D02340 | N05AH01 | Loxapine | Adasuve | Ferrer Internacional s.a. | ||
| 2013/2/1 | D09574 | L01XX44 | Aflibercept | Zaltrap | Sanofi-Aventis Groupe | BLA | |
| 2013/2/1 | D09729 | A10BJ03 | Lixisenatide | Lyxumia | Sanofi-Aventis Groupe | NME | |
| 2013/1/21 | D09727 | A10AE06 | Insulin degludec | Tresiba | Novo Nordisk A/S | NME | |
| 2013/1/21 | D10570 | A10AD06 | Insulin degludec / insulin aspart | Ryzodeg | Novo Nordisk A/S | ||
| 2013/1/14 | D09617 | V09AX05 | Florbetapir (18F) | Amyvid | Eli Lilly Nederland B.V. | NME | |
| 2013/1/14 | J07AH09 | meningococcal group-B vaccine (rDNA, component, adsorbed) | Bexsero | GSK Vaccines S.r.l. | |||
| 2013/1/8 | D08066 | L01EA01 | Imatinib | Imatinib Teva | Teva B.V. | G | |
| 2012/12/20 | D09535 | G04BD12 | Mirabegron | Betmiga | Astellas Pharma Europe B.V. | NME | |
| 2012/12/18 | D12495 | D03BA03 | concentrate of proteolytic enzymes enriched in bromelain | NexoBrid | MediWound Germany GmbH | O | BLA |
| 2012/11/26 | D09355 | A06AX04 | Linaclotide | Constella | Allergan Pharmaceuticals International Ltd | NME | |
| 2012/11/22 | D04905 | N06DX01 | Memantine hydrochloride | Memantine Merz | Merz Pharmaceuticals GmbH | ||
| 2012/11/22 | D09574 | S01LA05 | Aflibercept | Eylea | Bayer Pharma AG | BLA | |
| 2012/11/19 | D01223 | L01BC06 | Capecitabine | Capecitabine Medac | medac Gesellschaft f_r klinische Spezialpr_parate mbH | G | |
| 2012/11/19 | D01968 | M05BA08 | Zoledronic acid monohydrate | Zoledronic Acid Hospira | Hospira UK Limited | G | |
| 2012/11/19 | D08056 | M05BA06 | Ibandronic acid | Ibandronic acid Accord | Accord Healthcare Ltd | G | |
| 2012/11/15 | D09393 | D06BX02 | Ingenol mebutate | Picato | LEO Pharma A/S | NME | |
| 2012/11/12 | D09763 | A10BK01 | Dapagliflozin propanediol monohydrate | Forxiga | AstraZeneca AB | NME | |
| 2012/10/25 | D10843 | C10AX10 | Alipogene tiparvovec | Glybera | uniQure biopharma B.V. | O E | BLA |
| 2012/10/25 | D09587 | L01FX05 | Brentuximab vedotin | Adcetris | Takeda Pharma A/S | O C | BLA |
| 2012/10/23 | D09731 | L01ED01 | Crizotinib | Xalkori | Pfizer Ltd | C | NME |
| 2012/9/28 | D00540 | R03BB06 | Glycopyrronium bromide | Tovanor Breezhaler, Seebri Breezhaler, Enurev Breezhaler | Novartis Europharm Ltd. | ||
| 2012/9/20 | D03665 | L01BC08 | Decitabine | Dacogen | Janssen-Cilag International N V | O | NME |
| 2012/9/3 | D03218 | L01EK01 | Axitinib | Inlyta | Pfizer Ltd | NME | |
| 2012/9/3 | D10532 | B02BD11 | Catridecacog | NovoThirteen | Novo Nordisk A/S | ||
| 2012/8/30 | D06053 | A16AX08 | Teduglutide | Revestive | Shire Pharmaceuticals Ireland Ltd | O | NME |
| 2012/8/23 | D09960 | L01EJ01 | Ruxolitinib phosphate | Jakavi | Novartis Europharm Ltd | NME | |
| 2012/8/23 | D08689 | M05BA08 | Zoledronic acid | Zoledronic acid Mylan | Mylan S.A.S. | G | |
| 2012/8/23 | Copper (64Cu) chloride | Cuprymina | Sparkle S.r.l | ||||
| 2012/8/23 | D02500 | D06BB10 | Imiquimod | Zyclara | Meda AB | ||
| 2012/8/23 | D08884 | J01DI02 | Ceftaroline fosamil | Zinforo | AstraZeneca AB | NME | |
| 2012/8/16 | D08689 | M05BA08 | Zoledronic acid | Zoledronic acid Teva | Teva B.V. | G | |
| 2012/8/16 | D01968 | M05BA08 | Zoledronic acid monohydrate | Zoledronic acid Teva Pharma | Teva B.V. | G | |
| 2012/8/3 | D01968 | M05BA08 | Zoledronic acid monohydrate | Zoledronic acid medac | medac Gesellschaft f_r klinische Spezialpr_parate mbH | G | |
| 2012/7/23 | D09916 | R07AX02 | Ivacaftor | Kalydeco | Vertex Pharmaceuticals (Europe) Ltd | O | NME |
| 2012/7/23 | D10780 | N03AX22 | Perampanel | Fycompa | Eisai Europe Ltd | NME | |
| 2012/7/20 | D08837 | R03BB05 | Aclidinium bromide | Bretaris Genuair, Eklira Genuair | AstraZeneca AB | NME | |
| 2012/7/20 | D10264 | A10BD11 | Linagliptin / metformin hydrochloride | Jentadueto | Boehringer Ingelheim International GmbH | ||
| 2012/5/22 | D07866 | L01CD02 | Docetaxel | Docetaxel Kabi, Docetaxel Accord | Fresenius Kabi Oncology Plc, Accord Healthcare Ltd | G | |
| 2012/5/10 | D09654 | L01DB11 | Pixantrone dimaleate | Pixuvri | CTI Life Sciences Limited | C | |
| 2012/5/7 | D00775 | N07XX02 | Riluzole | Riluzole Zentiva | Aventis Pharma S.A. | ||
| 2012/4/24 | D10497 | H01CB05 | Pasireotide | Signifor | Novartis Europharm Limited | O | NME |
| 2012/4/20 | D01223 | L01BC06 | Capecitabine | Ecansya (previously Capecitabine Krka), Capecitabine Accord | Krka, d.d., Novo mesto, Accord Healthcare Ltd | G | |
| 2012/4/20 | D04370 | A04AA02 | Granisetron | Sancuso | Kyowa Kirin Limited | ||
| 2012/4/20 | D10535 | J07AH08 | Meningococcal group A, C, W 135 and Y conjugate vaccine | Nimenrix | Pfizer Limited | ||
| 2012/4/20 | D01223 | L01BC06 | Capecitabine | Capecitabine Teva | Teva Pharma B.V. | G | |
| 2012/4/20 | D01968 | M05BA08 | Zoledronic acid monohydrate | Zoledronic acid Actavis | Actavis Group PTC ehf | G | |
| 2012/4/13 | D00523 | C09CA04 | Irbesartan | Sabervel | Pharmathen S.A. | G | |
| 2012/4/13 | D00062 | R05CB16 | Mannitol | Bronchitol | Pharmaxis Pharmaceuticals Limited | O | |
| 2012/3/26 | D00945 | A10BG03 | Pioglitazone hydrochloride | Pioglitazone Teva Pharma, Pioglitazone Teva | Teva Pharma B.V., Teva B.V. | G | |
| 2012/3/21 | D00945 | A10BG03 | Pioglitazone hydrochloride | Pioglitazone Accord | Accord Healthcare Ltd | G | |
| 2012/3/15 | D00945 | A10BG03 | Pioglitazone hydrochloride | Pioglitazone Actavis, Glidipion (previously Pioglitazone Actavis Group) | Actavis Group PTC ehf | G | |
| 2012/3/9 | D00161 | L01BB02 | Mercaptopurine | Xaluprine (previously Mercaptopurine Nova Laboratories) | Nova Laboratories Ltd | O | |
| 2012/2/23 | D09687 | G03XB02 | Ulipristal acetate | Esmya | Gedeon Richter Ltd. | ||
| 2012/2/17 | D06407 | L01EX04 | Vandetanib | Caprelsa | Genzyme Europe BV | C | NME |
| 2012/2/17 | D10215 | J07BB01 | Prepandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture) | Vepacel | Nanotherapeutics Bohumil, s.r.o. | ||
| 2012/2/17 | D09996 | L01EC01 | Vemurafenib | Zelboraf | Roche Registration Ltd | NME | |
| 2012/2/13 | D02049 | J01XB01 | Colistimethate sodium | Colobreathe | Forest Laboratories UK Limited | ||
| 2012/1/13 | D03693 | R06AX27 | Desloratadine | Desloratadine ratiopharm, Desloratadine Actavis | ratiopharm GmbH, Actavis Group PTC ehf | G | |
| 2012/1/9 | D00896 | J05AG03 | Efavirenz | Efavirenz Teva | Teva B.V. | G | |
| 2011/12/22 | D00594 | A10BX02 | Repaglinide | Repaglinide Accord | Accord Healthcare Ltd | G | |
| 2011/12/14 | D02908 | L01XD04 | 5-Aminolevulinic acid hydrochloride | Ameluz | Biofrontera Bioscience GmbH | ||
| 2011/12/14 | D00709 | N03AX14 | Levetiracetam | Levetiracetam Sun | Sun Pharmaceutical Industries Europe B.V. | G | |
| 2011/12/7 | D08865 | C09CA09 | Azilsartan medoxomil | Edarbi | Takeda Pharma A/S | NME | |
| 2011/12/5 | D09394 | A07AA12 | Fidaxomicin | Dificlir | Astellas Pharma Europe BV | NME | |
| 2011/12/5 | D00709 | N03AX14 | Levetiracetam | Levetiracetam Actavis Group | Actavis Group PTC ehf | G | |
| 2011/11/28 | D10571 | J05AR08 | Emtricitabine / rilpivirine / tenofovir disoproxil fumarate | Eviplera | Gilead Sciences International Ltd | ||
| 2011/11/28 | D09958 | J05AG05 | Rilpivirine hydrochloride | Edurant | Janssen-Cilag International N.V. | NME | |
| 2011/11/28 | D03693 | R06AX27 | Desloratadine | Dasselta | Krka, d.d., Novo mesto | G | |
| 2011/11/24 | D03693 | R06AX27 | Desloratadine | Desloratadine Teva | Teva B.V | G | |
| 2011/11/24 | D10263 | A10BD10 | Saxagliptin / metformin hydrochloride | Komboglyze | AstraZeneca AB | ||
| 2011/11/16 | D09673 | N07XX08 | Tafamidis | Vyndaqel | Pfizer Ltd | O E | |
| 2011/11/3 | D00088 | H02AB09 | Hydrocortisone | Plenadren | Shire Services BVBA | O | |
| 2011/10/27 | P01BF05 | Piperaquine tetraphosphate / dihydroartemisinin | Eurartesim | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A | |||
| 2011/10/3 | D00709 | N03AX14 | Levetiracetam | Levetiracetam Accord, Levetiracetam Actavis, Matever | Accord Healthcare Ltd, Actavis Group PTC ehf, Pharmathen S.A. | G | |
| 2011/10/3 | D00627 | C09CA07 | Telmisartan | Telmisartan Teva Pharma | Teva B.V. | G | |
| 2011/9/30 | D00559 | N04BC05 | Pramipexole dihydrochloride monohydrate | Pramipexole Accord | Accord Healthcare Ltd | G | |
| 2011/9/16 | D01205 | N05CM18 | Dexmedetomidine hydrochloride | Dexdor | Orion Corporation | NME | |
| 2011/9/5 | D00696 | N05CD08 | Midazolam hydrochloride | Buccolam | Shire Services BVBA | ||
| 2011/9/5 | D09701 | L02BX03 | Abiraterone acetate | Zytiga | Janssen-Cilag International N.V. | NME | |
| 2011/9/2 | D02714 | L01EG02 | Everolimus | Votubia | Novartis Europharm Ltd | O | |
| 2011/9/2 | D06057 | J01XA03 | Telavancin hydrochloride | Vibativ | Clinigen Healthcare Ltd | NME | |
| 2011/8/26 | D00709 | N03AX14 | Levetiracetam | Levetiracetam ratiopharm, Levetiracetam Teva | ratiopharm GmbH, Teva B.V. | G | |
| 2011/8/24 | D09566 | A10BH05 | Linagliptin | Trajenta | Boehringer Ingelheim International GmbH | NME | |
| 2011/8/24 | D10293 | N04BA03 | Levodopa / carbidopa / entacapone | Levodopa/Carbidopa/Entacapone Orion | Orion Corporation | ||
| 2011/8/18 | D00781 | N04BX02 | Entacapone | Entacapone Orion | Orion Corporation | ||
| 2011/7/27 | D10856 | G03AA14 | Nomegestrol acetate / estradiol | Zoely | Teva B.V. | ||
| 2011/7/26 | D08056 | M05BA06 | Ibandronic acid | Ibandronic Acid Sandoz | Sandoz GmbH | G | |
| 2011/7/20 | D00063 | J01GB01 | Tobramycin | Tobi Podhaler | Novartis Europharm Ltd | O | |
| 2011/7/20 | D04127 | N07XX07 | Fampridine | Fampyra | Biogen Idec Ltd | C | NME |
| 2011/7/18 | D08876 | J05AP03 | Boceprevir | Victrelis | Merck Sharp & Dohme Ltd | NME | |
| 2011/7/13 | D04603 | L01FX04 | Ipilimumab | Yervoy | Bristol-Myers Squibb Pharma EEIG | BLA | |
| 2011/7/13 | D03068 | L04AG04 | Belimumab | Benlysta | Glaxo Group Ltd. | BLA | |
| 2011/7/13 | D03684 | M05BX04 | Denosumab | Xgeva | Amgen Europe B.V. | ||
| 2011/7/13 | D06067 | L01AX03 | Temozolomide | Temozolomide Sun | Sun Pharmaceutical Industries Europe B.V. | G | |
| 2011/6/17 | D04121 | A10BJ01 | Exenatide | Bydureon | AstraZeneca AB | ||
| 2011/6/17 | D03222 | L04AA28 | Belatacept | Nulojix | Bristol-Myers Squibb Pharma EEIG | BLA | |
| 2011/6/16 | D02558 | N06DA03 | Rivastigmine hydrogen tartrate | Rivastigmine Actavis | Actavis Group PTC ehf | G | |
| 2011/6/16 | D05768 | N04BC09 | Rotigotine | Leganto | UCB Manufacturing Ireland Ltd | ||
| 2011/6/15 | D08780 | B06AC01 | C1 inhibitor (human) | Cinryze | Shire Services BVBA | ||
| 2011/5/18 | D03163 | S01BC11 | Bromfenac sodium sesquihydrate | Yellox | Croma-Pharma GmbH | ||
| 2011/5/18 | D03213 | B01AF02 | Apixaban | Eliquis | Bristol-Myers Squibb / Pfizer EEIG | NME | |
| 2011/5/6 | D02312 | V03AB17 | Methylthioninium chloride | Methylthioninium chloride Proveblue | Provepharm SAS | G | |
| 2011/4/14 | D06458 | J06BA01 | Human normal immunoglobulin (SCIg) | Hizentra | CSL Behring GmbH | ||
| 2011/4/14 | D10290 | C09XA53 | Aliskiren / amlodipine | Rasilamlo | Novartis Europharm Ltd | ||
| 2011/4/14 | D10855 | C10BA03 | Fenofibrate / pravastatin | Pravafenix | Laboratoires SMB S.A. | ||
| 2011/3/28 | D09569 | N03AX21 | Retigabine | Trobalt | Glaxo Group Limited | NME | |
| 2011/3/17 | D04187 | L04AE01 | Fingolimod hydrochloride | Gilenya | Novartis Europharm Ltd | NME | |
| 2011/3/17 | D08914 | L01XX41 | Eribulin mesylate | Halaven | Eisai Europe Ltd | NME | |
| 2011/3/17 | D10452 | L01CD04 | Cabazitaxel | Jevtana | sanofi-aventis groupe | NME | |
| 2011/3/14 | D06399 | L01BC53 | Tegafur / gimeracil / oteracil monopotassium | Teysuno | Nordic Group BV | ||
| 2011/3/14 | D00749 | L04AK01 | Leflunomide | Repso | Teva B.V. | G | |
| 2011/3/4 | D10249 | C09DA04 | Irbesartan and hydrochlorothiazide | Ifirmacombi | Krka, d.d., Novo mesto | G | |
| 2011/3/4 | D05340 | N05AX13 | Paliperidone palmitate | Xeplion | Janssen-Cilag International N.V. | ||
| 2011/2/28 | D05744 | R03DX07 | Roflumilast | Daliresp, Libertek | Takeda GmbH | ||
| 2011/2/28 | D07507 | J05AR01 | Lamivudine / zidovudine | Lamivudine/Zidovudine Teva | Teva Pharma B.V. | G | |
| 2011/2/28 | D01583 | L04AX05 | Pirfenidone | Esbriet | Roche Registration Limited | O | NME |
| 2011/2/28 | D09596 | M09AB02 | Collagenase clostridium histolyticum | Xiapex | Swedish Orphan Biovitrum AB | BLA | |
| 2011/2/18 | D00781 | N04BX02 | Entacapone | Entacapone Teva | Teva Pharma B.V. | G | |
| 2011/1/21 | D08056 | M05BA06 | Ibandronic acid | Iasibon | Pharmathen S.A. | G | |
| 2011/1/6 | D02168 | L01CE01 | Topotecan hydrochloride | Potactasol | Actavis Group PTC ehf | G | |
| 2010/12/3 | D09017 | B01AC24 | Ticagrelor | Brilique | AstraZeneca AB | NME | |
| 2010/11/29 | D00749 | L04AK01 | Leflunomide | Leflunomide ratiopharm | ratiopharm GmbH | G | |
| 2010/11/29 | J07BB02 | Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | Aflunov | Seqirus S.r.l. | |||
| 2010/10/28 | D10845 | B06AC04 | Conestat alfa | Ruconest | Pharming Group N.V. | ||
| 2010/10/28 | D10823 | B01AC04 | Clopidogrel hydrochloride | Clopidogrel HCS | HCS bvba | G | |
| 2010/10/7 | D00752 | L04AA06 | Mycophenolate mofetil | Myclausen | Passauer Pharma GmbH | G | |
| 2010/10/7 | D09743 | C09DB04 | Telmisartan / amlodipine besylate | Twynsta | Boehringer Ingelheim International GmbH | ||
| 2010/9/30 | D00627 | C09CA07 | Telmisartan | Telmisartan Actavis | Actavis Group PTC ehf | G | |
| 2010/9/17 | D08056 | M05BA06 | Ibandronic acid | Ibandronic Acid Teva | Teva Pharma B.V. | G | |
| 2010/9/6 | D05711 | C01EB21 | Regadenoson | Rapiscan | Rapidscan Pharma Solutions EU Ltd | NME | |
| 2010/9/1 | D06665 | C01BG11 | Vernakalant hydrochloride | Brinavess | Cardiome UK Limited | ||
| 2010/9/1 | D02995 | N05AH05 | Asenapine maleate | Sycrest | N.V. Organon | NME | |
| 2010/8/31 | D01399 | N02AB03 | Fentanyl citrate | PecFent | Archimedes Development Ltd | G | |
| 2010/8/26 | D09029 | A16AB10 | Velaglucerase alfa | Vpriv | Shire Pharmaceuticals Ireland Ltd | O | NME |
| 2010/7/27 | D00749 | L04AK01 | Leflunomide | Leflunomide medac | medac Gesellschaft f_r klinische Spezialpr_parate mbH | G | |
| 2010/7/27 | D00292 | S01BA01 | Dexamethasone | Ozurdex | Allergan Pharmaceuticals Ireland | ||
| 2010/7/5 | D05744 | R03DX07 | Roflumilast | Daxas | Takeda GmbH | NME | |
| 2010/6/14 | D05380 | L01EX03 | Pazopanib hydrochloride | Votrient | Novartis Europharm Limited | NME | |
| 2010/6/10 | D02168 | L01CE01 | Topotecan hydrochloride | Topotecan Hospira | Hospira UK Ltd | ||
| 2010/6/10 | D00454 | N05AH03 | Olanzapine | Olanzapine Apotex | Apotex Europe B.V. | G | |
| 2010/6/10 | D00423 | J05AP01 | Ribavirin | Ribavirin Mylan (previously Ribavirin Three Rivers) | Generics [UK] Ltd | G | |
| 2010/6/8 | D03235 | L03AA02 | Filgrastim | Nivestim | Hospira UK Ltd | B | |
| 2010/6/4 | D00627 | C09CA07 | Telmisartan | Tolura | Krka, d.d., Novo mesto | G | |
| 2010/5/26 | D03684 | M05BX04 | Denosumab | Prolia | Amgen Europe B.V. | BLA | |
| 2010/4/29 | D02217 | G03XC01 | Raloxifene hydrochloride | Raloxifene Teva | Teva B.V. | G | |
| 2010/4/19 | D09314 | L01FA02 | Ofatumumab | Arzerra | Novartis Europharm Ltd | O | BLA |
| 2010/3/15 | D10513 | B01AC30 | Clopidogrel / acetylsalicylic acid | DuoPlavin | Sanofi Pharma Bristol-Myers Squibb SNC | ||
| 2010/3/15 | D06067 | L01AX03 | Temozolomide | Temozolomide Hexal | Hexal AG | G | |
| 2010/3/15 | D10261 | A10BD07 | Sitagliptin phosphate / metformin hydrochloride | Ristfor | Merck Sharp & Dohme Ltd | ||
| 2010/3/15 | D00583 | L01AC01 | Thiotepa | Tepadina | Adienne S.r.l. | O | |
| 2010/3/15 | D10513 | B01AC30 | Clopidogrel / acetylsalicylic acid | Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) | Sanofi-aventis groupe | ||
| 2010/3/15 | D06067 | L01AX03 | Temozolomide | Temozolomide Sandoz, Temozolomide Accord | Sandoz Pharmaceutical GmbH, Hospira UK Ltd | G | |
| 2010/3/15 | D10535 | J07AH08 | Meningococcal group A, C, W-135 and Y conjugate vaccine | Menveo | GSK Vaccines S.r.l. | ||
| 2010/3/15 | D06645 | A10BH01 | Sitagliptin phosphate | Ristaben | Merck Sharp & Dohme Ltd | ||
| 2010/3/11 | D03978 | B02BX05 | Eltrombopag olamine | Revolade | Novartis Europharm Limited | NME | |
| 2010/1/29 | D01965 | G04CA04 | Silodosin | Silodyx, Urorec | Recordati Ireland Ltd | NME | |
| 2010/1/28 | D06067 | L01AX03 | Temozolomide | Temozolomide Teva | Teva B.V. | G | |
| 2010/1/26 | D00627 | C09CA07 | Telmisartan | Telmisartan Teva | Teva B.V. | G | |
| 2010/1/26 | D07866 | L01CD02 | Docetaxel | Docetaxel Teva | Teva B.V. | G | |
| 2010/1/25 | D06067 | L01AX03 | Temozolomide | Temomedac | medac Gesellschaft f_r klinische Spezialpr_parate mbH | G | |
| 2010/1/25 | D08895 | G03GA09 | Corifollitropin alfa | Elonva | Merck Sharp & Dohme Limited | ||
| 2010/1/11 | D10844 | V09HA03 | Besilesomab | Scintimun | CIS bio international | ||
| 2010/1/8 | D00749 | L04AK01 | Leflunomide | Leflunomide Winthrop | Sanofi-Aventis Deutschland GmbH | ||
| 2009/12/23 | D10689 | N07XX05 | Amifampridine phosphate | Firdapse (previously Zenas) | BioMarin Europe Ltd | O E | |
| 2009/12/23 | D08514 | G04BE03 | Sildenafil | Sildenafil ratiopharm | Ratiopharm GmbH | G | |
| 2009/12/11 | D00454 | N05AH03 | Olanzapine | Olazax | Glenmark Pharmaceuticals s.r.o. | G | |
| 2009/12/11 | D03822 | N06DA03 | Rivastigmine | Rivastigmine 1 A Pharma, Rivastigmine Hexal | 1 A Pharma GmbH, Hexal AG | ||
| 2009/12/11 | D02558 | N06DA03 | Rivastigmine hydrogen tartrate | Rivastigmine Sandoz | Sandoz GmbH | ||
| 2009/12/10 | D00454 | N05AH03 | Olanzapine | Olazax Disperzi | Glenmark Pharmaceuticals s.r.o. | G | |
| 2009/12/10 | D02229 | G04BE03 | Sildenafil citrate | Sildenafil Actavis | Actavis Group PTC ehf | G | |
| 2009/12/10 | D00353 | J05AF05 | Lamivudine | Lamivudine Teva Pharma B.V. | Teva B.V. | G | |
| 2009/12/9 | D10455 | J07AL02 | Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) | Prevenar 13 | Pfizer Limited | ||
| 2009/12/3 | D00454 | N05AH03 | Olanzapine | Olanzapine Glenmark Europe | Glenmark Pharmaceuticals Europe Limited | G | |
| 2009/12/3 | D00454 | N05AH03 | Olanzapine | Olanzapine Glenmark | Glenmark Pharmaceuticals Europe Limited | G | |
| 2009/11/30 | D09319 | R03AC18 | Indacaterol maleate | Oslif Breezhaler, Hirobriz Breezhaler, Onbrez Breezhaler | Novartis Europharm Ltd. | NME | |
| 2009/11/30 | D04431 | J06BB04 | Human hepatitis-B immunoglobulin | Zutectra | Biotest Pharma GmbH | ||
| 2009/11/30 | D02229 | G04BE03 | Sildenafil citrate | Sildenafil Teva | Teva B.V. | G | |
| 2009/11/30 | D00435 | J05AG01 | Nevirapine | Nevirapine Teva | Teva B.V. | G | |
| 2009/11/26 | D10249 | C09DA04 | Irbesartan and hydrochlorothiazide | Irbesartan/Hydrochlorothiazide Teva | Teva B.V. | G | |
| 2009/11/26 | D03914 | C01BD07 | Dronedarone hydrochloride | Multaq | sanofi-aventis groupe | NME | |
| 2009/11/4 | D00594 | A10BX02 | Repaglinide | Repaglinide Krka | Krka, d.d., Novo mesto | G | |
| 2009/11/4 | D10286 | C09DX01 | Amlodipine / valsartan / hydrochlorothiazide | Copalia HCT | Novartis Europharm Ltd. | ||
| Amlodipine besylate / valsartan / hydrochlorothiazide | Dafiro HCT | Novartis Europharm Limited | |||||
| 2009/10/30 | D00523 | C09CA04 | Irbesartan | Irbesartan Teva | Teva B.V. | G | |
| 2009/10/29 | D10846 | B03XA01 | Epoetin theta | Eporatio | ratiopharm GmbH | ||
| 2009/10/23 | D00353 | J05AF05 | Lamivudine | Lamivudine Teva | Teva B.V. | G | |
| 2009/10/23 | D10846 | B03XA01 | Epoetin theta | Biopoin | Teva GmbH | ||
| 2009/10/23 | D09315 | L04AC08 | Canakinumab | Ilaris | Novartis Europharm Ltd | E | BLA |
| 2009/10/19 | J07BB02 | Pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | Foclivia | Novartis Vaccines Influenza Srl | E | ||
| 2009/10/16 | D10286 | C09DX01 | Amlodipine besylate / valsartan / hydrochlorothiazide | Exforge HCT | Novartis Europharm Ltd | ||
| 2009/10/16 | D10841 | M05BB03 | Alendronic acid / colecalciferol | Vantavo (previously Alendronate sodium and colecalciferol, MSD) | Merck Sharp & Dohme Ltd | ||
| 2009/10/16 | D10215 | J07BB01 | Pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture) | Pandemic Influenza Vaccine H5N1 Baxter AG | Nanotherapeutics Bohumil, s.r.o. | E | |
| 2009/10/16 | D10824 | B01AC04 | Clopidogrel besilate | Clopidogrel Apotex (previously Clopidogrel Mylan Pharma) | Apotex Europe B.V. | G | |
| 2009/10/15 | D10152 | A06AX05 | Prucalopride succinate | Resolor | Shire Pharmaceuticals Ireland Ltd | ||
| 2009/10/14 | D00594 | A10BX02 | Repaglinide | Enyglid | Krka, d.d., Novo mesto | G | |
| 2009/10/10 | J07BB02 | Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) | GlaxoSmithKline Biologicals S.A. | E | ||
| 2009/10/5 | M09AX02 | Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins | ChondroCelect | TiGenix N.V. | |||
| 2009/10/1 | D04358 | L04AB06 | Golimumab | Simponi | Janssen Biologics B.V. | BLA | |
| 2009/10/1 | D03441 | L04AB05 | Certolizumab pegol | Cimzia | UCB Pharma SA | BLA | |
| 2009/10/1 | D10262 | A10BH03 | Saxagliptin hydrochloride | Onglyza | AstraZeneca AB | NME | |
| 2009/9/28 | D00769 | B01AC04 | Clopidogrel hydrogen sulphate | Zyllt | Krka, d.d., Novo mesto | G | |
| 2009/9/23 | D10823 | B01AC04 | Clopidogrel hydrochloride | Clopidogrel TAD, Clopidogrel Krka | Tad Pharma GmbH, Krka, d.d., Novo mesto | G | |
| 2009/9/21 | D02229 | G04BE03 | Sildenafil citrate | Vizarsin | Krka, d.d., Novo mesto | G | |
| 2009/9/21 | D08618 | L01CE01 | Topotecan | Topotecan Teva | Teva B.V. | G | |
| 2009/9/21 | D10823 | B01AC04 | Clopidogrel hydrochloride | Clopidogrel Krka d.d. (previously Zopya), Clopidogrel Mylan, Clopidogrel Teva Pharma (previously Clopidogrel HCS) | Krka, d.d., Novo mesto, Mylan S.A.S., Teva B.V. | G | |
| 2009/9/21 | D00769 | B01AC04 | Clopidogrel hydrogen sulphate | Clopidogrel BGR (previously Zylagren) | Biogaran | G | |
| 2009/9/21 | D09032 | L01CA05 | Vinflunine ditartrate | Javlor | Pierre Fabre M_dicament | ||
| 2009/9/21 | D06558 | J01DF01 | Aztreonam lysine | Cayston | Gilead Sciences International Limited | O | |
| 2009/8/3 | D01213 | C03XA01 | Tolvaptan | Samsca | Otsuka Pharmaceutical Europe Ltd. | NME | |
| 2009/8/3 | D02714 | L01EG02 | Everolimus | Afinitor | Novartis Europharm Limited | NME | |
| 2009/7/31 | D08971 | L03AX16 | Plerixafor | Mozobil | Genzyme Europe B.V. | O | NME |
| 2009/7/28 | D07729 | B01AC04 | Clopidogrel | Clopidogrel Acino, Clopidogrel ratiopharm GmbH | Acino AG, Archie Samuel s.r.o. | G | |
| 2009/7/28 | D10824 | B01AC04 | Clopidogrel besilate | Grepid | Pharmathen S.A. | G | |
| 2009/7/28 | D00769 | B01AC04 | Clopidogrel hydrogen sulphate | Clopidogrel Teva (hydrogen sulphate) | Teva Pharma B.V. | G | |
| 2009/7/24 | D06174 | A11HA08 | Tocofersolan | Vedrop | Orphan Europe S.A.R.L. | E | |
| 2009/7/24 | D02168 | L01CE01 | Topotecan hydrochloride | Topotecan Actavis | Actavis Group PTC ehf | G | |
| 2009/7/20 | D01399 | N02AB03 | Fentanyl citrate | Instanyl | Takeda Pharma A/S | ||
| 2009/7/2 | D07603 | N06BC01 | Caffeine citrate | Peyona (previously Nymusa) | Chiesi Farmaceutici SpA | O | |
| 2009/7/1 | D00423 | J05AP01 | Ribavirin | Ribavirin Teva Pharma B.V. | Teva B.V. | G | |
| 2009/6/30 | D06404 | A10BJ02 | Liraglutide | Victoza | Novo Nordisk A/S | NME | |
| 2009/6/29 | D00594 | A10BX02 | Repaglinide | Repaglinide Teva | Teva Pharma B.V. | G | |
| 2009/6/24 | D01977 | L01EB01 | Gefitinib | Iressa | AstraZeneca AB | NME | |
| 2009/6/12 | D02593 | A02BC02 | Pantoprazole (as sodium sesquihydrate) | Pantecta Control, Pantoloc Control, Somac Control, Pantozol Control | Takeda GmbH | ||
| Pantoprazole sodium sesquihydrate | Controloc Control | Takeda GmbH | |||||
| 2009/6/10 | D06642 | V03AE02 | Sevelamer carbonate | Renvela | Genzyme Europe B.V. | ||
| 2009/5/15 | D09687 | G03AD02 | Ulipristal acetate | ellaOne | Laboratoire HRA Pharma | NME | |
| 2009/5/15 | D00250 | N01BX04 | Capsaicin | Qutenza | Astellas Pharma Europe B.V. | NME | |
| 2009/5/15 | D00107 | L04AD02 | Tacrolimus monohydrate | Modigraf | Astellas Pharma Europe B.V. | ||
| 2009/5/11 | D02558 | N06DA03 | Rivastigmine hydrogen tartrate | Nimvastid | Krka, d.d., Novo mesto | G | |
| 2009/4/21 | D09612 | N03AF04 | Eslicarbazepine acetate | Zebinix | BIAL - Portela & Ca, S.A. | NME | |
| 2009/4/20 | D09207 | L01FX03 | Catumaxomab | Removab | Neovii Biotech GmbH | ||
| 2009/4/17 | D03062 | G03XC02 | Bazedoxifene acetate | Conbriza | Pfizer Ltd | NME | |
| 2009/3/31 | D00423 | J05AP01 | Ribavirin | Ribavirin Teva | Teva B.V. | G | |
| 2009/3/31 | D05313 | J07BA02 | Japanese-encephalitis vaccine (inactivated, adsorbed) | Ixiaro | Valneva Austria GmbH | ||
| 2009/3/30 | D10213 | J07AL02 | Pneumococcal polysaccharide conjugate vaccine (adsorbed) | Synflorix | GlaxoSmithKline Biologicals S.A. | ||
| 2009/3/19 | D04430 | G03GA06 | Follitropin beta | Fertavid | Merck Sharp & Dohme Ltd | ||
| 2009/3/6 | D06619 | L03AX15 | Mifamurtide | Mepact | Takeda France SAS | O | |
| 2009/3/4 | J07BB01 | Influenza vaccine (H1N1)v (whole virion, inactivated, prepared in cell culture) | Celvapan | Nanotherapeutics Bohumil, s.r.o. | |||
| 2009/2/24 | J07BB02 | influenza vaccine (split virion, inactivated) | IDflu | Sanofi Pasteur S.A. | |||
| 2009/2/24 | J07BB02 | influenza vaccine (split virion, inactivated) | Intanza | Sanofi Pasteur MSD, SNC | |||
| 2009/2/23 | D05597 | B01AC22 | Prasugrel hydrochloride | Efient | Daiichi Sankyo Europe GmbH | NME | |
| 2009/2/19 | D02578 | N06AX22 | Agomelatine | Valdoxan, Thymanax | Les Laboratoires Servier, Servier (Ireland) Industries Ltd | ||
| 2009/2/17 | D08635 | L02BX02 | Degarelix acetate | Firmagon | Ferring Pharmaceuticals A/S | ||
| 2009/2/6 | D03235 | L03AA02 | Filgrastim | Filgrastim Hexal, Zarzio | Hexal AG, Sandoz GmbH | B | |
| 2009/2/4 | D08990 | B02BX04 | Romiplostim | Nplate | Amgen Europe B.V. | O | BLA |
| 2009/1/16 | D10289 | C09XA52 | Aliskiren hemifumarate / hydrochlorothiazide | Rasilez HCT | Novartis Europharm Limited | ||
| 2009/1/16 | D02596 | L04AC07 | Tocilizumab | RoActemra | Roche Registration Limited | BLA | |
| 2009/1/16 | D09214 | L04AC05 | Ustekinumab | Stelara | Janssen-Cilag International NV | BLA | |
| 2008/12/18 | D00559 | N04BC05 | Pramipexole dihydrochloride monohydrate | Pramipexole Teva | Teva Pharma B.V. | G | |
| 2008/12/17 | D03021 | L01BC07 | Azacitidine | Vidaza | Celgene Europe Limited | O | NME |
| 2008/12/2 | D01798 | A16AX07 | Sapropterin dihydrochloride | Kuvan | BioMarin International Limited | O | NME |
| 2008/12/1 | D00523 | C09CA04 | Irbesartan | Ifirmasta (previously Irbesartan Krka) | Krka, d.d., Novo mesto | G | |
| 2008/12/1 | D10743 | A10BD08 | Vildagliptin / metformin hydrochloride | Icandra (previously Vildagliptin / metformin hydrochloride Novartis), Zomarist | Novartis Europharm Limited | ||
| 2008/11/25 | D10512 | S01ED51 | Brinzolamide / timolol maleate | Azarga | Alcon Laboratories (UK) Ltd | ||
| 2008/11/19 | D07080 | A10BH02 | Vildagliptin | Jalra, Xiliarx | Novartis Europharm Limited | ||
| 2008/11/19 | D06623 | N05AH03 | Olanzapine pamoate monohydrate | Zypadhera | Eli Lilly Nederland B.V. | ||
| 2008/10/7 | D00454 | N05AH03 | Olanzapine | Olanzapine Mylan | Generics [UK] Ltd. | G | |
| 2008/10/7 | D04444 | L03AX14 | Histamine dihydrochloride | Ceplene | Meda AB | O E | |
| 2008/10/6 | B02BC | Human fibrinogen / human thrombin | Evicel | Omrix Biopharmaceuticals S.A. | |||
| 2008/10/1 | D02008 | G04BE08 | Tadalafil | Adcirca (previously Tadalafil Lilly) | Eli Lilly Nederland B.V. | ||
| 2008/9/30 | D07086 | B01AF01 | Rivaroxaban | Xarelto | Bayer Pharma AG | NME | |
| 2008/9/15 | D03235 | L03AA02 | Filgrastim | Biograstim | AbZ-Pharma GmbH | B | |
| 2008/9/15 | D03235 | L03AA02 | Filgrastim | Ratiograstim | Ratiopharm GmbH | B | |
| 2008/9/15 | D03235 | L03AA02 | Filgrastim | Tevagrastim | Teva GmbH | B | BLA |
| 2008/9/12 | D00559 | N04BC05 | Pramipexole dihydrochloride monohydrate | Oprymea | Krka, d.d., Novo mesto | G | |
| 2008/8/29 | D07299 | N03AX18 | Lacosamide | Vimpat | UCB Pharma SA | NME | |
| 2008/8/28 | D04112 | J05AG04 | Etravirine | Intelence | Janssen-Cilag International NV | NME | |
| 2008/7/25 | D05940 | V03AB35 | Sugammadex sodium | Bridion | Merck Sharp & Dohme Limited | NME | |
| 2008/7/16 | D07729 | B01AC04 | Clopidogrel | Clopidogrel Zentiva (previously Clopidogrel Winthrop) | Sanofi-aventis | ||
| 2008/7/16 | D10261 | A10BD07 | Sitagliptin phosphate monohydrate / metformin hydrochloride | Velmetia, Efficib, Janumet | Merck Sharp & Dohme Ltd | ||
| 2008/7/11 | D04492 | B06AC02 | Icatibant acetate | Firazyr | Shire Orphan Therapies GmbH | O | NME |
| 2008/7/9 | D05700 | C01EB18 | Ranolazine | Ranexa (previously Latixa) | Menarini International Operations Luxembourg S.A. (MIOL) | NME | |
| 2008/7/2 | D06618 | A06AH01 | Methylnaltrexone bromide | Relistor | PharmaSwiss Ceska Republika s.r.o | NME | |
| 2008/6/10 | D04024 | L01EH01 | Lapatinib ditosylate monohydrate | Tyverb | Novartis Europharm Limited | NME | |
| 2008/5/20 | D00746 | L03AB08 | Interferon beta-1b | Extavia | Novartis Europharm Ltd | ||
| 2008/5/14 | J07BB02 | Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | Prepandrix | GlaxoSmithKline Biologicals S.A. | |||
| 2008/4/25 | D06458 | J06BA01 | Human normal immunoglobulin (IVIg) | Privigen | CSL Behring GmbH | ||
| 2008/4/25 | D02465 | J02AX05 | Micafungin sodium | Mycamine | Astellas Pharma Europe B.V. | NME | |
| 2008/4/21 | D01206 | M04AA03 | Febuxostat | Adenuric | Menarini International Operations Luxembourg S.A. (MIOL) | NME | |
| 2008/4/21 | D07077 | C02KX02 | Ambrisentan | Volibris | Glaxo Group Ltd | O | NME |
| 2008/4/16 | D00754 | L04AX02 | Thalidomide | Thalidomide Celgene (previously Thalidomide Pharmion) | Celgene Europe Limited | O | |
| 2008/4/4 | D01399 | N02AB03 | Fentanyl citrate | Effentora | Teva B.V. | ||
| 2008/3/18 | D07082 | B01AE07 | Dabigatran etexilate | Pradaxa | Boehringer Ingelheim International GmbH | NME | |
| 2008/2/21 | D00752 | L04AA06 | Mycophenolate mofetil | Mycophenolate mofetil Teva, Myfenax | Teva Pharma B.V., Teva B.V. | G | |
| 2008/1/11 | D06597 | A04AD12 | Fosaprepitant dimeglumine | Ivemend | Merck Sharp & Dohme Ltd | NME | |
| 2008/1/11 | D06315 | R01AD12 | Fluticasone furoate | Avamys | Glaxo Group Limited | ||
| 2008/1/11 | D00491 | L01CD01 | Paclitaxel | Abraxane | Celgene Europe Ltd | ||
| 2008/1/10 | D06645 | A10BH01 | Sitagliptin phosphate monohydrate | Tesavel | Merck Sharp & Dohme Ltd | ||
| 2007/12/20 | D07133 | J05AJ01 | Raltegravir potassium | Isentress | Merck Sharp & Dohme Ltd | NME | |
| 2007/12/18 | D10847 | B03XA01 | Epoetin zeta | Silapo, Retacrit | Stada Arzneimittel AG, Hospira UK Limited | B | |
| 2007/12/13 | D10851 | J05AR06 | Efavirenz, emtricitabine and tenofovir disoproxil | Atripla | Bristol-Myers Squibb and Gilead Sciences Limited | ||
| 2007/12/12 | D00454 | N05AH03 | Olanzapine | Olanzapine Teva | Teva Pharma | G | |
| 2007/12/11 | D09744 | A10BD05 | Pioglitazone hydrochloride / metformin hydrochloride | Glubrava | Takeda Pharma A/S | ||
| 2007/12/11 | D05143 | S01BC10 | Nepafenac | Nevanac | Alcon Laboratories (UK) Ltd | NME | |
| 2007/12/3 | D05350 | L01FE02 | Panitumumab | Vectibix | Amgen Europe B.V. | BLA | |
| 2007/11/23 | D01027 | V03AB33 | Hydroxocobalamin | Cyanokit | SERB SA | ||
| 2007/11/19 | D06413 | L01EA03 | Nilotinib hydrochloride monohydrate | Tasigna | Novartis Europharm Ltd | O | NME |
| 2007/11/19 | D06068 | L01EG01 | Temsirolimus | Torisel | Pfizer Limited | O | NME |
| 2007/11/14 | D10743 | A10BD08 | Vildagliptin / metformin hydrochloride | Eucreas | Novartis Europharm Limited | ||
| 2007/9/27 | D00454 | N05AH03 | Olanzapine | Zalasta | Krka | G | |
| 2007/9/26 | D07080 | A10BH02 | Vildagliptin | Galvus | Novartis Europharm Limited | ||
| 2007/9/20 | D03211 | J02AX06 | Anidulafungin | Ecalta | Pfizer Limited | NME | |
| 2007/9/20 | D10212 | J07BM02 | Human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed) | Cervarix | GlaxoSmithKline Biologicals S.A. | ||
| 2007/9/18 | D06670 | J05AX09 | Maraviroc | Celsentri | ViiV Healthcare UK Limited | NME | |
| 2007/9/17 | D06199 | L01CX01 | Trabectedin | Yondelis | Pharma Mar S.A. | O | NME |
| 2007/9/7 | D02908 | L01XD04 | 5-Aminolevulinic acid hydrochloride | Gliolan | Medac GmbH | O | NME |
| 2007/8/28 | D03231 | B03XA01 | Epoetin alfa | Epoetin Alfa Hexal, Abseamed, Binocrit | Hexal AG, Medice Arzneimittel P_tter GmbH & Co. KG, Sandoz GmbH | B | |
| 2007/8/22 | D05134 | L01BB07 | Nelarabine | Atriance | Novartis Europharm Limited | O E | NME |
| 2007/8/22 | D06412 | C09XA02 | Aliskiren hemifumarate | Rasilez | Novartis Europharm Limited | NME | |
| 2007/8/3 | D03297 | H01AC03 | Mecasermin | Increlex | Ipsen Pharma | O E | NME |
| 2007/7/30 | D10850 | R01BA52 | Desloratadine / pseudoephedrine sulphate | Aerinaze | Merck Sharp & Dohme Ltd. | ||
| 2007/7/23 | D04028 | A08AB01 | Orlistat | Alli (previously Orlistat GSK) | Glaxo Group Limited | ||
| 2007/7/23 | D01646 | V08CA06 | Gadoversetamide | Optimark | Mallinckrodt Deutschland GmbH | NME | |
| 2007/7/23 | D06458 | J06BA01 | Human normal immunoglobulin | Flebogamma DIF (previously Flebogammadif) | Instituto Grifols S.A. | ||
| 2007/7/20 | D09998 | B03XA03 | Methoxy polyethylene glycol / epoetin beta | Mircera | Roche Registration Ltd | BLA | |
| 2007/6/29 | D08170 | N05CH01 | Melatonin | Circadin | RAD Neurim Pharmaceuticals EEC Limited | ||
| 2007/6/29 | D00341 | L01XX05 | Hydroxycarbamide | Siklos | Addmedica | O | |
| 2007/6/25 | D10848 | G03GA30 | Follitropin alfa / lutropin alfa | Pergoveris | Merck Serono Europe Ltd. | ||
| 2007/6/25 | D05339 | N05AX13 | Paliperidone | Invega | Janssen-Cilag International NV | NME | |
| 2007/6/20 | D03940 | L04AJ01 | Eculizumab | Soliris | Alexion Europe SAS | O | BLA |
| 2007/6/14 | D04687 | L04AX04 | Lenalidomide | Revlimid | Celgene Europe Ltd | O | NME |
| 2007/6/1 | J07BB02 | Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | Optaflu | Novartis Influenza Vaccines Marburg GmbH | |||
| 2007/5/24 | D05720 | D06AX13 | Retapamulin | Altargo | Glaxo Group Ltd | NME | |
| 2007/5/21 | D03203 | L04AA24 | Abatacept | Orencia | Bristol-Myers Squibb Pharma EEIG | BLA | |
| 2007/4/24 | D06675 | J05AF11 | Telbivudine | Sebivo | Novartis Europharm Limited | NME | |
| 2007/4/23 | D00107 | L04AD02 | Tacrolimus monohydrate | Advagraf | Astellas Pharma Europe B.V. | ||
| 2007/4/20 | D08923 | G04BD11 | Fesoterodine fumarate | Toviaz | Pfizer Limited | NME | |
| 2007/4/20 | D07866 | L01CD02 | Docetaxel | Docetaxel Winthrop | Aventis Pharma S.A. | ||
| 2007/3/21 | D06645 | A10BH01 | Sitagliptin phosphate monohydrate | Xelevia, Januvia | Merck Sharp & Dohme Ltd | NME | |
| 2007/2/15 | D07523 | A16AA06 | Betaine anhydrous | Cystadane | Orphan Europe S.A.R.L. | O | NME |
| 2007/2/12 | D06478 | J05AE10 | Darunavir ethanolate | Prezista | Janssen-Cilag International NV | NME | |
| 2007/1/22 | D05697 | S01LA04 | Ranibizumab | Lucentis | Novartis Europharm Ltd | BLA | |
| 2007/1/19 | D00523 | C09CA04 | Irbesartan | Irbesartan Zentiva (previously Irbesartan Winthrop) | Sanofi-aventis groupe | ||
| 2007/1/19 | D10249 | C09DA04 | Irbesartan and hydrochlorothiazide | Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) | sanofi-aventis groupe | ||
| 2007/1/17 | D03230 | A10AB01 A10AC01 A10AD01 |
Insulin human | Insulin Human Winthrop | Sanofi-aventis Deutschland GmbH | ||
| 2007/1/17 | D09745 | C09DB01 | Amlodipine (as besylate) / valsartan | Imprida, Exforge | Novartis Europharm Ltd | ||
| 2007/1/16 | D09745 | C09DB01 | Amlodipine (as besylate) / valsartan | Copalia, Dafiro | Novartis Europharm Ltd | ||
| 2007/1/16 | D05775 | N03AF03 | Rufinamide | Inovelon | Eisai Ltd | O | NME |
| 2007/1/8 | D09848 | A10BD06 | Pioglitazone / glimepiride | Tandemact | Takeda Pharma A/S | ||
| 2007/1/8 | D04499 | A16AB09 | Idursulfase | Elaprase | Shire Human Genetic Therapies AB | O E | BLA |
| 2007/1/4 | D05928 | N03AX17 | Stiripentol | Diacomit | Biocodex | O | NME |
| 2007/1/4 | D10841 | M05BB03 | Alendronate sodium trihydrate / colecalciferol | Adrovance | Merck Sharp & Dohme Ltd | ||
| 2006/11/20 | D06414 | L01EA02 | Dasatinib monohydrate | Sprycel | Bristol-Myers Squibb Pharma EEIG | O | NME |
| 2006/11/20 | D04121 | A10BJ01 | Exenatide | Byetta | AstraZeneca AB | NME | |
| 2006/9/26 | D10250 | N07BC51 | Buprenorphine / naloxone | Suboxone | Indivior UK Limited | ||
| 2006/9/26 | D06282 | N07BA03 | Varenicline tartrate | Champix | Pfizer Limited | NME | |
| 2006/9/20 | D01738 | V08DA04 | Perflutren | Luminity | Lantheus MI UK Ltd. | ||
| 2006/9/20 | D10192 | J07BM01 | Human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed) | Silgard, Gardasil | Merck Sharp & Dohme Ltd, Sanofi Pasteur MSD, SNC | ||
| 2006/8/28 | D03669 | V03AC03 | Deferasirox | Exjade | Novartis Europharm Limited | NME | |
| 2006/7/28 | D09744 | A10BD05 | Pioglitazone / metformin hydrochloride | Competact | Takeda Pharma A/S | ||
| 2006/7/28 | D07807 | V03AF02 | Dexrazoxane hydrochloride | Savene | Clinigen Healthcare Ltd | ||
| 2006/7/28 | D08858 | B01AB02 | Antithrombin alfa | ATryn | GTC Biotherapeutics UK Limited | E | |
| 2006/7/19 | D06272 | L01EX02 | Sorafenib tosilate | Nexavar | Bayer Pharma AG | O | NME |
| 2006/7/19 | D06402 | L01EX01 | Sunitinib malate | Sutent | Pfizer Limited | NME | |
| 2006/6/27 | D06886 | L04AG03 | Natalizumab | Tysabri | Biogen Idec Limited | BLA | |
| 2006/6/27 | D10211 | J07BH02 | Rotavirus vaccine, live | RotaTeq | Sanofi Pasteur MSD SNC | ||
| 2006/6/26 | D04008 | J05AF10 | Entecavir monohydrate | Baraclude | Bristol-Myers Squibb Pharma EEIG | NME | |
| 2006/5/29 | D03546 | L01BB06 | Clofarabine | Evoltra | Genzyme Europe B.V. | E | NME |
| 2006/5/19 | D10840 | S01ED51 | Bimatoprost / timolol maleate | Ganfort | Allergan Pharmaceuticals Ireland | ||
| 2006/5/19 | J07BK02 | Zoster vaccine (live) | Zostavax | Sanofi Pasteur MSD, SNC | |||
| 2006/5/5 | J07BD52 | Measles, mumps and rubella vaccine (live) | M-M-RVAXPRO | Sanofi Pasteur MSD SNC | |||
| 2006/4/24 | D01079 | J01AA12 | Tigecycline | Tygacil | Pfizer Ltd. | NME | |
| 2006/4/24 | D09815 | S01ED51 | Travoprost / timolol maleate | DuoTrav | Alcon Laboratories (UK) Ltd | ||
| 2006/4/12 | D02691 | H01AC01 | Somatropin | Omnitrope | Sandoz GmbH | B | |
| 2006/4/6 | J07BD | Measles, mumps, rubella and varicella vaccine (live) | ProQuad | Sanofi Pasteur MSD, SNC | |||
| 2006/3/29 | D03207 | A16AB07 | Alglucosidase alfa | Myozyme | Genzyme Europe B.V. | BLA | |
| 2006/2/21 | D10193 | J07BH01 | Rotavirus vaccine, live, attenuated | Rotarix | GlaxoSmithKline Biologicals S.A. | ||
| 2006/2/15 | D05768 | N04BC09 | Rotigotine | Neupro | UCB Manufacturing Ireland Ltd | NME | |
| 2006/1/31 | D05386 | S01LA03 | Pegaptanib sodium | Macugen | PharmaSwiss Ceska Republika s.r.o | NME | |
| 2006/1/24 | D06565 | A16AB08 | Galsulfase | Naglazyme | BioMarin Europe Ltd. | E | BLA |
| 2006/1/19 | V09 | Yttrium [90Y] chloride | Yttriga | Eckert & Ziegler Radiopharma GmbH | |||
| 2006/1/19 | D01080 | J01XX09 | Daptomycin | Cubicin | Merck Sharp & Dohme Ltd | NME | |
| 2006/1/19 | D06458 | J06BA01 | Human normal immunoglobulin | Kiovig | Baxter AG | ||
| 2005/10/28 | D02229 | G04BE03 | Sildenafil citrate | Revatio | Pfizer Limited | ||
| 2005/10/25 | D08095 | C01EB17 | Ivabradine hydrochloride | Corlentor, Procoralan | Les Laboratoires Servier | NME | |
| 2005/10/25 | D08605 | J05AE09 | Tipranavir | Aptivus | Boehringer Ingelheim International GmbH | NME | |
| 2005/10/25 | D05251 | R03DX05 | Omalizumab | Xolair | Novartis Europharm Ltd | ||
| 2005/10/25 | D02555 | J02AC04 | Posaconazole | Noxafil | Merck Sharp & Dohme Ltd | NME | |
| 2005/10/13 | D05866 | N07XX04 | Sodium oxybate | Xyrem | UCB Pharma Ltd | NME | |
| 2005/9/19 | D04023 | L01EB02 | Erlotinib hydrochloride | Tarceva | Roche Registration Limited | NME | |
| 2005/8/24 | D10841 | M05BB03 | Alendronic acid / colecalciferol | Fosavance | Merck Sharp & Dohme Ltd | ||
| 2005/4/15 | D08689 | M05BA08 | Zoledronic acid monohydrate | Aclasta | Novartis Europharm Limited | ||
| 2005/3/22 | D05343 | A04AA05 | Palonosetron hydrochloride | Aloxi | Helsinn Birex Pharmaceuticals Ltd. | NME | |
| 2005/3/10 | D00538 | N03AX15 | Zonisamide | Zonegran | Eisai Ltd | NME | |
| 2005/2/21 | D02297 | J05AR03 | Emtricitabine / tenofovir disoproxil fumarate | Truvada | Gilead Sciences International Limited | ||
| 2005/2/21 | D05177 | A16AX04 | Nitisinone | Orfadin | Swedish Orphan Biovitrum International AB | NME | |
| 2005/2/21 | D08686 | N02BG08 | Ziconotide acetate | Prialt | Eisai Ltd | NME | |
| 2005/2/21 | D02562 | N04BD02 | Rasagiline mesilate | Azilect | Teva Pharma GmbH | NME | |
| 2005/2/2 | D06475 | J07BC01 | Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed) | Fendrix | GlaxoSmithKline Biologicals S.A. | ||
| 2005/1/12 | D06409 | L01FG01 | Bevacizumab | Avastin | Roche Registration Limited | BLA | |
| 2004/12/17 | D08775 | J05AR02 | Abacavir sulfate / lamivudine | Kivexa | ViiV Healthcare UK Limited | ||
| 2004/12/17 | D01179 | N06AX21 | Duloxetine hydrochloride | Cymbalta, Xeristar | Eli Lilly Nederland B.V. | NME | |
| 2004/11/16 | D02933 | L01XX35 | Anagrelide hydrochloride | Xagrid | Shire Pharmaceutical Contracts Limited | O E | |
| 2004/10/22 | D03505 | H05BX01 | Cinacalcet hydrochloride | Mimpara | Amgen Europe B.V. | NME | |
| 2004/10/22 | D01699 | G04BD10 | Darifenacin hydrobromide | Emselex | Merus Labs Luxco S._ R.L. | NME | |
| 2004/10/13 | D06408 | A16AX05 | Zinc acetate dihydrate | Wilzin | Orphan Europe S.A.R.L. | ||
| 2004/9/27 | D04540 | A10AB06 | Insulin glulisine | Apidra | sanofi-aventis Deutschland GmbH | NME | |
| 2004/9/21 | D08468 | M05BX03 | Strontium ranelate | Osseor, Protelos | Les Laboratoires Servier | ||
| 2004/9/20 | D06503 | L01BA04 | Pemetrexed disodium | Alimta | Eli Lilly Nederland B.V. | NME | |
| 2004/9/20 | D03136 | B01AE06 | Bivalirudin | Angiox | The Medicines Company UK Ltd | NME | |
| 2004/8/11 | D01179 | N06AX21 | Duloxetine hydrochloride | Ariclaim, Yentreve | Eli Lilly Nederland B.V. | ||
| 2004/7/29 | D00126 | C01EB16 | Ibuprofen | Pedea | Orphan Europe S.A.R.L. | ||
| 2004/7/12 | D03835 | J05AE07 | Fosamprenavir calcium | Telzir | ViiV Healthcare UK Limited | ||
| 2004/7/6 | D02716 | N02BF02 | Pregabalin | Lyrica | Pfizer Limited | NME | |
| 2004/6/29 | D03455 | L01FE01 | Cetuximab | Erbitux | Merck KGaA | BLA | |
| 2004/6/15 | D00465 | G04BD04 | Oxybutynin | Kentera (previously Oxybutynin Nicobrand) | Nicobrand Ltd. | ||
| 2004/6/8 | B02BC | Human fibrinogen / human thrombin | TachoSil | Takeda Austria GmbH | |||
| 2004/6/4 | D01164 | N05AX12 | Aripiprazole | Abilify | Otsuka Pharmaceutical Europe Ltd | NME | |
| 2004/6/1 | D04539 | A10AE05 | Insulin detemir | Levemir | Novo Nordisk A/S | NME | |
| 2004/4/28 | D00420 | L01XX23 | Mitotane | Lysodren | Laboratoire HRA Pharma | ||
| 2004/4/28 | D03530 | J07AE01 | Cholera vaccine (inactivated, oral) | Dukoral | Valneva Sweden AB | ||
| 2004/4/26 | D03150 | L01XG01 | Bortezomib | Velcade | Janssen-Cilag International NV | NME | |
| 2004/4/14 | D01370 | L01BB04 | Cladribine | Litak | Lipomed GmbH | ||
| 2004/3/10 | D01161 | L02BA03 | Fulvestrant | Faslodex | AstraZeneca UK Ltd | NME | |
| 2004/3/10 | D03582 | C10AC04 | Colesevelam hydrochloride | Cholestagel | Genzyme Europe B.V. | NME | |
| 2004/3/2 | D05401 | B02BD02 | Octocog alfa | Advate | Baxter AG | ||
| 2004/3/2 | D01276 | J05AE08 | Atazanavir sulphate | Reyataz | Bristol-Myers Squibb Pharma EEIG | NME | |
| 2004/2/23 | D04486 | M05BA06 | Ibandronic acid sodium monohydrate | Bonviva | Roche Registration Ltd. | ||
| 2004/1/16 | D04489 | V10XX02 | Ibritumomab tiuxetan | Zevalin | Spectrum Pharmaceuticals B.V. | ||
| 2003/11/11 | D02968 | A04AD12 | Aprepitant | Emend | Merck Sharp & Dohme Ltd. | NME | |
| 2003/10/24 | D01199 | J05AF09 | Emtricitabine | Emtriva | Gilead Sciences International Ltd. | NME | |
| 2003/10/17 | D10293 | N04BA03 | Levodopa / carbidopa / entacapone | Stalevo | Orion Corporation | ||
| 2003/9/16 | D02721 | B01AC11 | Iloprost trometamol | Ventavis | Bayer Schering Pharma AG | NME | |
| 2003/9/8 | D02597 | L04AB04 | Adalimumab | Humira | AbbVie Ltd | ||
| 2003/7/9 | D00248 | L01AB01 | Busulfan | Busilvex | Pierre Fabre M_dicament | ||
| 2003/6/10 | D06078 | H05AA02 | Teriparatide | Forsteo | Eli Lilly Nederland B.V. | ||
| 2003/6/10 | D04670 | A16AB05 | Laronidase | Aldurazyme | Genzyme Europe B.V. | ||
| 2003/5/27 | D02499 | J05AX07 | Enfuvirtide | Fuzeon | Roche Registration Limited | NME | |
| 2003/3/24 | V09 | Yttrium [90Y] chloride | Ytracis | CIS bio international | |||
| 2003/3/6 | D09989 | G04BE09 | Vardenafil hydrochloride | Levitra | Bayer Pharma AG | ||
| 2003/3/6 | D01655 | J05AF08 | Adefovir dipivoxil | Hepsera | Gilead Sciences International Limited | NME | |
| 2003/3/4 | D03260 | G04BE09 | Vardenafil hydrochloride trihydrate | Vivanza | Bayer Pharma AG | NME | |
| 2003/1/24 | D07130 | A16AA05 | Carglumic acid | Carbaglu | Orphan Europe S.A.R.L. | O | NME |
| 2002/11/20 | D05032 | A16AX06 | Miglustat | Zavesca | Actelion Ltd | O | NME |
| 2002/11/13 | D05394 | H01AX01 | Pegvisomant | Somavert | Pfizer Limited | NME | |
| 2002/11/12 | D02008 | G04BE08 | Tadalafil | Cialis | Eli Lilly Nederland B.V. | NME | |
| 2002/10/7 | D03230 | A10AD01 | Insulin human (rDNA) | Actraphane, Actrapid | Novo Nordisk A/S | ||
| 2002/10/7 | D03230 | A10AC01 | insulin human (rDNA) | Insulatard, Protaphane | Novo Nordisk A/S | ||
| 2002/10/7 | D03230 | A10AD01 | insulin human (rDNA) | Mixtard | Novo Nordisk A/S | ||
| 2002/8/30 | J07BC20 | Hepatitis-A (inactivated) and hepatitis-B (rDNA) (HAB) vaccine (adsorbed) | Ambirix | GlaxoSmithKline Biologicals S.A. | |||
| 2002/8/22 | D06889 | L03AA13 | Pegfilgrastim | Neulasta | Amgen Europe B.V. | ||
| 2002/8/22 | D10839 | G03AA13 | Norelgestromin / ethinyl estradiol | Evra | Janssen-Cilag International NV | ||
| 2002/6/20 | D00900 | J05AH02 | Oseltamivir phosphate | Tamiflu | Roche Registration Ltd. | NME | |
| 2002/6/20 | D02747 | L03AB11 | Peginterferon alfa-2a | Pegasys | Roche Registration Limited | ||
| 2002/5/17 | D01192 | S01GX09 | Olopatadine hydrochloride | Opatanol | Alcon Laboratories (UK) Ltd | NME | |
| 2002/5/17 | D04905 | N06DX01 | Memantine hydrochloride | Axura | Merz Pharmaceuticals GmbH | ||
| 2002/5/15 | D01227 | C02KX01 | Bosentan monohydrate | Tracleer | Actelion Registration Ltd | NME | |
| 2002/5/15 | D04905 | N06DX01 | Memantine hydrochloride | Ebixa | H. Lundbeck A/S | NME | |
| 2002/4/22 | D09219 | C09DA07 | Telmisartan / hydrochlorothiazide | PritorPlus | Bayer Pharma AG | ||
| 2002/4/19 | D09219 | C09DA07 | Telmisartan / hydrochlorothiazide | Kinzalkomb, MicardisPlus | Bayer Pharma AG, Boehringer Ingelheim International GmbH | ||
| 2002/4/18 | D04909 | A11GB01 | Ertapenem sodium | Invanz | Merck Sharp & Dohme Ltd | NME | |
| 2002/3/22 | D03717 | M01AH04 | Parecoxib sodium | Dynastat | Pfizer Limited | ||
| 2002/3/21 | D01844 | B01AX05 | Fondaparinux sodium | Arixtra | Aspen Pharma Trading Limited | NME | |
| 2002/3/19 | D00578 | J02AC03 | Voriconazole | Vfend | Pfizer Limited | NME | |
| 2002/3/8 | D02724 | S01EE03 | Bimatoprost | Lumigan | Allergan Pharmaceuticals Ireland | NME | |
| 2002/3/8 | D02934 | L04AC03 | Anakinra | Kineret | Swedish Orphan Biovitrum AB (publ) | ||
| 2002/3/5 | D02106 | L01XX27 | Arsenic trioxide | Trisenox | Teva B.V. | NME | |
| 2002/2/28 | D00107 | D11AH01 | Tacrolimus monohydrate | Protopic | LEO Pharma A/S | ||
| 2002/2/5 | D01982 | J05AF07 | Tenofovir disoproxil fumarate | Viread | Gilead Sciences International Limited | NME | |
| 2001/11/27 | D01964 | S01EE04 | Travoprost | Travatan | Alcon Laboratories (UK) Ltd | NME | |
| 2001/11/7 | D01441 | L01EA01 | Imatinib mesilate | Glivec | Novartis Europharm Ltd | NME | |
| 2001/10/24 | D06066 | L01XD05 | Temoporfin | Foscan | Biolitec Pharma Ltd | ||
| 2001/10/24 | D02501 | J02AX04 | Caspofungin acetate | Cancidas (previously Caspofungin MSD) | Merck Sharp & Dohme Ltd | NME | |
| 2001/8/3 | D02784 | A16AB03 | Agalsidase alfa | Replagal | Shire Human Genetic Therapies AB | ||
| 2001/8/3 | D03228 | A16AB04 | Agalsidase beta | Fabrazyme | Genzyme Europe B.V. | ||
| 2001/8/1 | D04477 | A10AC04 | Insulin lispro | Liprolog | Eli Lilly Nederland B.V. | ||
| 2001/8/1 | D00074 | R07AX01 | Nitric oxide | INOmax | Linde Healthcare AB | NME | |
| 2001/7/16 | D08796 | B01AD12 | Human protein C | Ceprotin | Baxter AG | ||
| 2001/7/11 | D00168 | L01BC01 | Cytarabine | DepoCyte | Pacira Limited | ||
| 2001/7/9 | D01078 | J01FA15 | Telithromycin | Ketek | Aventis Pharma S.A. | NME | |
| 2001/7/3 | D08797 | B02BD04 | Human coagulation factor IX | Nonafact | Sanquin Plasma Products B.V. | ||
| 2001/6/8 | D03651 | B03XA02 | Darbepoetin alfa | Aranesp | Amgen Europe B.V. | ||
| 2001/4/27 | D04432 | J07BC01 | Hepatitis-B vaccine (rDNA) | HBVaxPro | Sanofi Pasteur MSD SNC | ||
| 2001/4/3 | D01111 | A10BX03 | Nateglinide | Starlix | Novartis Europharm Ltd | NME | |
| 2001/3/29 | D03106 | L01XF03 | Bexarotene | Targretin | Eisai Ltd | NME | |
| 2001/3/26 | D05962 | V08DA05 | Sulphur hexafluoride | SonoVue | Bracco International B.V. | ||
| 2001/3/20 | D00829 | D11AX16 | Eflornithine hydrochloride monohydrate | Vaniqa | Almirall, S.A. | ||
| 2001/3/20 | D01968 | M05BA08 | Zoledronic acid / zoledronic acid monohydrate | Zometa | Novartis Europharm Limited | NME | |
| 2001/3/20 | D02498 | J05AR10 | Lopinavir / ritonavir | Kaletra | AbbVie Ltd | NME | |
| 2001/3/13 | D00753 | L04AH01 | Sirolimus | Rapamune | Pfizer Limited | NME | |
| 2001/2/23 | D06070 | B01AD11 | Tenecteplase | Metalyse | Boehringer Ingelheim International GmbH | ||
| 2001/2/23 | D05704 | V03AF07 | Rasburicase | Fasturtec | Sanofi-aventis groupe | ||
| 2001/2/16 | D02691 | H01AC01 | Somatropin | NutropinAq | Ipsen Pharma | ||
| 2001/2/2 | D03478 | G03GA08 | Choriogonadotropin alfa | Ovitrelle | Merck Serono Europe Limited | ||
| 2001/2/2 | D10213 | J07AL02 | Pneumococcal saccharide conjugated vaccine, adsorbed | Prevenar | Pfizer Limited | ||
| 2001/2/2 | D01223 | L01BC06 | Capecitabine | Xeloda | Roche Registration Limited | ||
| 2001/1/29 | D00594 | A10BX02 | Repaglinide | Prandin | Novo Nordisk A/S | ||
| 2001/1/22 | D02735 | M03AX01 | Botulinum toxin type B | NeuroBloc | Eisai Ltd. | ||
| 2001/1/15 | D03693 | R06AX27 | Desloratadine | Neoclarityn, Aerius, Azomyr | Merck Sharp & Dohme Ltd | NME | |
| 2000/12/28 | D10838 | J05AR04 | Abacavir (as sulfate) / lamivudine / zidovudine | Trizivir | ViiV Healthcare UK Limited | ||
| 2000/11/29 | D04824 | G03GA07 | Lutropin alfa | Luveris | Merck Serono Europe Ltd. | ||
| 2000/10/23 | J07CA09 | Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed) | Infanrix Hexa | GlaxoSmithKline Biologicals S.A. | |||
| 2000/10/13 | D00945 | A10BG03 | Pioglitazone hydrochloride | Actos | Takeda Pharma A/S | NME | |
| 2000/10/11 | D00945 | A10BG03 | Pioglitazone hydrochloride | Glustin | Takeda Pharma A/S | ||
| 2000/10/11 | D02815 | L01XF02 | Alitretinoin | Panretin | Eisai Ltd | NME | |
| 2000/9/29 | D00709 | N03AX14 | Levetiracetam | Keppra | UCB Pharma SA | NME | |
| 2000/8/28 | D03257 | L01FD01 | Trastuzumab | Herceptin | Roche Registration Limited | ||
| 2000/8/4 | D05401 | B02BD02 | Octocog alfa | Helixate NexGen, Kogenate Bayer | Bayer Pharma AG | ||
| 2000/8/1 | D04475 | A10AD05 | Insulin aspart | NovoMix | Novo Nordisk A/S | ||
| 2000/7/27 | D10014 | V09AB03 | Ioflupane (123l) | DaTSCAN | GE Healthcare Limited | NME | |
| 2000/7/27 | D01162 | S01LA01 | Verteporfin | Visudyne | Novartis Europharm Limited | NME | |
| 2000/7/13 | D01275 | L01DB01 | Doxorubicin hydrochloride | Myocet | Teva B.V. | ||
| 2000/6/27 | D03250 | A10AE04 | Insulin glargine | Toujeo (previously Optisulin) | sanofi-aventis Deutschland GmbH | ||
| 2000/6/9 | D03250 | A10AE04 | Insulin glargine | Lantus | sanofi-aventis Deutschland GmbH | NME | |
| 2000/5/29 | D02748 | L03AB10 | Peginterferon alfa-2b | ViraferonPeg | Merck Sharp & Dohme Ltd | ||
| 2000/5/25 | D02748 | L03AB10 | Peginterferon alfa-2b | PegIntron | Merck Sharp & Dohme Limited | ||
| 2000/5/17 | D08010 | H01CC01 | Ganirelix | Orgalutran | Merck Sharp & Dohme Limited | ||
| 2000/3/9 | D00652 | S01EC04 | Brinzolamide | Azopt | Alcon Laboratories (UK) Ltd. | ||
| 2000/3/9 | D02745 | L03AB05 | Interferon alfa-2b | IntronA | Merck Sharp & Dohme Limited | ||
| 2000/3/9 | D06120 | H01AB01 | Thyrotropin alfa | Thyrogen | Genzyme Europe B.V. | ||
| 2000/2/3 | D00454 | N05AH03 | Olanzapine | Zyprexa Velotab | Eli Lilly Nederland B.V. | ||
| 2000/2/3 | D00742 | L04AB01 | Etanercept | Enbrel | Pfizer Limited | ||
| 2000/1/28 | D01983 | V03AE02 | Sevelamer hydrochloride | Renagel | Genzyme Europe B.V. | ||
| 2000/1/20 | D07475 | G02CX01 | Atosiban acetate | Tractocile | Ferring Pharmaceuticals A/S | ||
| 1999/12/8 | D05868 | A16AX03 | Sodium phenylbutyrate | Ammonaps | Swedish Orphan Biovitrum International AB | ||
| 1999/9/7 | D04475 | A10AB05 | Insulin aspart | NovoRapid | Novo Nordisk A/S | NME | |
| 1999/9/2 | D00749 | L04AK01 | Leflunomide | Arava | Sanofi-Aventis Deutschland GmbH | ||
| 1999/8/25 | D07416 | V03AC02 | Deferiprone | Ferriprox | Apotex Europe BV | NME | |
| 1999/8/13 | D02737 | J06BD01 | Palivizumab | Synagis | AbbVie Ltd | ||
| 1999/8/13 | D02598 | L04AB02 | Infliximab | Remicade | Janssen Biologics B.V. | ||
| 1999/7/29 | D00353 | J05AF05 | Lamivudine | Zeffix | Glaxo Group Ltd | ||
| 1999/7/8 | D00891 | J05AF06 | Abacavir sulfate | Ziagen | ViiV Healthcare UK Limited | ||
| 1999/7/1 | D06888 | B01AC16 | Eptifibatide | Integrilin | Glaxo Group Ltd | ||
| 1999/5/28 | D00896 | J05AG03 | Efavirenz | Sustiva, Stocrin | Bristol-Myers Squibb Pharma EEIG, Merck Sharp & Dohme Ltd. | ||
| 1999/5/7 | D00423 | J05AP01 | Ribavirin | Rebetol | Merck Sharp & Dohme Limited | NME | |
| 1999/4/13 | D08562 | L03AX11 | Tasonermin | Beromun | Boehringer Ingelheim International GmbH | ||
| 1999/4/13 | D01685 | H01CC02 | Cetrorelix acetate | Cetrotide | Merck Serono Europe Ltd. | NME | |
| 1999/4/13 | D08232 | B02BD02 | Moroctocog alfa | ReFacto AF | Pfizer Ltd | ||
| 1999/1/27 | D02249 | S01GX06 | Emedastine difumarate | Emadine | Alcon Laboratories (UK) Ltd. | ||
| 1999/1/26 | D06067 | L01AX03 | Temozolomide | Temodal | Merck Sharp & Dohme Ltd. | NME | |
| 1998/12/16 | D00627 | C09CA07 | Telmisartan | Micardis, Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG) | Boehringer Ingelheim International GmbH, Bayer Pharma AG | ||
| 1998/12/11 | D00627 | C09CA07 | Telmisartan | Pritor | Bayer Pharma AG | ||
| 1998/12/4 | D03822 | N06DA03 | Rivastigmine | Prometax | Novartis Europharm Limited | ||
| 1998/10/16 | D10249 | C09DA04 | Irbesartan and hydrochlorothiazide | Karvezide | Sanofi-aventis groupe | ||
| 1998/10/15 | D10249 | C09DA04 | Irbesartan and hydrochlorothiazide | CoAprovel | Sanofi Clir SNC | ||
| 1998/10/9 | D03058 | L04AC02 | Basiliximab | Simulect | Novartis Europharm Limited | ||
| 1998/9/22 | D00781 | N04BX02 | Entacapone | Comtan | Novartis Europharm Limited | NME | |
| 1998/9/18 | D02500 | D06BB10 | Imiquimod | Aldara | Meda AB | ||
| 1998/9/16 | D00781 | N04BX02 | Entacapone | Comtess | Orion Corporation | ||
| 1998/9/14 | D02229 | G04BE03 | Sildenafil citrate | Viagra | Pfizer Limited | ||
| 1998/8/17 | D00594 | A10BX02 | Repaglinide | NovoNorm | Novo Nordisk A/S | NME | |
| 1998/8/5 | D02217 | G03XC01 | Raloxifene hydrochloride | Evista, Optruma | Daiichi Sankyo Europe GmbH, Eli Lilly Nederland B.V. | ||
| 1998/7/29 | D04028 | A08AB01 | Orlistat | Xenical | Roche Registration Ltd. | NME | |
| 1998/7/15 | D00769 | B01AC04 | Clopidogrel hydrogen sulfate | Iscover, Plavix | Sanofi-aventis groupe, Sanofi Clir SNC | ||
| 1998/6/2 | D02994 | L01FA01 | Rituximab | MabThera | Roche Registration Ltd | NME | |
| 1998/5/18 | D01738 | V08DA01 | Perflutren | Optison | GE Healthcare AS | NME | |
| 1998/5/12 | D02558 | N06DA03 | Rivastigmine | Exelon | Novartis Europharm Ltd | NME | |
| 1998/5/7 | D01749 | V04CX05 | 13C-Urea | Pylobactell | Torbet Laboratories Limited | ||
| 1998/5/4 | D04554 | L03AB07 | Interferon beta-1a | Rebif | Merck Serono Europe Ltd | ||
| 1998/3/18 | D07507 | J05AR01 | Lamivudine / zidovudine | Combivir | ViiV Healthcare UK Limited | ||
| 1998/2/23 | D00559 | N04BC05 | Pramipexole dihydrochloride monohydrate | Mirapexin | Boehringer Ingelheim International GmbH | ||
| 1998/2/5 | D05795 | V10BX02 | Samarium [153Sm] lexidronam pentasodium | Quadramet | CIS bio international | ||
| 1998/2/5 | D00435 | J05AG01 | Nevirapine | Viramune | Boehringer Ingelheim International GmbH | ||
| 1997/11/17 | D03020 | A16AB02 | Imiglucerase | Cerezyme | Genzyme Europe B.V. | ||
| 1997/10/14 | D00559 | N04BC05 | Pramipexole dihydrochloride monohydrate | Sifrol | Boehringer Ingelheim International GmbH | ||
| 1997/8/27 | D00786 | N04BX01 | Tolcapone | Tasmar | Meda AB | ||
| 1997/8/27 | D05201 | B02BD04 | Nonacog alfa | BeneFIX | Pfizer Ltd | ||
| 1997/8/27 | D00523 | C09CA04 | Irbesartan | Karvea, Aprovel | Sanofi-aventis groupe, Sanofi Clir SNC | ||
| 1997/8/14 | D01749 | V04CX05 | 13C-urea | Helicobacter Test INFAI | INFAI, Institut f_r biomedizinische Analytik & NMR-Imaging GmbH | ||
| 1997/7/16 | D03232 | B03XA01 | Epoetin beta | NeoRecormon | Roche Registration Limited | ||
| 1997/6/23 | D10468 | A16AA04 | Mercaptamine bitartrate | Cystagon | Orphan Europe S.A.R.L. | NME | |
| 1997/3/13 | D04554 | L03AB07 | Interferon beta-1a | Avonex | Biogen Idec Ltd | ||
| 1997/2/21 | D03230 | A10AB01 A10AC01 A10AD01 |
Insulin human | Insuman | Sanofi-aventis Deutschland GmbH | ||
| 1997/2/14 | D05944 | V04D | Sulesomab | LeukoScan | Immunomedics GmbH | ||
| 1997/2/10 | J07BC20 | Hepatitis-A (inactivated) and hepatitis-B (rDNA) (HAB) vaccine (adsorbed) | Twinrix Paediatric | GlaxoSmithKline Biologicals S.A. | |||
| 1996/11/12 | D02168 | L01CE01 | Topotecan hydrochloride | Hycamtin | Novartis Europharm Limited | ||
| 1996/10/4 | D01160 | J05AE01 | Saquinavir mesilate | Invirase | Roche Registration Limited | ||
| 1996/10/4 | D00897 | J05AE02 | Indinavir sulphate | Crixivan | Merck Sharp & Dohme Ltd | ||
| 1996/9/27 | D00454 | N05AH03 | Olanzapine | Zyprexa | Eli Lilly Nederland B.V. | ||
| 1996/9/20 | J07BC20 | HepatitisA (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) | Twinrix Adult | GlaxoSmithKline Biologicals S.A. | |||
| 1996/8/29 | D05721 | B01AD07 | Reteplase | Rapilysin | Actavis Group PTC ehf | ||
| 1996/8/26 | D00427 | J05AE03 | Ritonavir | Norvir | AbbVie Ltd | ||
| 1996/8/8 | D00353 | J05AF05 | Lamivudine | Epivir | ViiV Healthcare UK Limited | ||
| 1996/6/25 | D04486 | M05BA06 | Ibandronic acid sodium monohydrate | Bondronat | Roche Registration Ltd. | NME | |
| 1996/6/21 | D01275 | L01DB01 | Doxorubicin hydrochloride | Caelyx | Janssen-Cilag International N.V. | ||
| 1996/6/10 | D00775 | N07XX02 | Riluzole | Rilutek | Aventis Pharma S.A. | ||
| 1996/5/8 | D00445 | J05AF04 | Stavudine | Zerit | Bristol-Myers Squibb Pharma EEIG | ||
| 1996/5/3 | D04430 | G03GA06 | Follitropin beta | Puregon | Merck Sharp & Dohme Limited | ||
| 1996/4/30 | D04477 | A10AC04 | Insulin lispro | Humalog | Eli Lilly Nederland B.V. | ||
| 1996/2/23 | D00172 | B02BD08 | Eptacog alfa (activated) | NovoSeven | Novo Nordisk A/S | ||
| 1996/2/14 | D00967 | L02BA02 | Toremifene citrate | Fareston | Orion Corporation | ||
| 1996/2/14 | D00752 | L04AA06 | Mycophenolate mofetil | CellCept | Roche Registration Ltd. | ||
| 1995/11/30 | D00746 | L03AB08 | Interferon beta-1b | Betaferon | Bayer Pharma AG | ||
| 1995/11/27 | D02165 | L01CD02 | Docetaxel trihydrate | Taxotere | Aventis Pharma S.A. | ||
| 1995/10/20 | D04429 | G03GA05 | Follitropin alfa | GONAL-f | Merck Serono Europe Ltd. | ||
| Date | KEGG | ATC | Common name | Drug name | Company | |
| 2024/7/24 | D12908 | (B02BD17) | Fidanacogene elaparvovec | Beqvez (previously Durveqtix) | Pfizer Europe MA EEIG | A C P |
| 2023/2/20 | D12500 | B02BD16 | Etranacogene dezaparvovec | Hemgenix | CSL Behring GmbH | O C |
| 2022/8/24 | D12434 | B02BD15 | Valoctocogene roxaparvovec | Roctavian | BioMarin International Limited | O C |
| 2022/7/18 | D12407 | A16AB26 | Eladocagene exuparvovec | Upstaza | PTC Therapeutics International Limited | O E |
| 2022/4/4 | D11990 | L01XL08 | Lisocabtagene maraleucel | Breyanzi | Bristol-Myers Squibb Pharma EEIG | |
| 2021/8/18 | D11556 | L01XL07 | Idecabtagene vicleucel | Abecma | Celgene Europe BV | O C |
| 2021/7/16 | D12150 | A16AX21 | Elivaldogene autotemcel | Skysona | Bluebird bio (Netherlands) B.V. | O |
| 2020/12/17 | N07 | Autologous CD34+ cells encoding ARSA gene | Libmeldy | Orchard Therapeutics (Netherlands) BV | O | |
| 2020/12/14 | D11880 | L01XL06 | Brexucabtagene autoleucel | Tecartus | Kite Pharma EU B.V. | O |
| 2019/5/29 | B06A | Autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene | Zynteglo | bluebird bio (Netherlands) B.V. | O | |
| 2018/11/22 | D11008 | S01XA27 | Voretigene neparvovec | Luxturna | Novartis Europharm Limited | |
| 2018/8/23 | D11144 | L01XL03 | Axicabtagene ciloleucel | Yescarta | Kite Pharma EU B.V. | |
| 2018/8/22 | D11386 | L01XL04 | Tisagenlecleucel | Kymriah | Novartis Europharm Limited | |
| 2018/3/23 | D11397 | L04AX08 | Darvadstrocel | Alofisel | Tigenix, S.A.U. | |
| 2017/7/10 | M09AX02 | Spheroids of human autologous matrix-associated chondrocytes | Spherox | CO.DON AG | ||
| 2016/8/18 | L01 | Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2) | Zalmoxis | MolMed SpA | ||
| 2016/5/26 | L03 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence | Strimvelis | GlaxoSmithKline Trading Services Limited | ||
| 2015/12/16 | D09966 | L01XL02 | Talimogene laherparepvec | Imlygic | Amgen Europe B.V. | |
| 2015/2/17 | S01XA19 | Ex vivo expanded autologous human corneal epithelial cells containing stem cells | Holoclar | Chiesi Farmaceutici S.p.A. | ||
| 2009/10/5 | M09AX02 | Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins | ChondroCelect (withdrawn) | TiGenix N.V. |